<SEC-DOCUMENT>0001477932-25-008717.txt : 20251202
<SEC-HEADER>0001477932-25-008717.hdr.sgml : 20251202
<ACCEPTANCE-DATETIME>20251201182813
ACCESSION NUMBER:		0001477932-25-008717
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		37
FILED AS OF DATE:		20251202
DATE AS OF CHANGE:		20251201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UPEXI, INC.
		CENTRAL INDEX KEY:			0001775194
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				833378978
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291879
		FILM NUMBER:		251541102

	BUSINESS ADDRESS:	
		STREET 1:		3030 ROCKY POINT DRIVE
		STREET 2:		SUITE 420
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33607
		BUSINESS PHONE:		701-353-5425

	MAIL ADDRESS:	
		STREET 1:		3030 ROCKY POINT DRIVE
		STREET 2:		SUITE 420
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GROVE, INC.
		DATE OF NAME CHANGE:	20190429
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>upxi_s1.htm
<DESCRIPTION>FORM S-1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:upxi="http://upxi.com/20251201"><head><title>upxi_s1.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-12-01to2025-12-01" id="ixv-5132">0001775194</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2025-12-01to2025-12-01" format="ixt:booleanfalse" id="ixv-5133">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="upxi-20251201.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-12-01to2025-12-01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001775194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-01</xbrli:startDate><xbrli:endDate>2025-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>As filed with the U.S. Securities and Exchange Commission on December 1, 2025</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;"><strong>Registration No. 333-</strong></p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:DocumentType" id="ixv-5153">S-1</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:50%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityRegistrantName" id="ixv-5154">UPEXI, INC.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>(Exact name of registrant as specified in its charter)</em></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="ixv-5155">Delaware</ix:nonNumeric></strong></p></td><td style="width:5%;"/><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>5900</strong></p></td><td style="width:5%;"/><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityTaxIdentificationNumber" id="ixv-5156">83-3378978</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>(State or Other Jurisdiction of&#160;</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>Incorporation or Organization)</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>(Primary Standard Industrial</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>Classification Code Number)</em></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>(I.R.S. Employer&#160;</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><em>Identification Number)</em></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityAddressAddressLine1" id="ixv-5157">3030 North Rocky Point Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityAddressAddressLine2" id="ixv-5158">Suite 420</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityAddressCityOrTown" id="ixv-5159">Tampa</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityAddressStateOrProvince" id="ixv-5160">FL</ix:nonNumeric> <ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityAddressPostalZipCode" id="ixv-5161">33607</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline">(<ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:CityAreaCode" id="ixv-5162">727</ix:nonNumeric>) <ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:LocalPhoneNumber" id="ixv-5163">287-2800</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Address, including zip code, and telephone number including area code, of Registrant&#8217;s principal executive offices)&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Allan Marshall, President and Chief Executive Officer</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Upexi, Inc.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>3030 North Rocky Point Drive, Suite 420</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Tampa, FL 33607</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="text-decoration:underline">(727) 287-2800</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Name, address, including zip code, and telephone number including area code, of agent for service)&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>With copies to:</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Peter Campitiello</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Lucosky Brookman LLP</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>101 Wood Avenue South, 5</strong>th <strong>Floor</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Woodbridge, NJ 08830</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Tel. No.: (732) 395-4517</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Fax No.: (732) 395-4401</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Approximate date of commencement of proposed sale to the public:</strong> As soon as practicable after this Registration Statement is declared effective.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. &#9746;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Large accelerated filer&#160;</p></td><td style="width:20%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#9744;&#160;</p></td><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Accelerated filer</p></td><td style="width:20%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#9744;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="ixv-5164">Non-accelerated filer</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#9746;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Smaller reporting company</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="ixv-5165">&#9746;</ix:nonNumeric></p></td></tr><tr style="height:15px"><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Emerging growth company</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-5166">&#9746;</ix:nonNumeric>&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If an emerging growth company, indicate by checkmark if the registrant has not elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <ix:nonNumeric contextRef="From2025-12-01to2025-12-01" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" id="ixv-5167">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the Commission, acting pursuant to said section 8(a), may determine.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="color:red">The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities, nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:30%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>PRELIMINARY PROSPECTUS</strong></p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>SUBJECT TO COMPLETION</strong></p></td><td style="width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;"><strong><span style="color:red">DATED&#160;DECEMBER 1, 2025</span></strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Upexi, Inc.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Up to 3,289,474 Shares of Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Up to 3,289,474 Shares of Common Stock Underlying Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This preliminary prospectus relates to the offering and potential resale by the Selling Stockholder identified herein (the &#8220;Selling Stockholder&#8221;) of up to 6,578,948 shares of common stock, $0.00001 par value (&#8220;Common Stock&#8221;) of Upexi, Inc. (the &#8220;Company&#8221; or &#8220;Upexi&#8221;), which consists of (i) 3,289,474 shares of Common Stock (the &#8220;PIPE Shares&#8221;) issued to that certain investor (the &#8220;Investor&#8221;) of the PIPE Offering (as defined herein), pursuant to that certain Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;), dated November 26, 2025, and (ii) 3,289,474 shares of Common Stock (the &#8220;Warrant Shares&#8221;) issuable upon exercise of the Warrants (as defined herein), by and between the Company and the Investor (the &#8220;Selling Stockholder&#8221;).&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Selling Stockholder may from time to time sell, transfer or otherwise dispose of any or all of the securities in a number of different ways and at varying prices. See &#8220;Plan of Distribution&#8221; beginning on page&#160;49 of this prospectus for more information.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We are not selling any shares of Common Stock in this offering, and we will not receive any proceeds from the sale of shares by the Selling Stockholder.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our Common Stock is currently quoted on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;UPXI&#8221;. On November 27, 2025, the closing price of our Common Stock as reported on Nasdaq was $2.80 per share.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Selling Stockholder may offer all or part of the shares for resale from time to time through public or private transactions, at either prevailing market prices or at privately negotiated prices.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This prospectus provides a general description of the securities being offered. You should read this prospectus and the registration statement of which it forms a part before you invest in any securities. We may amend or supplement this prospectus from time to time by filing amendments as required. You should read this entire prospectus and any amendments or supplements carefully before you make your investment decision.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Investing in our securities involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page&#160;16 of this prospectus for a discussion of certain risks that you should consider in connection with an investment in our securities.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">The date of this preliminary prospectus is December 1, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="TOCMF">TABLE OF CONTENTS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a1">Cautionary Note Regarding Forward-Looking Statements</a></p></td><td style="width:1%;"/><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4</p></td><td style="width:1%;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a2">Prospectus Summary</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5</p></td><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a3">Risk Factors</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">18</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a4">Use of Proceeds</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">37</p></td><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a5">Determination of Offering Price</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">37</p></td><td/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a6">Business</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">37</p></td><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a7">Selling Stockholder</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">48</p></td><td/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a8">Plan of Distribution</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">49</p></td><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a9">Where You Can Find More Information</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">52</p></td><td/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#a10">Incorporation of Certain Documents by Reference</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">53</p></td><td/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>You may only rely on the information contained in this prospectus or that we have referred you to. We have not authorized anyone to provide you with different information. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities other than the Common Stock offered by this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any Common Stock in any circumstances in which such offer or solicitation is unlawful. Neither the delivery of this prospectus nor any sale made in connection with this prospectus shall, under any circumstances, create any implication that there has been no change in our affairs since the date of this prospectus is correct as of any time after its date.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a1">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This prospectus contains forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. They are generally identifiable by use of the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;projects,&#8221; &#8220;continuing,&#8221; &#8220;ongoing,&#8221; &#8220;expects,&#8221; &#8220;management believes,&#8221; &#8220;we believe,&#8221; &#8220;we intend&#8221; or the negative of these words or other variations on these words or comparable terminology. These statements may be found under the sections entitled &#8220;Business,&#8221; as well as in this prospectus generally. In particular, these include statements relating to future actions, prospective products, market acceptance, future performance or results of current and anticipated products, sales efforts, expenses, and the outcome of contingencies such as legal proceedings and financial results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Examples of forward-looking statements in this prospectus include, but are not limited to, our expectations regarding our business strategy, business prospects, operating results, operating expenses, working capital, liquidity and capital expenditure requirements. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, terms and availability of components, pricing levels, the timing and cost of capital expenditures, competitive conditions and general economic conditions. These statements are based on our management&#8217;s expectations, beliefs and assumptions concerning future events affecting us, which in turn are based on currently available information. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Important factors that could cause actual results to differ materially from the results and events anticipated or implied by such forward-looking statements include, but are not limited to:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"/><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">changes in the market acceptance of our products;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">increased levels of competition;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">changes in political, economic or regulatory conditions generally and in the markets in which we operate;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">our relationships with our key customers;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">our ability to retain and attract senior management and other key employees;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">our ability to quickly and effectively respond to new technological developments;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">our ability to protect our trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the proprietary rights of the Company; and</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">fluctuations in price of Solana;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">other risks, including those described in the &#8220;Risk Factors&#8221; discussion of this prospectus.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for us to predict all of those risks, nor can we assess the impact of all of those risks on our business or the extent to which any factor may cause actual results to differ materially from those contained in any forward-looking statement. The forward-looking statements in this prospectus are based on assumptions management believes are reasonable. However, due to the uncertainties associated with forward-looking statements, you should not place undue reliance on any forward-looking statements. Further, forward-looking statements speak only as of the date they are made, and unless required by law, we expressly disclaim any obligation or undertaking to publicly update any of them in light of new information, future events, or otherwise.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a2">PROSPECTUS SUMMARY</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>This summary highlights selected information appearing elsewhere in this prospectus. While this summary highlights what we consider to be important information about us, you should carefully read this entire prospectus before investing in our Common Stock, especially the risks and other information we discuss under the headings &#8220;Risk Factors&#8221; and our consolidated financial statements and related notes incorporated by reference herein. Our fiscal year end is June 30. Some of the statements made in this prospectus discuss future events and developments, including our future strategy and our ability to generate revenue, income and cash flow. These forward-looking statements involve risks and uncertainties which could cause actual results to differ materially from those contemplated in these forward-looking statements. See &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221;. Unless otherwise indicated or the context requires otherwise, the words &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221;, &#8220;Upexi,&#8221; and the &#8220;Company&#8221; refer to Upexi, Inc., a Delaware corporation, and unless the context indicates otherwise, also includes our wholly-owned subsidiaries.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Company</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Upexi is a brand owner specializing in the development, manufacturing, and distribution of consumer products. The Company has recently diversified into the Cryptocurrency industry and cash management of assets through a Cryptocurrency Portfolio, primarily focused in Solana tokens and staking of those tokens.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Our Solana Treasury Strategy</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Early in 2025, we updated and modified our cash management and treasury strategy to include holding digital currency assets directly on our balance sheet. This was a shift from before when we held excess cash primarily in FDIC-insured interest-bearing accounts. The change to adopt this strategy results from our intention to obtain the highest yield on excess cash. Under our new approach, our treasury policy focuses primarily on Solana (&#8220;SOL&#8221;). The approach involves applying a public-market treasury model to an asset that is considered earlier in its lifecycle with respect to both development and usage as well as institutional adoption compared to Bitcoin.&#160;Management will focus its resources to this digital asset strategy and a significant portion of the balance sheet will be allocated to holding Solana in the Company&#8217;s digital asset treasury. Currently our treasury is exclusively dedicated to the SOL digital asset and currently we do not intend to dedicate any of the treasury allocated capital to other digital assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our treasury strategy is intended to bring value to our shareholders in these ways:</p></td></tr><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We plan to utilize intelligent capital markets issuance &#8211; including the issuance of both equity and convertible debt - where we may issue capital in an accretive fashion for the benefit of shareholders to purchase and hold more Solana.&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We will stake the majority of the Solana in our treasury to earn a staking yield and turn the treasury into a productive asset. Currently we are staking approximately 95% of our SOL treasury, and intend to maintain a similar or higher percentage going forward.&#160;We do not hedge our SOL and do not have plans to hedge our SOL in the future.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We will purchase locked Solana at a discount to the current spot price, which will provide higher gains for our shareholders as the discount moves to par over time.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Note that we are underpinned by Solana, which we believe is the leading high-performance blockchain and may see its price rise in the future - if this occurs, our Solana treasury will move up in value, also benefiting shareholders.&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Our Staking Program</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pursuant to our treasury strategy, we will use our SOL in the treasury to generate a return through various opportunities with the most significant portion being allocated to our Staking Program. We will utilize several Validators in the Staking Program to reduce our risk with a single Validator and maximize the overall yield from the Staking Program. We will also dedicate a portion of the SOL in our staking program to utilize smaller Validators to help improve the overall Solana ecosystem. These Validators are scrutinized through our due diligence program and are initially only given a small amount of SOL for the Company to be able to verify the expected performance and yield, and to ensure that the Validator should be included in our future allocation of SOL to Validators. Management evaluates the validators on a routine basis around performance, yield, and economics, and makes monthly adjustments on the overall allocation of the SOL in the treasury based on our evaluation. Currently we have approximately 95% of our SOL treasury staked, and target a similar or higher percentage in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We maintain possession and control of the SOL when it is staked at all times. Native staking is generally considered a safe activity, as it is done in-protocol (i.e.. is built into Solana itself), and as, unlike other networks, Solana has not implemented &#8220;slashing&#8221; penalties for validators that either intentionally misbehave or perform their duties poorly. As such, the major risk with staking is that we choose a validator with poor performance who realizes a low staking yield. Additionally, as part of the &#8220;activating&#8221; and &#8220;exiting&#8221; processes of SOL staking, any staked SOL will be inaccessible for a period of time determined by a range of factors, resulting in certain liquidity risks that we manage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Process of Staking</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Management has bi-weekly meetings to evaluate treasury operations, including the staking of the Company&#8217;s SOL. Based on these meetings, management determines the allocation of the SOL treasury to the Staking Program and determines the amount of allocation to each Validator, ensuring that no single validator has such a large percentage of our stake that it represents concentration risk.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If it is determined to reduce the amount of the SOL dedicated to the Staking Program or it is determined to change the allocation of SOL to a Validator, we will initiate an unstaking process and notify the Validator of the change, which effectively reverses the delegation of the SOL from the applicable validator node.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana has a cooldown period known as the &#8220;deactivation period,&#8221; which is the time it takes for the unstaked SOL to become fully liquid. During this period, the tokens are not actively earning rewards, but they are also not yet available for transfer or use. The length of this period can vary based on network conditions but is generally expected to be 48 hours or less. Once the cooldown period is complete, the Company will have complete control over the SOL, including the ability to sell the SOL or transfer it as determined by management.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Liquidity Management</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company&#8217;s staking program involves the temporary loss of the ability to transfer, assign a new Validator or otherwise dispose of the SOL. Under normal conditions, the Company will regain complete control over its unstaked SOL within two days of initiating the unstaking. However, there can be no guarantee that such process will result in the Company regaining complete control of its SOL in time to satisfy its current obligations. We maintain a certain amount of liquid SOL in the treasury and a certain amount of cash to ensure that the Company is able to satisfy its current obligations.&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">How We Earn Staking Rewards</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To earn staking rewards, we delegate our SOL to leading Solana validators via Solana&#8217;s in-protocol delegation system.&#160;This means we deposit our SOL tokens into a stake account, which is then delegated to a validator&#8217;s vote account.&#160;We utilize native staking only, and stake to top validators who have demonstrated a track record of high performance, high yield generation, and attractive delegator economics.&#160;We use multiple validators to both maximize the return on our Solana treasury and to mitigate the risk of having only one or two validators for our treasury staking.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">SOL and the Solana Network</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">SOL is a digital asset that is created and transmitted through the operations of the peer-to-peer Solana network (the &#8220;Solana blockchain&#8221; or &#8220;Solana network&#8221;), which is a decentralized network of computers operating the implementation of the Solana protocol. While certain entities such as Solana Labs, Inc. (&#8220;Solana Labs&#8221;) and the Solana Foundation have influence over the Solana network&#8217;s development and governance (which was particularly true during the network&#8217;s early years), no single entity owns or operates the Solana network, the infrastructure of which is collectively maintained by a decentralized user base. The Solana network allows the creation and exchange of tokens, including SOL, which are recorded on the Solana network. SOL can be used to pay for goods and services, including to send a transaction on the Solana network, or it can be swapped to other tokens or converted to fiat currencies, such as the U.S. dollar, at rates determined on digital asset trading platforms or in individual end-user-to-end-user transactions under a market-based system. Furthermore, the Solana network allows users to write and implement general purpose code known as smart contracts or programs that create decentralized applications, and for users to openly interact with said decentralized applications.&#160;Using programs, users can create decentralized applications covering a variety of categories and subsectors, including borrow/lend protocols, decentralized exchanges, social applications, web3 gaming, tokenized assets, AI agents, decentralized physical infrastructure networks, and many more.&#160;As such, the Solana network expands blockchain use well beyond just a peer-to-peer money system.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Solana protocol introduced the proof-of-history timestamping mechanism. Proof-of-history is not a consensus mechanism, but a cryptographic clock that enables greater organization without extensive communication, thereby increasing throughput.&#160;Proof-of-history enables leaders to know when its their turn to produce a block, rather than requiring the entire network to first come to an agreement on the prior block before the leader can begin their work.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In addition to the proof-of-history mechanism, the Solana network uses a proof-of-stake consensus mechanism to incentivize SOL holders to validate transactions. Unlike proof-of-work, in which miners expend computational and energy resources to be the miner to propose a block and receive the block reward, in proof-of-stake, validators pledge or &#8220;stake&#8221; coins, perform duties such as proposing or validating blocks, and receive staking rewards generally in proportion to the amount of coins staked.&#160;A validator that performs its duties poorly, whether maliciously or unintentionally, would receive lower or no rewards. Proof-of-stake is viewed as more energy efficient and scalable than proof-of-work. Together proof-of-history combined with a proof-of-stake consensus model are some of the components on Solana that enable high throughput and low-latency transaction processing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Overview of the Solana Network</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In order to own, transfer or use SOL directly on the Solana network on a peer-to-peer basis (as opposed to through an intermediary, such as a custodian or centralized exchange), a person generally must have internet access to connect to the Solana network and set up a wallet, which is the software that safeguards a user&#8217;s keypair (public key plus secret key). SOL transactions may be made directly between end-users without the need for an intermediary. To transact on the Solana network, a user, typically through an application such as a wallet or smart contract, will board the transaction to the current leader, who will organize the transactions into shards before the network processes and validates such transactions.&#160;Using cryptography and its proof-of-stake consensus mechanism, the Solana network can come to a shared state of the network in a decentralized fashion and without a centralized leader.&#160;Blocks are built on top of prior ones by subsequent leaders, continuing the process.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Prior to transacting on Solana, a user generally must first install on its computer or mobile device a software program that will allow the user to generate a private and public key pair such as a wallet. The wallet also enables the user to connect to the Solana network, interact with decentralized applications, and transfer or swap tokens with other users or applications.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Each user has their own key pair that is stored in such software, like a wallet.&#160;To receive SOL in a peer-to-peer transaction, the SOL recipient must provide its public key to the party initiating the transfer. This activity is analogous to a recipient for a transaction in U.S. dollars providing a routing address in wire instructions to the payor so that cash may be wired to the recipient&#8217;s account. The payor approves the transfer to the address provided by the recipient by &#8220;signing&#8221; a transaction that consists of the recipient&#8217;s public key with the private key of the address from where the payor is transferring the SOL. The recipient, however, does not make public or provide to the sender its private key (though the network can still verify the validity of the signature - ie. that it was signed by the holder of the private key &#8211; using cryptography).With cold storage our Custodian maintains all of the private keys.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Neither the recipient nor the sender reveal their private keys in a peer-to-peer transaction because the private key authorizes transfer of the funds in that address to other users. Therefore, if a user loses their private key, the user may permanently lose access to the SOL contained in the associated address. Likewise, SOL is irretrievably lost if the private key associated with them is deleted and no backup has been made. When sending SOL, a user&#8217;s Solana network software program must validate the transaction with the sender&#8217;s associated private key. In addition, since every computation on the Solana network requires processing power, there is a mandatory transaction fee involved with the transfer that is paid by the payor. The resulting digitally validated transaction is sent by the user&#8217;s Solana network software program to the Solana network validators to allow transaction confirmation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana network validators record and confirm transactions when they validate and add blocks of information to the Solana blockchain. When a validator is selected to validate a block, it creates that block, which includes data relating to (i) the verification of newly submitted and accepted transactions and (ii) a reference to the prior block in the Solana blockchain to which the new block is being added. The validator becomes aware of outstanding, unrecorded transaction requests through peer-to-peer data packet transmission and distribution discussed above.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Upon the addition of a block of SOL transactions, the Solana network software program of both the spending party and the receiving party will show confirmation of the transaction on the Solana blockchain and reflect an adjustment to the SOL balance in each party&#8217;s Solana network public key, completing the SOL transaction. Once a transaction is confirmed on the Solana blockchain, it is irreversible.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Some SOL transactions are conducted &#8220;off-blockchain&#8221; and are therefore not recorded on the Solana blockchain. These &#8220;off-blockchain transactions&#8221; involve the transfer of control over, or ownership of, a specific digital wallet holding SOL or the reallocation of ownership of certain SOL in a pooled-ownership digital wallet, such as a digital wallet owned by a digital asset trading platform. If a transaction takes place through a centralized digital asset exchange or a custodian&#8217;s internal books and records, it is not broadcast to the Solana network or recorded on the Solana blockchain. In contrast to on-blockchain transactions, which are publicly recorded on the Solana blockchain, information and data regarding off-blockchain transactions are generally not publicly available. Therefore, off-blockchain transactions are not truly SOL transactions in that they do not involve the transfer of transaction data on the Solana network and do not reflect a movement of SOL between addresses recorded on the Solana blockchain. For these reasons, off-blockchain transactions are not immutable or irreversible as any such transfer of SOL ownership is not cryptographically protected by the protocol behind the Solana network or recorded in, and validated through, the blockchain mechanism.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Since inception, transaction fees on the Solana Network have comprised of a fixed rate of 0.000005 SOL per transaction, plus a variable fee component based on the computation resources used during the transaction. SOL holders can also pay an additional prioritization fee to expedite their transaction.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong><span style="text-decoration:underline">Validators</span></strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In proof-of-stake, validators risk or stake coins to be randomly selected to validate transactions and are rewarded for performing their responsibilities and behaving in accordance with protocol rules. Malfunctions that cause validators to go offline and, in turn, inhibit them from performing their duties can result in financial penalties. Any malicious activity, such as making incorrect attestations or otherwise violating protocol rules results may result in lower rewards or the lost opportunity to gain rewards. The penalty varies depending on the type of offense and correlation to potential offenses by other validators.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Validators are typically professional operations that design and build dedicated machines and data centers, including &#8220;clusters,&#8221; which are groups of validators that act cohesively and combine their processing to confirm transactions. When a validator confirms a transaction, the validator and any associated stakers receive a fee. During the course of ordering transactions and validating blocks, validators may be able to prioritize certain transactions in return for increased transaction fees, an incentive system known as &#8220;Maximal Extractable Value&#8221; or &#8220;MEV.&#8221; For example, in blockchain networks that facilitate DeFi protocols in particular, such as the Solana network, users may attempt to gain an advantage over other users by offering greater transaction fees.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Validators less commonly capture MEV in the Solana network because, unlike the Ethereum network, it does not publicly expose transactions before they are accepted by a validator.&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Staking rewards on the Solana network are determined by the protocol and are distributed to validators and their associated stakers based on the proportion of their stake relative to the total active stake in the network. The rewards are funded by inflationary issuance of new tokens and transaction fees collected on the network. The specific amount each validator and staker receives depends on, among other things, their share of the total stake, the validator&#8217;s uptime and performance, and the overall network conditions.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The historical range of staking rewards on the Solana network has varied due to differing levels of network congestion and protocol parameters. The actual annualized reward rate has fluctuated over time, reflecting changes in network activity, inflation rates, and protocol adjustments.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Staking rewards on Solana are distributed at regular intervals. At the end of each epoch, with one epoch being roughly 2 days, the reward is calculated. The reward is automatically distributed at the beginning of the subsequent epoch. This regular reward frequency ensures that participants receive their share of rewards in a timely manner, reflecting their contribution to network security and transaction validation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">How We Purchase or Sell Digital Assets</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Our Management team reviews the Company&#8217;s short term obligations and excess cash available to dedicate to the Treasury Strategy.&#160;When it is determined that the Company has excess cash available to dedicate to the Treasury Strategy we deploy that capital into one of our custodians and through acquisition strategies with the custodians and our asset manager, we acquire the SOL over several days or weeks to maximize the number of SOL that is acquired with the capital deployed. If it was determined that the treasury needed to liquidate part of its SOL, the same process of selling the SOL into the market would be used.</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Use of Custodians and Storage of SOL Tokens</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We do not self-custody and only utilize third-party qualified custodians to hold our Solana.&#160;We use qualified custodians that utilize risk management and operational best practices around items like hot vs. cold storage, access controls, custody technology, insurance, etc. Our primary custodian is BitGo Trust Company, Inc. (&#8220;BitGo&#8221;). We also maintain a custodial relationship with Coinbase, Inc. and are in the process of distributing our treasury to different custodians and onboarding other qualified custodians to ensure that we mitigate our Solana treasury risk through the use of several qualified custodians.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Storage of Our Digital Assets in our SOL Treasury</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>The Custodians</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Custodians are responsible for safekeeping all of the SOL owned by the Company. We maintain multiple Custodians to reduce the risk of a single failure and we plan to expand to additional custodians as our Treasury grows. The Custodian accounts are all opened by the Company, this segregates our assets into an individual custodian account owned by the Company and access is monitored and controlled by the Company. Our Asset Management Company is given access to the Custodian accounts with established controls to ensure transactions require consensus of a minimum of two individuals when assets are being transferred between wallets and additional controls if an asset of the Treasury is moved out of the Custodians control. The assets go through the Custodians Trust Company, which maintains its own insurance and is regulated by their respective state where the trust is incorporated in.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our primary custodian is currently BitGo Trust Company, Inc. a&#160;South Dakota corporation (&#8220;BitGo&#8221;)&#160;and is regulated by the state of South Dakota. On May 1, 2025, we entered into a Custodial Services Agreement with BitGo (the &#8220;BitGo Agreement&#8221;) to hold our digital currency. The term of the BitGo Agreement is for one year with successive one-year renewals unless prior notice of non-renewal is given by either party. The Company pays BitGo a monthly digital asset storage fee based upon the market value of the assets in storage, plus $500. The BitGo Agreement is terminable by either the Company or BitGo on thirty days&#8217; notice as a result of a breach of the Agreement and may be suspended by BitGo if the Company violates the intended use of the account or due to a change in the applicable law, litigation or bankruptcy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our secondary custodian is Coinbase Inc., a subsidiary of Coinbase Global, Inc., a Delaware corporation, which is primarily used for the acquisition of digital assets. On May 5, 2025, the Company entered into an Institutional Client Agreement with Coinbase (the &#8220;Coinbase Agreement&#8221;). The Coinbase Agreement is terminable at will by either the Company or Coinbase.&#160; The Company pays Coinbase its regularly scheduled fees based on the dollar trading volume over a thirty-day period. The Coinbase Agreement is terminable by either the Company or Coinbase on ten days&#8217; notice as a result of a breach of the Agreement and may be suspended by Coinbase if the Company violates the intended use of the account or due to a change in the applicable law, governmental proceeding, litigation or bankruptcy. Coinbase may also close the Company&#8217;s account if it has been inactive for more than one year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">BitGo maintains a $250,000,000 policy against loss, theft and misuse. Currently we have approximately $192,724,750 of treasury value at Bitgo, based on the SOL price of $137.39 per token. Coinbase has an insurance policy for any cash held in the account of $250,000. We currently have less than $250,000 of cash held at Coinbase and less than $100,000 in SOL value, based on the SOL price of $137.39 per token. At the current price of SOL as of the date of this prospectus, these policies are adequate to fully cover the full loss of our SOL.&#160;&#160;There are other tokens locked tokens owned in omnibus wallets and loaned on a short term basis not included in the Company&#8217;s custodian accounts.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana, as with all digital assets, can be highly volatile. Management reviews the account balances and the total value held with a custodians to allocate the Company&#8217;s holdings between multiple accounts and custodians to mitigate risk. We do not use self-storage for any of the SOL treasury assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Private keys are generated by the Custodians in key generation ceremonies at secure locations using offline devices that have never been connected to a network. Private keys are generated according to detailed procedures using specialized offline devices and within these secure facilities to mitigate risk of hacks, errors, or other unintended external exposure. Key ceremony processes are highly controlled, require segregation of duties across multiple parties and are reviewed and witnessed by designated oversight personnel. Thorough validations and signoffs are performed to verify the integrity and security of key generation ceremonies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Custodians hold a majority of SOL in cold storage and provides a user interface for the Company to manage the allocation of SOL between cold and hot storage for the wallets. The Company maintains more than 98% of its SOL treasury in cold wallets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Custodians have multiple, redundant cold storage sites, which are geographically distributed including sites within the United States. Cold storage locations of the Custodians are monitored by 24x7 on-site security, video surveillance and alarms, hardened room structures, and access to these facilities is controlled by multi-person controls, multi-team access rules, and multi-factor authentication. The locations of the cold storage sites may change at the discretion of the Custodians and are kept confidential by the Custodians for security purposes. Transactions from cold to hot storage require physical access, according to the above controls, to one or more cold storage facilities, as well as systematically enforced approvals and integrity verifications, before the secure device can be used to cryptographically complete the transaction. At no point during this process is the private key removed from the secure device(s) nor the cold storage facility. Once these security processes have been completed, a transfer on the Solana network can be executed, as signed using the private keys held offline in cold storage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Custodians also maintain geographically dispersed backups of private keys, which are cryptographically generated into shards and stored in separate locations; multiple locations must be accessed to reconstruct a single key. The storage facilities are highly secured, and include 24x7 on-premises security presence, video surveillance, and alarms for unexpected entry. Access to facilities is controlled by multi-person controls, multi- team access rules, and multi-factor authentication.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">All of our Custodians have SOC type 2 reports that the Company has reviewed and we get regular bridge reports from our Custodians to help ensure the controls are being maintained. Our Custodians maintain their own insurance policies to cover our loss, which is in addition to the policies that we maintain ourselves. We currently have two qualified Custodians that we have approved for our treasury use and we are in the process of onboarding a third as part of our risk management process.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company is charged for storage fees, staking fees and transaction fees for services specifically requested by the Company or the Asset Management Company. Except as set forth above the contract terms of the agreements are typically for one to three years and can be terminated upon 30 day notice and payment of all fees due and one month of additional fees.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">SOL &#8211; the Token of the Solana Blockchain</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana (SOL) is the native token of the Solana blockchain. According to Solana Compass &#8211; a popular website covering the Solana ecosystem that also runs a Solana validator &#8211; Solana was created with an initial supply of 500m SOL, though much of the initial supply was locked or earmarked for various use cases such as for the community, investors, foundation, team, etc. New Solana tokens are brought into existence primarily through inflationary rewards distributed to validators (and delegators). Solana currently has a total supply of 615.1m SOL, a circulating supply of 559.5m, and no maximum supply. The Solana staking yield is made up of three primary components: inflationary rewards, transaction/priority fees, and maximal extractable value (MEV). Inflationary rewards started out at 8.0%, currently sit at 4.2%, and will fall 15% every epoch-year until it reaches a long-term floor of 1.5%. There are currently 26.9m locked SOL, representing 4.4% of the total SOL supply with various vesting schedules. Historically, 50% of all transaction fees were burned (with the other 50% going to the validator), but now all transaction fees go to the validator after the passage and adoption of Solana Improvement Document 96 (SIMD-96).&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">How SOL is Used</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">SOL is used as part of Solana&#8217;s proof-of-stake consensus mechanism. In general, proof-of-stake blockchains have block producers called validators that run nodes, bond or stake the protocol&#8217;s native token, propose blocks when chosen to do so, and validate/sign the transactions and blocks of others when not. Validators are chosen to produce a block in proportion to their stake, which makes it extremely costly for bad actors to attempt to control the network and add invalid transactions to the blockchain. Validators receive staking rewards for the work they perform, which further incentivizes validators to behave properly, as they would otherwise miss out on such rewards. Other proof-of-stake networks often &#8220;slash&#8221; some or all of a validator&#8217;s stake if it intentionally or unintentionally performs its duties poorly, for example, by double-signing a transaction, though Solana has not implemented slashing at this time. In addition to its use within consensus, SOL is also a &#8220;gas token&#8221;, meaning that users of the Solana blockchain pay SOL to validators (and delegators) as compensation for processing their transactions. As such, the value of SOL may increase if/as the Solana blockchain sees greater usage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We see three particularly notable items giving Solana a technical advantage compared to many smart contract blockchain peers. First, Solana&#8217;s proof-of-history gives validators a notion of time and enables them to produce blocks when it&#8217;s their turn without requiring the network to first agree upon the current block. This results in immense speed advantages. Second, unlike peer blockchains that often use single-threaded virtual machines, Solana enables parallel transaction execution to increase throughput and advantage of future hardware improvements resulting from an increasing CPU core counts. Lastly, Solana optimized for speed and security, and is naturally growing into decentralization as hardware and bandwidth costs fall over time, optimally positioning it well along the Blockchain Trilemma.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">The Solana Ecosystem</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As one of the first &#8220;second-generation&#8221; high performance blockchains, Solana uniquely enjoys both the best-in-class technology described above, as well as strong network effects that have attracted a large, growing, and vibrant ecosystem of users, developers, and decentralized applications. Indeed, while Solana is focused on bringing global finance onchain (commonly referred to as &#8220;onchain Nasdaq&#8221; or &#8220;Internet Capital Markets&#8221;), Solana&#8217;s performance and technical capabilities enable a plethora of use cases from decentralized finance (&#8220;DeFi&#8221;) to decentralized physical infrastructure networks (&#8220;DePIN&#8221;), AI agents, social media, gaming, stablecoins, real-world assets (&#8220;RWA&#8221;s), and more. Moreover, according to Electric Capital&#8217;s 2024 Developer Report, Solana is the #1 ecosystem for new developers, growing 83% in 2024, with this metric often considered a leading indicator of blockchain growth. Lastly, we note that Solana often leads all blockchains in key metrics such as daily active users, decentralized application revenues, and decentralized exchange volumes, sometimes putting up better metrics than all other chains combined.&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>The Brands</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img1.jpg" alt="upxi_s1img1.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">LuckyTail, where at-home care meets innovation. We connect pet owners with the products they need to simplify and improve at-home wellness and grooming care for their beloved pets, empowering pet parents to provide their cherished furry companions with the pampering they deserve in the comfort of their own space.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img2.jpg" alt="upxi_s1img2.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At PRAX, we fuel modern go-getters to achieve their best selves through innovative energy solutions. Powered by paraxanthine&#8212;an advanced alternative to caffeine, our mission is to support your hustle and power your ambitions. Energize better, perform smarter, fuel different.&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img3.jpg" alt="upxi_s1img3.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At Cure Mushrooms, we have harnessed the extraordinary benefits of nature&#8217;s most powerful superfood: functional mushrooms. Our suite of premium mushroom extracts are meticulously crafted to elevate overall well-being, offering a wide spectrum of health benefits and a holistic approach to everyday wellness. From fortifying your immune system, to sharpening cognition, to combating the rigors of daily stress, our products are designed to deliver full-body wellness and convenience with every serving.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img4.jpg" alt="upxi_s1img4.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At Moonwlkr, we craft cannabinoid experiences that take you beyond the ordinary. By combining award-winning natural flavors and one-of-a-kind blends, we invite you to feel the thrill of the unknown, the calm of weightless relaxation, or the anticipation of a new adventure.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img5.jpg" alt="upxi_s1img5.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At Gumi Labs we manufacture gummies and other products supporting our health and wellness products, including those products manufactured with hemp ingredients.&#160; Our manufacturing facility has been moved to Florida and is at full capacity.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our History</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company operates manufacturing and/or distribution centers supporting health and wellness products, including those products manufactured with hemp ingredients and our overall distribution operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">July 2020 &#8211; the Company purchased Infusionz LLC.&#160;Infusionz was a similar business in the manufacturing and distribution of products and owned certain product brands that we believe could be expanded through the merger.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">June 2021 &#8211; Upexi Inc. became a listed company on the Nasdaq stock exchange.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2021 &#8211; The Company purchased the assets of VitaMedica Corporation, a California corporation (VitaMedica). VitaMedica is a leading online seller of supplements for surgery, recovery, skin, beauty, health and wellness.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">October 2021 &#8211; The Company purchased Interactive Offers, LLC, a Delaware limited liability company. Interactive provides programmatic advertising with its SAAS platform, which allows for programmatic advertisement placement automatically on any partners&#8217; sites from a simple dashboard.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">April 2022 &#8211; The Company purchased 55% of Cygnet Online, LLC, a Delaware limited liability company (&#8220;Cygnet&#8221;). Cygnet operates a warehouse and distribution center for the management of day-to-day operations for product liquidation through Amazon and other on-line resellers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2022 &#8211; The Company purchased the assets to the brand LuckyTail. The acquisition of LuckyTail provided the Company with a foothold in the pet care industry and a strong presence on Amazon and its eCommerce store, offering nutritional and grooming products domestically and internationally.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">October 2022 &#8211; The Company purchased E-Core Technology, Inc. d/b/a New England Technology, Inc. (&#8220;E-Core&#8221;), a Florida corporation. E-Core distributes non-owned branded products to national retail distributors and has branded products in the toy industry that E-Core sells direct to consumers through online sales channels and to national retail distributors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">October 2022 &#8211; The Company sold all rights to Infusionz brands and the manufacturing of certain private label business. Infusionz was originally purchased by the Company in July of 2020.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">July 2023 &#8211; The Company notified the Buyer of the Infusionz brands and the manufacturing business of the defaults and notified the Buyer that all obligations and undertakings to the Buyer are terminated. The Company started manufacturing again for brands owned by the Company to ensure there was no interruption to the supply chain of the products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2023 &#8211; The Company purchased the remaining ownership of Cygnet.&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2023 &#8211; The Company sold one hundred percent (100%) of the issued and outstanding equity of its wholly owned subsidiary Interactive Offers, LLC.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">May 2024 &#8211; The Company sold its equity interest in the wholly owned subsidiary VitaMedica, a Nevada corporation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">June 2024 &#8211; The Company sold its equity interest in the wholly owned subsidiary E-Core Technology, Inc. d/b/a New England Technology, Inc. a Florida corporation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">January 2025 &#8211; The Company announced the strategy of establishing a digital currency holding company to invest and capitalize on the opportunities of cryptocurrency.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">April 2025 &#8211; The Company consummated a $100 million private placement offering and used the net proceeds from the offering to fund its treasury strategy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">July 2025 &#8211; The Company consummated a $50 million private placement offering and a $151.2 million convertible note offering in consideration for the exchange of Solana to continue to build its SOL treasury strategy.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">November 2025 &#8211; The Company consummated a $10 million private placement offering and used the net proceeds from the offering to further fund its treasury strategy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Regulations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Treasury Strategy</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The laws and regulations applicable to Solana and digital assets are evolving and subject to interpretation and change.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Governments around the world have reacted differently to digital assets; certain governments have deemed them illegal, and others have allowed their use and trade without restriction, while in some jurisdictions, such as the U.S., digital assets are subject to overlapping, uncertain and evolving regulatory requirements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As digital assets have grown in both popularity and market size, the U.S. Executive Branch, Congress and a number of U.S. federal and state agencies, including the Financial Crimes Enforcement Network, the CFTC, the SEC, the Financial Industry Regulatory Authority, the Consumer Financial Protection Bureau, the Department of Justice, the Department of Homeland Security, the Federal Bureau of Investigation, the IRS and state financial regulators, have been examining the operations of digital asset networks, digital asset users and digital asset exchanges, with particular focus on the extent to which digital assets can be used to violate state or federal laws, including to facilitate the laundering of proceeds of illegal activities or the funding of criminal or terrorist enterprises, and the safety and soundness and consumer-protective safeguards of exchanges or other service-providers that hold, transfer, trade or exchange digital assets for users. Many of these state and federal agencies have issued consumer advisories regarding the risks posed by digital assets to investors. In addition, federal and state agencies, and other countries have issued rules or guidance regarding the treatment of digital asset transactions and requirements for businesses engaged in activities related to digital assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Depending on the regulatory characterization of Solana, the markets for cryptocurrency in general, and our activities in particular, our business and our Solana acquisition strategy may be subject to regulation by one or more regulators in the United States and globally. Ongoing and future regulatory actions may alter, to a materially adverse extent, the nature of digital assets markets, the participation of industry participants, including service providers and financial institutions in these markets, and our ability to pursue our Solana strategy. Additionally, U.S. state and federal and foreign regulators and legislatures have taken action against industry participants, including digital assets businesses, and enacted restrictive regimes in response to adverse publicity arising from hacks, consumer harm, or criminal activity stemming from digital assets activity. U.S. federal and state energy regulatory authorities are also monitoring the total electricity consumption of cryptocurrency mining, and the potential impacts of cryptocurrency mining to the supply and dispatch functionality of the wholesale grid and retail distribution systems. Many state legislative bodies have passed, or are actively considering, legislation to address the impact of cryptocurrency mining in their respective states.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The CFTC takes the position that some digital assets fall within the definition of a &#8220;commodity&#8221; under the Commodities Exchange Act of 1936, as amended, or CEA. Under the CEA, the CFTC has broad enforcement authority to police market manipulation and fraud in spot digital assets markets in which we may transact. Beyond instances of fraud or manipulation, the CFTC generally does not oversee cash or spot market exchanges or transactions involving digital asset commodities that do not utilize margin, leverage, or financing. In addition, CFTC regulations and CFTC oversight and enforcement authority apply with respect to futures, swaps, other derivative products and certain retail leveraged commodity transactions involving digital asset commodities, including the markets on which these products trade.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In addition, because transactions in Solana provide a degree of anonymity, they are susceptible to misuse for criminal activities, such as money laundering. This misuse, or the perception of such misuse, could lead to greater regulatory oversight of Solana and Solana platforms, and there is the possibility that law enforcement agencies could close Solana platforms or other Solana-related infrastructure with little or no notice and prevent users from accessing or retrieving Solana held via such platforms or infrastructure.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As noted above, activities involving Solana and other digital assets may fall within the jurisdiction of more than one financial regulator and various courts and such laws and regulations are rapidly evolving and increasing in scope.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Consumer Products Business</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In the United States, hemp products that are manufactured by Upexi are regulated by the U.S. Food and Drug Administration, the Federal Trade Commission, the United States Department of Agriculture (&#8220;USDA&#8221;), and various state agencies within the individual states. As an initial matter, the hemp products manufactured and distributed by Upexi must meet the requirements of the Agricultural Improvement Act of 2018 (the &#8220;Farm Bill&#8221;). Under the Farm Bill, all hemp products must contain no more than 0.3% of 9-delta-tetraydrocannabidiols (&#8220;9-delta&#8221;) on a dry why weight basis.&#160;To ensure compliance with this provision, Upexi requires all hemp products it manufactures and distributes to contain no more than 0.3% of all tetraydrocannabidiols not simply 9-delta.&#160;The Farm Bill also requires that Upexi only use hemp manufacturers/producers that are duly licensed under state law or pursuant to the regulations issued by the USDA.&#160;Consequently, the Company processes, develops, manufactures, and sells its products pursuant to the Farm Bill. CBD products manufactured and distributed by Upexi must also meet the requirements of the federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and the federal Food and Drug Administration&#8217;s (the &#8220;FDA&#8221;) regulations implementing the FDCA. While neither the FDCA nor FDA has specific provisions that relate to the marketing of hemp products, the products are subject to the general adulteration and labeling provisions of the FDCA and FDA&#8217;s regulations depending on whether the product is marketed as a cosmetic, dietary supplement or food. The permissibility of hemp products containing cannabinoids remains in a state of flux. The FDA has issued guidance titled &#8220;FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)&#8221;, pursuant to which the FDA has taken the position that cannabidiol (&#8220;CBD&#8221;) is prohibited from use as an ingredient in a food or beverage or as a dietary ingredient in or as a dietary supplement based on several provisions of the FDCA. In the definition of &#8220;dietary supplement&#8221; found in the FDCA at Section 201(ff), an article authorized for investigation as a&#160;new drug, antibiotic, or biological for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, is excluded from the definition of dietary supplement. A similar provision in the FDCA at 301(ll) makes it a prohibited act to introduce or deliver into commerce any food with a substance that was investigated as a new drug prior to being included in a food. There are no similar exclusions for the use of CBD in non-drug topical products, as long as such products otherwise comply with applicable laws. The FDA created a task force to address the further regulation of CBD and other cannabis-derived products and is currently evaluating the applicable science and pathways for regulating CBD and other cannabis-derived ingredients.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Additionally, various states have enacted state-specific laws pertaining to the handling, manufacturing, labeling, and sale of CBD and other hemp products. Compliance with state-specific laws and regulations could impact our operations in those specific states. It is important to note that FDA has not taken any specific positions regarding the regulatory status of other cannabinoids, for example CBDA, CBDG, and CBDN. Finally, the Federal Trade Commission is the agency that is vested with ensuring that all marketing claims for hemp products are truthful and non-misleading.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Treasury Strategy</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has adopted a treasury policy under which the principal holding in its treasury reserve on the balance sheet will be allocated to digital assets, and specifically long term strategy of holding Solana (&#8220;SOL&#8221;) by applying a proven public-market treasury model to an asset that we believe is earlier in its lifecycle, structurally reflexive, and vastly underexposed as compared to Bitcoins.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Products</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Upexi is a brand owner specializing in the development, manufacturing, and distribution of consumer products. We reach consumers through our direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The market, customers and distribution methods for eCommerce products are large and diverse. While Amazon remains the largest eCommerce channel, others are carving out a big chunk of the market, including Walmart, eBay, and Etsy. More opportunities are popping up for sellers as well. Being able to navigate multiple marketplaces is a key to our success and helps reach different demographics and consumers with specific buying behaviors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our target customers are first and foremost end consumers via internet sales; however, we see growth opportunities in direct-to-consumer retail stores, cooperatives, affiliate sales and master distributors. As we continue to develop our business, these markets may change, be re-prioritized or eliminated as management responds to consumer and regulatory developments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Competitive Strengths</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We attribute our success to our consumer products by controlling each phase of the process from manufacturing to order fulfillment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As the manufacturer of our primary products, we are able to control our costs and improve profitability at each step of the process, starting with the development of new products.&#160;Our products take priority in manufacturing give us a higher inventory turnover rate and accelerates the timeline for new product launches.&#160;In addition, we are able to adjust to market demands and change production schedules to ensure we maintain optimized inventory levels.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our primary sales channel is our ecommerce site and our marketing team is led by an expert in the online direct to consumer sales as she has been with the brand since its inception. We have the ability to direct product manufacturing and increase sales with special promotions and product variations with little or no delay in bringing the product to market.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our direct to consumer focus reduces the overall supply costs as we do not have retail outlets or maintain distribution networks for small retail operations.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our executive team comes from a background in logistics, with CEO, Allan Marshall, the founder of XPO Logistics (formerly known as Segmentz, Inc.). With increased shipping costs affecting online retailers, our strength is understanding this and finding ways to lower our costs and overhead, thus increasing profit margins on all of our products.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Growth Strategy</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our growth will focus on the expansion of our brands portfolio through organic growth and optimization of our supply chain.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Direct-to-Consumer expansion.&#160;</em>Our direct-to-consumer business is expected to be our growth driver for the next several years with additional brands and products.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Talent acquisition.&#160;</em>A large part of our acquisition process is to not only evaluate the brand/product offerings, but to understand the team that has been responsible for its success. In a tough market for hiring, this has proven to be a strategic method for bringing on talent. We not only get a great brand, but look to retain the personnel, often the heartbeat of said brand, give them resources, and even utilize them for other brands that we have launched internally or acquired. We strongly believe that continued success relies on a growing team of experts across various industries.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Competition</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">There is heavy competition in our products and we are able to carve out certain niche markets within the industry and there are few competitors that control their manufacturing to distribution as we do. Our goal is to compete through our product delivery and introduction of new products that we manufacture and deliver directly to the consumer giving us an advantage on our competitors. We will focus on profitability, and grow efficiently, without the requirement of additional capital.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Government Regulation&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Treasury Strategy</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The laws and regulations applicable to Solana and digital assets are evolving and subject to interpretation and change.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Governments around the world have reacted differently to digital assets; certain governments have deemed them illegal, and others have allowed their use and trade without restriction, while in some jurisdictions, such as the U.S., digital assets are subject to overlapping, uncertain and evolving regulatory requirements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As digital assets have grown in both popularity and market size, the U.S. Executive Branch, Congress and a number of U.S. federal and state agencies, including the Financial Crimes Enforcement Network, the CFTC, the SEC, the Financial Industry Regulatory Authority, the Consumer Financial Protection Bureau, the Department of Justice, the Department of Homeland Security, the Federal Bureau of Investigation, the IRS and state financial regulators, have been examining the operations of digital asset networks, digital asset users and digital asset exchanges, with particular focus on the extent to which digital assets can be used to violate state or federal laws, including to facilitate the laundering of proceeds of illegal activities or the funding of criminal or terrorist enterprises, and the safety and soundness and consumer-protective safeguards of exchanges or other service-providers that hold, transfer, trade or exchange digital assets for users. Many of these state and federal agencies have issued consumer advisories regarding the risks posed by digital assets to investors. In addition, federal and state agencies, and other countries have issued rules&#160;or guidance regarding the treatment of digital asset transactions and requirements for businesses engaged in activities related to digital assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Depending on the regulatory characterization of Solana, the markets for cryptocurrency in general, and our activities in particular, our business and our Solana acquisition strategy may be subject to regulation by one or more regulators in the United States and globally. Ongoing and future regulatory actions may alter, to a materially adverse extent, the nature of digital assets markets, the participation of industry participants, including service providers and financial institutions in these markets, and our ability to pursue our Solana strategy. Additionally, U.S. state and federal and foreign regulators and legislatures have taken action against industry participants, including digital assets businesses, and enacted restrictive regimes in response to adverse publicity arising from hacks, consumer harm, or criminal activity stemming from digital assets activity. U.S. federal and state energy regulatory authorities are also monitoring the total electricity consumption of cryptocurrency mining, and the potential impacts of cryptocurrency mining to the supply and dispatch functionality of the wholesale grid and retail distribution systems. Many state legislative bodies have passed, or are actively considering, legislation to address the impact of cryptocurrency mining in their respective states.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The CFTC takes the position that some digital assets fall within the definition of a &#8220;commodity&#8221; under the CEA. Under the CEA, the CFTC has broad enforcement authority to police market manipulation and fraud in spot digital assets markets in which we may transact. Beyond instances of fraud or manipulation, the CFTC generally does not oversee cash or spot market exchanges or transactions involving digital asset commodities that do not utilize margin, leverage, or financing. In addition, CFTC regulations and CFTC oversight and enforcement authority apply with respect to futures, swaps, other derivative products and certain retail leveraged commodity transactions involving digital asset commodities, including the markets on which these products trade.</p></td></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">In addition, because transactions in Solana provide a degree of anonymity, they are susceptible to misuse for criminal activities, such as money laundering. This misuse, or the perception of such misuse, could lead to greater regulatory oversight of Solana and Solana platforms, and there is the possibility that law enforcement agencies could close Solana platforms or other Solana-related infrastructure with little or no notice and prevent users from accessing or retrieving Solana held via such platforms or infrastructure.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As noted above, activities involving Solana and other digital assets may fall within the jurisdiction of more than one financial regulator and various courts and such laws and regulations are rapidly evolving and increasing in scope.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Consumer Products Business</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We are subject to laws and regulations affecting our operations in a number of areas. These laws and regulations affect the Company&#8217;s activities in areas, including, but not limited to, the hemp business in the United States, the consumer products and nutritional supplement markets in the United States, consumer protection, labor, intellectual property ownership and infringement, import and export requirements, federal and state healthcare, environmental and safety. The successful execution of our business objectives will be contingent upon our compliance with all applicable laws and regulations and obtaining all necessary regulatory approvals, permits and registrations, which may be onerous and expensive. Any such costs, which may rise in the future as a result of changes in such applicable laws and regulations and the expansion of the Company&#8217;s business, could make our products less attractive to our customers, delay the introduction of new products, and require the Company to implement policies and procedures designed to ensure compliance with applicable laws and regulations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We operate our business in markets that are both highly regulated and rapidly evolving. We are subject to numerous federal and state laws and regulations affecting the manufacturing, packaging, labeling and sale of food, beverages, dietary supplements, and personal care products/cosmetics, as well as the use of hemp and hemp-derived ingredients like CBD in such products. The FDA regulates hemp and hemp-derived ingredients in FDA-regulated products pursuant to the provisions of the FDCA and regulations promulgated pursuant to it, in particular those related to adulteration and labeling of cosmetic, food, and dietary supplements. The FDA has issued guidance on the subject and issued letters to companies regarding claims made for products and the use of such ingredients in various products. The FDA also initiated a task force to evaluate pathways for further regulation of hemp and hemp-derived ingredients. At various times, bills pertaining to the regulation of hemp and hemp-derived ingredients have been introduced in both the U.S. Senate and the U.S. House of Representatives, and additional proposed legislation is expected to be introduced in the future to clarify the regulatory status of cannabinoids from hemp generally and CBD generally. Future legislation approved by Congress and signed by the President, or rulemaking promulgated by the FDA, could either positively or adversely impact the future sale of products by the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We are currently not subject to any foreign regulations as we do not currently distribute or export any products, including hemp or CBD related products outside the U.S. Additionally, we are not aware of any foreign regulations that we had to comply with in regard to the sale of our flavoring products to one end user customer in the U.S. who distributed such products to Europe where it had operations. The responsibility for compliance with any European regulations would be on such customer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Additionally, numerous states have passed forms of hemp legislation governing the cultivation of hemp, as well as the further processing and sale of hemp and products with hemp or hemp-derived ingredients. Those states that have not yet enacted laws or issued regulations pertaining to hemp and hemp-derived ingredients may do so in the near future. Unless Congress specifically enacts laws preempting the state regulations of hemp products, we will continue to be subject not only to federal law but various state laws. Presently, Upexi only distributes hemp-products in states that it is legal to do so. Changes in the state laws and regulations could again either positively or adversely affect our ability to sell products in those states.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Employees</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has 59 full-time employees working out of its headquarters in Tampa, Florida, its Odessa, Florida, manufacturing facility, its distribution warehouse in Tampa, Florida or individuals&#8217; home-based offices.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-top:#000000 1px solid;border-right:#000000 1px solid;border-bottom:#000000 1px solid;border-left:#000000 1px solid;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="4"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>THE OFFERING</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This preliminary prospectus relates to the offer and sale from time to time of up to 6,578,948 shares of Common Stock by the Selling Stockholder.&#160;</p></td></tr><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Common Stock offered by the Selling Stockholder:</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Up to 6,578,948 shares of Common Stock including 3,289,474 shares of Common Stock from the PIPE Offering, as that term is defined herein, and 3,289,474 shares of Common Stock issuable upon exercise of the Warrants, at an exercise price of $4.00 per Warrant Share. The Warrants were exercisable immediately upon issuance and may be exercised at any time until all of the Warrants issued in the PIPE Offering are exercised in full</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Common Stock outstanding prior to this offering (1)&#160;</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">63,208,083 shares of Common Stock (inclusive of the PIPE Shares).</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Common stock to be outstanding after the offering (1)</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">66,497,557&#160;shares of Common Stock, assuming the Investor exercises all Warrants.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Use of proceeds</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We will not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholder. All of the net proceeds from the sale of the PIPE Shares will go to the Selling Stockholder as described below in the sections entitled &#8220;<em>Selling Stockholder</em>&#8221; and &#8220;<em>Plan of Distribution</em>&#8221;. In the case of the Warrant Shares to be issued to the Selling Stockholder, upon exercise of the Warrants for cash, the Selling Stockholder would pay us an exercise price of $4.00 per Warrant Share, subject to any adjustment pursuant to the terms of the Warrants, or an aggregate of approximately $13 million if the Warrants are exercised in full for cash. We have agreed to bear the expenses relating to the registration of the shares of Common Stock for the Selling Stockholder.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td colspan="3" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Risk factors</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Investing in our securities is highly speculative and involves a high degree of risk. You should carefully consider the information set forth in the &#8220;<em>Risk Factors</em>&#8221; section beginning on page&#160;__ before deciding to invest in our securities.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;"><strong>Trading symbol</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our Common Stock is currently quoted on the Nasdaq Capital Market under the trading symbol &#8220;UPXI&#8221;.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">(1)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The number of shares of our Common Stock outstanding prior to and to be outstanding immediately after this offering, as set forth in the table above, is based on 63,208,083 and 66,497,557 shares outstanding as of December 1, 2025, and excludes:</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">694,478&#160;shares of our common stock issuable upon the exercise of stock options outstanding as of December 1, 2025, at a weighted average exercise price of $3.43 per share;&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">170,664&#160;shares of our common stock issuable upon exercise of warrants outstanding as of December 1, 2025, at a weighted average exercise price of $15.39 per share;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">35,479,872 shares of our common stock issuable upon the conversion of debt;</p></td></tr><tr style="height:15px"><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">138,889 shares of our common stock issuable upon the conversion of Series A Preferred Stock; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">4,514,000 shares of common stock that have been granted as a restricted stock grant under our 2019 Incentive plan and upon vesting will be issued.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="a3">RISK FACTORS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Investing in our securities involves a great deal of risk. Careful consideration should be made of the following factors as well as other information included in this prospectus before deciding to purchase our securities. There are many risks that affect our business and results of operations, some of which are beyond our control. Our business, financial condition or operating results could be materially harmed by any of these risks. This could cause the trading price of our securities to decline, and you may lose all or part of your investment. Additional risks that we do not yet know of or that we currently think are immaterial may also affect our business and results of operations.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Risks Related to Upexi</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Upexi does not anticipate paying any dividends on its common stock.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">No dividends have been paid on Upexi&#8217;s common stock. Upexi does not intend to pay cash dividends on its common stock in the foreseeable future, and anticipate that profits, if any, received from operations will be reinvested into its business. Any decision to pay dividends will depend upon its financial condition, operating results, and current and anticipated cash needs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>You may experience additional dilution in the future.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To raise additional capital, Upexi may in the future offer additional securities, including shares of its Common Stock,&#160;at prices that may not be the same as the price per share in this offering. Upexi may sell shares or other securities in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which Upexi sells additional shares of common stock, or securities convertible or exchangeable into common stock, in future transactions may be higher or lower than the price per share paid by investors in this Offering. Furthermore, sales of a substantial number of shares of Upexi&#8217;s common stock in the public markets, or the perception that such sales could occur, could depress the market price of Upexi&#8217;s common stock.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Shares eligible for future sale may adversely affect the market.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">From time to time, certain of Upexi&#8217;s stockholders may be eligible to sell all or some of their shares of common stock by means of ordinary brokerage transactions in the open market pursuant to Rule 144, promulgated under the Securities Act, subject to certain limitations. In general, pursuant to recent amendments to Rule 144, a non-affiliate stockholder who has satisfied a six-month holding period may, under certain circumstances, sell its shares, without limitation. Any substantial sale of Upexi&#8217;s common stock pursuant to Rule 144 or pursuant to any resale prospectus (including sales by investors of securities purchased in this offering) may have a material adverse effect on the market price of the common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Our limited operating history makes it difficult for potential investors to evaluate our business prospects and management.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company was incorporated on&#160;September 5, 2018, and only commenced operations thereafter. Accordingly, we have a limited operating history upon which to base an evaluation of our business and prospects. Operating results for future periods are subject to numerous uncertainties, and we cannot assure you that the Company will achieve or sustain profitability in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company&#8217;s prospects must be considered in light of the risks encountered by companies in the early stage of development, particularly companies in new and rapidly evolving markets. Future operating results will depend upon many factors, including our success in attracting and retaining motivated and qualified personnel, our ability to establish short term credit lines or obtain financing from other sources, such as this Offering, our ability to develop and market new products, our ability to control costs, and general economic conditions. We cannot assure you that the Company will successfully address any of these risks. There can be no assurance that our efforts will be successful or that we will ultimately be able to attain profitability.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>If we are unable to protect our intellectual property rights, our competitive position could be harmed.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our commercial success will depend in part on our ability to obtain and maintain appropriate intellectual property protection in the United States and foreign countries with respect to our proprietary formulations and products. Our ability to successfully implement our business plan depends on our ability to build and maintain brand recognition using trademarks, service marks, trade dress and other intellectual property. We may rely on trade secrets, trademark, patent and copyright laws, and confidentiality and other agreements with employees and third parties, all of which offer only limited protection. The steps we have taken and the steps we will take to protect our proprietary rights may not be adequate to preclude misappropriation of our proprietary information or infringement of our intellectual property rights. If our efforts to protect our intellectual property are unsuccessful or inadequate, or if any third party misappropriates or infringes on our intellectual property, the value of our brands may be harmed, which could have a material adverse effect on the Company&#8217;s business and prevent our brands from achieving or maintaining market acceptance. Protecting against unauthorized use of our trademarks and other intellectual property rights may be expensive, difficult and in some cases not possible. In some cases, it may be difficult or impossible to detect third-party infringement or misappropriation of our intellectual property rights and proving any such infringement may be even more difficult.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We may not be able to effectively manage growth.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As we continue to grow our business and develop products, we expect to need additional research, development, managerial, operational, sales, marketing, financial, accounting, legal and other resources. The Company expects its growth to place a substantial strain on its managerial, operational and financial resources. The Company cannot assure that it will be able to effectively manage the expansion of its operations, or that its facilities, systems, procedures or controls will be adequate to support its operations. The Company&#8217;s inability to manage future growth effectively would have a material adverse effect on its business, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Our management may not be able to control costs in an effective or timely manner.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company&#8217;s management has made reasonable efforts to assess, predict and control costs and expenses. However, the Company only has a brief operating history upon which to base those efforts. Implementing our business plan may require more employees, capital equipment, supplies or other expenditure items than management has predicted. Likewise, the cost of compensating employees and consultants or other operating costs may be higher than management&#8217;s estimates, which could lead to sustained losses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We expect our quarterly financial results to fluctuate.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We expect our net sales and operating results to vary significantly from quarter to quarter due to a number of factors, including changes in:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Demand for our products;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our ability to obtain and retain existing customers or encourage repeat purchases;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our ability to manage our product inventory;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">General economic conditions, both domestically and in foreign markets;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Advertising and other marketing costs; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Costs of creating and expanding product lines.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As a result of the variability of these and other factors, our operating results in future quarters may be below the expectations of our stockholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We&#160;are subject to the reporting requirements of U.S. federal securities laws, which can be expensive.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We are subject to the information and reporting requirements of the Exchange Act and other federal securities laws, including compliance with the Sarbanes-Oxley Act. The costs of preparing and filing annual and quarterly reports, proxy statements and other information with the SEC and furnishing audited consolidated financial statements to stockholders will cause our expenses to be higher than they would have if we had remained privately held. In addition, it may be time-consuming, difficult and costly for us to develop and implement the corporate governance requirements, internal controls and reporting procedures required by the federal securities laws. This may divert management&#8217;s attention from other business concerns, which could have a material adverse effect on our business, financial condition, and results of operations. We may need to hire additional financial reporting, internal controls and other finance personnel in order to develop and implement appropriate internal controls and reporting procedures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Cybersecurity breaches of our IT systems could degrade our ability to conduct our business operations and deliver products and services to our customers, delay our ability to recognize revenue, compromise the integrity of our software products, result in significant data losses and the theft of our intellectual property, damage our reputation, expose us to liability to third parties and require us to incur significant additional costs to maintain the security of our networks and data.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We increasingly depend upon our IT systems to conduct virtually all of our business operations, ranging from our internal operations and product development activities to our marketing and sales efforts and communications with our customers and business partners. Computer programmers may attempt to penetrate our network security, or that of our website, and misappropriate our proprietary information or cause interruptions of our service. Because the techniques used by such computer programmers to access or sabotage networks change frequently and may not be recognized until launched against a target, we may be unable to anticipate these techniques. In addition, sophisticated hardware and operating system software and applications that we produce or procure from third parties may contain defects in design or manufacture, including &#8220;bugs&#8221; and other problems that could unexpectedly interfere with the operation of the system. We have also outsourced a number of our business functions to third-party contractors, including our manufacturers and logistics providers, and our business operations also depend, in part, on the success of our contractors&#8217; own cybersecurity measures. Similarly, we rely upon distributors, resellers and system integrators to sell our products and our sales operations depend, in part, on the reliability of their cybersecurity measures. Additionally, we depend upon our employees to appropriately handle confidential data and deploy our IT resources in a safe and secure fashion that does not expose our network systems to security breaches and the loss of data. Accordingly, if our cybersecurity systems and those of our contractors fail to protect against unauthorized access, sophisticated cyberattacks and the mishandling of data by our employees and contractors, our ability to conduct our business effectively could be damaged in a number of ways.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We may incur significant costs and require significant management resources to evaluate our internal control over financial reporting as required under Section 404 of the Sarbanes-Oxley Act, and any failure to comply or any adverse result from such evaluation may have an adverse effect on our stock price.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As a smaller reporting company, as defined in Rule 12b-2 under the Exchange Act, we will be required to evaluate our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002 (&#8220;Section 404&#8221;) and to include an internal control report. This report must include management&#8217;s assessment of the effectiveness of our internal control over financial reporting as of the end of the fiscal year. This report must also include disclosure of any material weaknesses in internal control over financial reporting that we have identified. Failure to comply, or any adverse results from such an evaluation could result in a loss of investor confidence in our financial reports and have an adverse effect on the trading price of our equity securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Increases in costs, disruption of supply or shortage of raw materials could harm our business.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials. Any such increase or supply interruption could materially negatively impact our business, prospects, financial condition and operating results. We use various raw materials in our business including industrial hemp, pecmate, pectin and other raw materials used in the product manufacturing process. The prices for these raw materials fluctuate depending on market conditions and global demand for these materials and could adversely affect our business and operating results. Substantial increases in the prices for our raw materials increase our operating costs and could reduce our margins if we cannot recoup the increased costs through increased prices for our products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Our failure to meet the continuing listing requirements of the Nasdaq Capital Market could result in a de-listing of our securities.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If we fail to satisfy the continuing listing requirements of Nasdaq, such as the corporate governance, stockholders&#8217; equity or minimum closing bid price requirements, Nasdaq may take steps to delist our Common Stock. Such a delisting would likely have a negative effect on the price of our Common Stock and would impair your ability to sell or purchase our Common Stock when you wish to do so. In the event of a delisting, we would likely take actions to restore our compliance with Nasdaq&#8217;s listing requirements, but we can provide no assurance that any such action taken by us would allow our Common Stock to become listed again, stabilize the market price or improve the liquidity of our securities, prevent our Common Stock from dropping below the Nasdaq minimum bid price requirement or prevent future non-compliance with Nasdaq&#8217;s listing requirements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could adversely affect our operating results.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company, including costs associated with public company reporting and corporate governance requirements. These requirements include compliance with Section 404 and other provisions of the Sarbanes-Oxley Act, as well as rules implemented by the Securities and Exchange Commission, or SEC, and the Nasdaq. In addition, our management team will also have to adapt to the requirements of being a public company. We expect complying with these rules and regulations will substantially increase our legal and financial compliance costs and make some activities more time-consuming and costly.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The increased costs associated with operating as a public company will decrease our net income or increase our net loss and may require us to reduce costs in other areas of our business or increase the prices of our products. Additionally, if these requirements divert our management&#8217;s attention from other business concerns, they could have a material adverse effect on our business, financial condition and operating results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As a public company, we also expect that it may be more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our board of directors or as our executive officers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We are eligible to be treated as an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and a &#8220;smaller reporting company&#8221; within the meaning of the Securities Act, and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies or smaller reporting companies will make our Common Stock less attractive to investors.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including (1) not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, (2) reduced disclosure obligations regarding executive compensation in this annual report and our periodic reports and proxy statements and (3) exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. In addition, as an emerging growth company, we are only required to provide two years of audited consolidated financial statements and two years of selected financial data in this annual report. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our Common Stock held by non-affiliates exceeds $700.0 million as of any December 31 before that time or if we have total annual gross revenue of $1.0 billion or more during any fiscal year before that time, after which, in each case, we would no longer be an emerging growth company as of the following December 31 or, if we issue more than $1.0 billion in non-convertible debt during any three-year period before that time, we would cease to be an emerging growth company immediately.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Additionally, we are a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited consolidated financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our shares of Common Stock held by non-affiliates exceeds $250 million as of the prior the end of our second fiscal quarter ending December 31 of each year, or (2) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our ordinary shares held by non-affiliates exceeds $700 million as of the prior to the end of our second fiscal quarter ending December 31 of each year. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our consolidated financial statements with other public companies difficult or impossible.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">After we are no longer an &#8220;emerging growth company,&#8221; we expect to incur additional management time and cost to comply with the more stringent reporting requirements applicable to companies that are deemed accelerated filers or large accelerated filers, including complying with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We cannot predict or estimate the amount of additional costs we may incur or the timing of such costs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Risks Relating to Our Business and Industry</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We operate in a highly competitive environment, and if we are unable to compete with our competitors, our business, financial condition, results of operations, cash flows and prospects could be materially adversely affected.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We operate in a highly competitive environment. Our competition includes all other companies that are in the business of producing or distributing hemp-based products for personal use or consumption. Many of our competitors have greater resources that may enable them to compete more effectively than us in the CBD industry.<strong>&#160;</strong>Some of our competitors have a longer operating history and greater capital resources, facilities and product line diversity, which may enable them to compete more effectively in this market. Our competitors may devote their resources to developing and marketing products that will directly compete with our product lines. The Company expects to face additional competition from existing competitors and new market entrants. If a significant number of new entrants enter the market in the near term, the Company may experience increased competition for market share and may experience downward pricing pressure on the Company&#8217;s products as new entrants increase production. Such competition may cause us to encounter difficulties in generating revenues and market share, and in positioning our products in the market. If we are unable to successfully compete with existing companies and new entrants to the market, our lack of competitive advantage will have a negative impact on our business and financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Unfavorable publicity or consumer perception of our products or similar products developed and distributed by other companies could have a material adverse effect on our reputation, which could result in decreased sales and fluctuations in our business, financial condition and results of operations.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We depend on consumer perception regarding the safety and quality of our products, as well as similar products marketed and distributed by other companies. Consumer perception of hemp-based products can be significantly influenced by adverse publicity in the form of published scientific research, national media attention or other publicity, which may associate consumption of our products or other similar products with adverse effects or question the benefits and/or effectiveness of our products or similar products. A new product may initially be received favorably, resulting in high sales of that product, but that level of sales may not be sustainable as consumer preferences change over time. Future scientific research or publicity could be unfavorable to our industry or any of our particular products and may not be consistent with earlier favorable research or publicity. Unfavorable research or publicity could have a material adverse effect on our ability to generate sales.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Our failure to appropriately and timely respond to changing consumer preferences and demand for new products could significantly harm our customer relationships and have a material adverse effect on our business, financial condition and results of operations.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our business is subject to changing consumer trends and preferences. Our failure to accurately predict or react to these trends could negatively impact on consumer opinion of us as a source for the latest products, which in turn could harm our customer relationships and cause us to lose market share. The success of our product offerings depends upon a number of factors, including our ability to:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Anticipate customer needs;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Innovate and develop new products;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Successfully introduce new products in a timely manner;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Price our products competitively with retail and online competitors;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Deliver our products in sufficient volumes and in a timely manner; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Differentiate our product offerings from those of our competitors.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If we do not introduce new products or make enhancements to meet the changing needs of our customers in a timely manner, some of our products could be rendered obsolete, which could have a material adverse effect on our financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Future acquisitions or strategic investments and partnerships could be difficult to identify and integrate with our business, disrupt our business, and adversely affect our financial condition and results of operations.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We may seek to acquire or invest in businesses and product lines that we believe could complement or expand our product offerings, or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various expenses in identifying, investigating, and pursuing suitable acquisitions, whether or not the acquisitions are completed. Future acquisitions could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our financial position and results of operations. In addition, if an acquired business or product line fails to meet our expectations, our business, financial condition, and results of operations may be adversely affected.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Failure to successfully integrate acquired businesses and their products and other assets into our Company, or if integrated, failure to further our business strategy, may result in our inability to realize any benefit from such acquisition.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We expect to grow by acquiring relevant businesses, including other cannabis-related businesses. The consummation and integration of any acquired business, product or other assets into our Company may be complex and time consuming and, if such businesses and assets are not successfully integrated, we may not achieve the anticipated benefits, cost-savings or growth opportunities. Furthermore, these acquisitions and other arrangements, even if successfully integrated, may fail to further our business strategy as anticipated, expose our Company to increased competition or other challenges with respect to our products or geographic markets, and expose us to additional liabilities associated with an acquired business, technology or other asset or arrangement.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>The failure to attract and retain key employees could hurt our business.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our success also depends upon our ability to attract and retain numerous highly qualified employees. The loss of one or more members of our management team or other key employees or consultants could materially harm our business, financial condition, results of operations and prospects. We face competition for personnel and consultants from other companies, universities, public and private research institutions, government entities and other organizations. Our failure to attract and retain skilled management and employees may prevent or delay us from pursuing certain opportunities. If we fail to successfully fill many management roles, fail to fully integrate new members of our management team, lose the services of key personnel, or fail to attract additional qualified personnel, it will be significantly more difficult for us to achieve our growth strategies and success.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We have limited supply sources, and price increases or supply shortages of key raw materials could materially and adversely affect our business, financial condition and results of operations.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our products are composed of certain key raw materials. If the prices of such raw materials increase significantly, it could result in a significant increase in our product development costs. If raw material prices increase in the future, we may not be able to pass on such price increases to our customers. A significant increase in the price of raw materials that cannot be passed on to customers could have a material adverse effect on our business, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company believes that its continued success will depend upon the availability of raw materials that permit the Company to meet its labeling claims and quality control standards. The supply of our industrial hemp is subject to the same risks normally associated with agricultural production, such as climactic conditions, insect infestations and availability of manual labor or equipment for harvesting. Any significant delay in or disruption of the supply of raw materials could substantially increase the cost of such materials, could require product reformulations, the qualification of new suppliers and repackaging and could result in a substantial reduction or termination by the Company of its sales of certain products, any of which could have a material adverse effect upon the Company. Accordingly, there can be no assurance that the disruption of the Company&#8217;s supply sources will not have a material adverse effect on the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Loss of key contracts with our suppliers, renegotiation of such agreements on less favorable terms or other actions these third parties may take could harm our business.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Most of our agreements with suppliers of our industrial hemp, including our key supplier contract, are short term. The loss of these agreements, or the renegotiation of these agreements on less favorable economic or other terms, could limit our ability to procure raw material to manufacture our products. This could negatively affect our ability to meet consumer demand for our products. Upon expiration or termination of these agreements, our competitors may be able to secure industrial hemp from our existing suppliers which will put the company at a competitive disadvantage in the market.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>There is limited availability of clinical studies.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Although hemp plants have a long history of human consumption, there is little long-term experience with human consumption of certain of these innovative product ingredients or combinations thereof in concentrated form. Although the Company performs research and/or tests the formulation and production of its products, there is limited clinical data regarding the safety and benefits of ingesting industrial hemp-based products. Any instance of illness or negative side effects of ingesting industrial hemp-based products would have a material adverse effect on our business and operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We face substantial risk of product liability claims and potential adverse product publicity.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Like any other retailer, distributor or manufacturer of products that are designed to be ingested, we face an inherent risk of exposure to product liability claims, regulatory action and litigation if our products are alleged to have caused loss or injury. In the event we do not have adequate insurance or contractual indemnification, product liability claims could have a material adverse effect on the Company. The Company is not currently a named defendant in any product liability lawsuit; however, other manufacturers and distributors of hemp-based products currently are or have been named as defendants in such lawsuits. The successful assertion or settlement of any uninsured claim, a significant number of insured claims, or a claim exceeding the Company&#8217;s insurance coverage could have a material adverse effect on the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We may be unable to attract and retain independent distributors for our products.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As a direct selling company, our revenue depends in part upon the number and productivity of our independent distributors. Like most direct selling companies, we experience high levels of turnover among our independent distributors from year to year, who may terminate their service at any time. Generally, we need to increase the productivity of our independent distributors and/or retain existing independent distributors and attract additional independent distributors to maintain and/or increase product sales. Many factors affect our ability to attract and retain independent distributors, including the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">publicity regarding our Company, our products, our distribution channels and our competitors;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">public perceptions regarding the value and efficacy of our products;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">ongoing motivation of our independent distributors;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">government regulations;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">general economic conditions;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">our compensation arrangements, training and support for our independent distributors; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">competition in the market.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our results of operations and financial condition could be materially and adversely affected if our independent distributors are unable to maintain their current levels of productivity, or if we are unable to retain existing distributors and attract new distributors in sufficient numbers to maintain present sales levels and sustain future growth.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We could incur obligations resulting from the activities of our independent distributors.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We sell our products through a network of independent distributors. Independent distributors are independent contractors who operate their own business separately and apart from the Company. We may not be able to control certain aspects of our distributors&#8217; activities that may impact our business. If local laws and regulations, or the interpretation thereof, change and require us to treat our independent distributors as employees, or if our independent distributors are deemed by local regulatory authorities in one or more of the jurisdictions in which we operate to be our employees rather than independent contractors under existing laws and interpretations, we may be held responsible for a variety of obligations that are imposed upon employers relating to their employees, including employment-related taxes and penalties, which could have a material adverse effect on our financial condition and results of operations. In addition, there is the possibility that some jurisdictions may seek to hold us responsible for false product or earnings-related claims due to the actions of our independent distributors. Liability for any of these issues could have a material adverse effect on our business, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>If our independent distributors&#8217; failure to comply with applicable advertising laws and regulations could adversely affect our financial conditions and results of operations.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The advertisement of our products is subject to extensive regulations in the markets in which we do business. Our independent distributors may fail to comply with such regulations governing the advertising of our products. We cannot ensure that all marketing materials used by our independent distributors comply with applicable regulations, including bans on false or misleading product and earnings-related claims. If our independent distributors fail to comply with applicable regulations, we could be subjected to claims of false advertising, misrepresentation, significant financial penalties, and/or costly mandatory product recalls and relabeling requirements with respect to our products, any of which could have a material adverse effect on our business, reputation, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Risks Relating to Investing in Solana</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>The launch of central bank digital currencies (&#8220;CBDCs&#8221;) may adversely impact our business.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The introduction of a government-issued digital currency could eliminate or reduce the need or demand for private-sector issued crypto currencies or significantly limit their utility. National governments around the world could introduce CBDCs, which could in turn limit the size of the market opportunity for cryptocurrencies, including Solana.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Absent federal regulations, there is a possibility that Solana may be classified as a &#8220;security.&#8221; Any classification of Solana as a &#8220;security&#8221; would subject us to additional regulation and could materially impact the operation of our business.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We believe that Solana is not a security but neither the SEC nor any other U.S. federal or state regulator publicly stated whether they agree with our assessment. Despite the Trump Administration&#8217;s Executive Order titled &#8220;Strengthening American Leadership in Digital Financial Technology&#8221; which includes as an objective, &#8220;protecting and promoting the ability of individual citizens and private sector entities alike to access and &#8230; to maintain self-custody of digital assets,&#8221; Solana has not yet been classified with respect to U.S. federal securities laws. Therefore, while (for the reasons discussed below) we have concluded that Solana is not a &#8220;security&#8221; within the meaning of the U.S. federal securities laws, and registration of the Company under The Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;) is therefore not required under the applicable securities laws, we acknowledge that a regulatory body or federal court may determine otherwise. Our conclusion, even if reasonable under the circumstances, would not preclude legal or regulatory action based on such a finding that Solana is a &#8220;security&#8221; which would require us to register as an investment company under the 1940 Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We have also adapted our process for analyzing the U.S. federal securities law status of Solana and other cryptocurrencies over time, as guidance and case law have evolved. As part of our U.S. federal securities law analytical process, we take into account a number of factors, including the various definitions of &#8220;security&#8221; under U.S. federal securities laws and federal court decisions interpreting the elements of these definitions, such as the U.S. Supreme Court&#8217;s decisions in the <em>Howey</em> and <em>Reves </em>cases, as well as court rulings, reports, orders, press releases, public statements, and speeches by the SEC Commissioners and SEC Staff providing guidance on when a digital asset or a transaction to which a digital asset may relate may be a security for purposes of U.S. federal securities laws. Our position that Solana is not a &#8220;security&#8221; is premised, among other reasons, on our conclusion Solana does not meet the elements of the <em>Howey</em> test. Among the reasons for our conclusion that Solana is not a security is that holders of Solana do not have a reasonable expectation of profits from our efforts in respect of their holding of Solana. Also, Solana ownership does not convey the right to receive any interest, rewards, or other returns</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We acknowledge, however, that the SEC, a federal court or another relevant entity could take a different view. The regulatory treatment of Solana is such that it has drawn significant attention from legislative and regulatory bodies, in particular the SEC which has previously stated it deemed Solana a security.. Application of securities laws to the specific facts and circumstances of digital assets is complex and subject to change. Our conclusion, even if reasonable under the circumstances, would not preclude legal or regulatory action based on a finding that Solana, or any other digital asset we might hold is a &#8220;security.&#8221; As such, we are at risk of enforcement proceedings against us, which could result in potential injunctions, cease-and-desist orders, fines, and penalties if Solana was determined to be a security by a regulatory body or a court. Such developments could subject us to fines, penalties, and other damages, and adversely affect our business, results of operations, financial condition, and prospects.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>If we were deemed to be an investment company under the 1940 Act, applicable restrictions likely would make it impractical for us to continue segments of our business as currently contemplated.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Under Sections 3(a)(1)(A) and (C) of the 1940 Act, a company generally will be deemed to be an &#8220;investment company&#8221; if (i) it is, or holds itself out as being, engaged primarily, or proposes to engage primarily, in the business of investing, reinvesting, or trading in securities or (ii) it engages, or proposes to engage, in the business of investing, reinvesting, owning, holding, or trading in securities and it owns or proposes to acquire investment securities having a value exceeding 40% of the value of its total assets (exclusive of U.S. government securities, shares of registered money market funds under Rule 2a-7 of the 1940 Act, and cash items) on an unconsolidated basis. Rule 3a-1 under the 1940 Act generally provides that notwithstanding the Section 3(a)(1)(C) test described in clause (ii) above, an entity will not be deemed to be an &#8220;investment company&#8221; for purposes of the 1940 Act if no more than 45% of the value of its assets (exclusive of U.S. government securities, shares of registered money market funds under Rule 2a-7 of the 1940 Act, and cash items) consists of, and no more than 45% of its net income after taxes (for the past four fiscal quarters combined) is derived from, securities other than U.S. government securities, shares of registered money market funds under Rule 2a-7 of the 1940 Act, securities issued by employees&#8217; securities companies, securities issued by qualifying majority owned subsidiaries of such entity, and securities issued by qualifying companies that are controlled primarily by such entity. We do not believe that we are an &#8220;investment company&#8221; as such term is defined in either Section 3(a)(1)(A) or Section 3(a)(1)(C) of the 1940 Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">26</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Since our formation, we have been a brand owner specializing in the development, manufacturing and distribution of consumer products.&#160;Recently, we have begun focusing on pursuing opportunities to expand our portfolio into coins, digital assets and M&amp;A in the fintech space. With respect to Section 3(a)(1)(A), following the Offering, approximately 97% percent of the proceeds of the Offering will be used to acquire Solana, which will be an amount in excess of 40% of our total assets. Since we believe Solana is not an investment security, we do not hold ourselves out as being engaged primarily, or propose to engage primarily, in the business of investing, reinvesting, or trading in securities within the meaning of Section&#160;3(a)(1)(A) of the 1940 Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">With respect to Section 3(a)(1)(C), we believe we satisfy the elements of Rule 3a-1 and therefore are deemed not to be an investment company under, and we intend to conduct our operations such that we will not be deemed an investment company under, Section 3(a)(1)(C). We believe that we are not an investment company pursuant to Rule 3a-1 under the 1940 Act because, on a consolidated basis with respect to wholly-owned subsidiaries but otherwise on an unconsolidated basis, no more than 45% of the value of the Company&#8217;s total assets (exclusive of U.S. government securities, shares of registered money market funds under Rule 2a-7 of the 1940 Act, and cash items) consists of, and no more than 45% of the Company&#8217;s net income after taxes (for the last four fiscal quarters combined) is derived from, securities other than U.S. government securities, shares of registered money market funds under Rule 2a-7 of the 1940 Act, securities issued by employees&#8217; securities companies, securities issued by qualifying majority owned subsidiaries of the Company, and securities issued by qualifying companies that are controlled primarily by the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana and other digital assets, as well as new business models and transactions enabled by blockchain technologies, present novel interpretive questions under the 1940 Act. There is a risk that assets or arrangements that we have concluded are not securities could be deemed to be securities by the SEC or another authority for purposes of the 1940 Act, which would increase the percentage of securities held by us for 1940 Act purposes. The SEC has requested information from a number of participants in the digital assets ecosystem, regarding the potential application of the 1940 Act to their businesses. For example, in an action unrelated to the Company, in February 2022, the SEC issued a cease-and-desist order under the 1940 Act to BlockFi Lending LLC, in which the SEC alleged that BlockFi was operating as an unregistered investment company because it issued securities and also held more than 40% of its total assets, excluding cash, in investment securities, including the loans of digital assets made by BlockFi to institutional borrowers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If we were deemed to be an investment company, Rule 3a-2 under the 1940 Act is a safe harbor that provides a one-year&#160;grace period for transient investment companies that have a bona fide intent to be engaged primarily, as soon as is reasonably possible (in any event by the termination of such one-year period), in a business other than that of investing, reinvesting, owning, holding, or trading in securities, with such intent evidenced by the company&#8217;s business activities and an appropriate resolution of its board of directors. The grace period is available not more than once every three years and runs from the earlier of (i) the date on which the issuer owns securities and/or cash having a value exceeding 50% of the issuer&#8217;s total assets on either a consolidated or unconsolidated basis or (ii) the date on which the issuer owns or proposes to acquire investment securities having a value exceeding 40% of the value of such issuer&#8217;s total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Accordingly, the grace period may not be available at the time that we seek to rely on Rule 3a-2; however, Rule 3a-2 is a safe harbor and we may rely on any exemption or exclusion from investment company status available to us under the 1940 Act at any given time. Furthermore, reliance on Rule 3a-2, Section 3(a)(1)(C), or Rule 3a-1 could require us to take actions to dispose of securities, limit our ability to make certain investments or enter into joint ventures, or otherwise limit or change our service offerings and operations. If we were to be deemed an investment company in the future, restrictions imposed by the 1940 Act&#8212;including limitations on our ability to issue different classes of stock and equity compensation to directors, officers, and employees and restrictions on management, operations, and transactions with affiliated persons&#8212;likely would make it impractical for us to continue our business as contemplated, and could have a material adverse effect on our business, results of operations, financial condition, and prospects.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We may be subject to regulatory developments related to crypto assets and crypto asset markets, which could adversely affect our business, financial condition, and results of operations.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As Solana and other digital assets are relatively novel and the application of state and federal securities laws and other laws and regulations to digital assets is unclear in certain respects, it is possible that regulators in the United States or foreign countries may interpret or apply existing laws and regulations in a manner that adversely affects the price of Solana. The U.S. federal government, states, regulatory agencies, and foreign countries may also enact new laws and regulations, or pursue regulatory, legislative, enforcement or judicial actions, that could materially impact the price of Solana or the ability of individuals or institutions such as us to own or transfer Solana.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If Solana is determined to constitute a security for purposes of the federal securities laws, the additional regulatory restrictions imposed by such a determination could adversely affect the market price of Solana and in turn adversely affect the market price of our common stock. Moreover, the risks of us engaging in a Solana treasury strategy have created, and could continue to create complications due to the lack of experience that third parties have with companies engaging in such a strategy, such as increased costs of director and officer liability insurance or the potential inability to obtain such coverage on acceptable terms in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">27</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Engaging in certain activities involving crypto assets classified as commodities, could subject us to additional regulation by the Commodity Futures Trading Commission (&#8220;CFTC&#8221;), and potentially oversight by the National Futures Association (&#8220;NFA&#8221;).</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If our activities require CFTC registration, we may be required to comply with extensive regulatory obligations, which could result in significant costs and operational disruptions. For example, depending on our activities, we could be required to register a commodity pool, commodity pool operator, and/or commodity trading advisor with the CFTC through the NFA. Compliance with these additional regulatory requirements could result in substantial,&#160;non-recurring expenses, adversely affecting an investment in our securities. If we determine not to comply with such regulations, we may be forced to cease certain operations, which could negatively impact our investors. Additionally, current and future legislative or regulatory developments, including new CFTC interpretations, could impact how crypto assets are classified and traded.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Regulatory scrutiny or shifting enforcement priorities could subject our crypto asset activities to significant compliance costs, legal liabilities, and operational disruptions, even absent formal classification as securities or commodities.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our Solana asset activities are subject to a rapidly evolving and uncertain regulatory environment involving multiple jurisdictions and regulatory authorities, including the SEC, CFTC, FinCEN, and various state and foreign regulators. Regulatory authorities across different countries often adopt inconsistent or conflicting approaches toward cryptocurrencies and related services, leading to uncertainty in regulatory application. Even absent formal classification of our crypto assets as securities, commodities, or other regulated products, shifting regulatory interpretations or enforcement priorities could significantly increase scrutiny of our activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Recent enforcement actions in the cryptocurrency industry illustrate the potential for rapid and unforeseen changes in regulatory stances. Should regulators assert jurisdiction over our crypto asset activities, we may face substantial compliance costs, legal liabilities, operational disruptions, reputational harm, or be compelled to substantially alter or discontinue certain activities altogether.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This regulatory uncertainty elevates the risk of inadvertent violations, potentially resulting in enforcement actions, sanctions, or cease-and-desist orders requiring immediate changes to our business operations. Furthermore, new legislation or regulatory actions could ban, restrict, or impose stringent licensing or operational requirements on crypto asset activities. Given the interconnected nature of global regulatory oversight, regulatory developments in one jurisdiction can prompt similar actions elsewhere, amplifying the compliance burdens we face and further increasing operational complexity and costs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We may also face litigation or regulatory enforcement actions related to crypto asset transactions, custody, disclosures, staking, or compliance practices. Regulatory agencies, including the SEC, CFTC, state regulators, or private plaintiffs, could assert claims alleging violations of securities laws, fraud, fiduciary breaches, or other misconduct. Defending such actions would involve significant costs, consume substantial management resources, and could result in adverse judgments, regulatory fines, cease-and-desist&#160;orders, forced operational modifications, or reputational damage that materially impact our business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Companies that adopt crypto asset treasury or similar activities have also historically been subject to increased scrutiny from regulators, investors, and the public. Some transitions have triggered enforcement actions, investigations, and litigation relating to inadequate or misleading disclosures, potential insider trading, regulatory noncompliance, and operational deficiencies. We may similarly face heightened regulatory oversight and investor scrutiny, increasing the risk of litigation or regulatory investigations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Our management relies upon the advice of an asset manager through an asset management agreement to assist in building a narrowly focused investment strategy and the execution of the Company&#8217;s strategy and may not yield the desired return.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our management and our asset managers will have broad discretion in the application of the net proceeds from any offering by the Company and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our common stock. The failure to apply these funds effectively could result in financial losses that could cause the price of our common stock to decline.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We may use the net proceeds from any offering by the Company to purchase additional Solana, the price of which has been, and will likely continue to be, highly volatile.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We may use the net proceeds from any offering by the Company to purchase additional Solana. Solana is a highly volatile asset. Solana does not pay interest, but if management determines to stake the Solana tokens in treasury, rewards can be earned on Solana. The ability to generate a return on investment from the net proceeds from any offering by the Company will depend on whether there is appreciation in the value of Solana following our purchases of Solana with the net proceeds from any offering by the Company. Future fluctuations in Solana&#8217;s trading prices may result in our converting Solana purchased with the net proceeds from any offering into cash with a value substantially below the net proceeds from such an offering.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">28</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Momentum pricing</em></strong><strong>.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The value of a single unit of SOL as represented by the Index may also be subject to momentum pricing due to speculation regarding future appreciation in value, leading to greater volatility that could adversely affect the value of the Shares. Momentum pricing typically is associated with growth stocks and other assets whose valuation, as determined by the investing public, is impacted by appreciation in value. Momentum pricing may result in speculation regarding future appreciation in the value of digital assets, which inflates prices and leads to increased volatility. As a result, SOL may be more likely to fluctuate in value due to changing investor confidence in future appreciation or depreciation in prices, which could adversely affect the price of SOL, and, in turn, our stock price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>The trading prices of many digital assets, including SOL, have experienced extreme volatility in recent periods and may continue to do so. Extreme volatility in the future, including declines in the trading prices of SOL, could have a material adverse effect on the value of the Shares and the Shares could lose all or substantially all of their value</em></strong><em>.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The trading prices of many digital assets, including SOL, have experienced extreme volatility throughout their existence, including in recent periods and may continue to do so. For instance, following significant increases throughout the majority of 2020, digital asset prices, including SOL, experienced significant volatility throughout 2021 and 2022. This volatility became extreme in November 2022 when FTX Trading Ltd. (&#8220;FTX&#8221;) halted customer withdrawals. Developments during the last cryptocurrency bear market led to extreme volatility and disruption in digital asset markets, a loss of confidence in participants of the digital asset ecosystem, significant negative publicity surrounding digital assets broadly and market-wide declines in liquidity. Digital asset prices, including SOL, have continued to fluctuate widely through the date of this prospectus. For example, according to Bloomberg, Solana&#8217;s 90-day realized volatility has generally ranged from 70-100% over the last several months.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Extreme volatility in the future, including declines in the trading prices of SOL, could have a material adverse effect on the value of the Shares and the Shares could lose all or substantially all of their value. Furthermore, negative perception, a lack of stability and standardized regulation in the digital asset economy may reduce confidence in the digital asset economy and may result in greater volatility in the price of SOL and other digital assets, including a depreciation in value.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Currently, we do not hedge against SOL volatility, as our goal is to benefit shareholders through long-term value appreciation rather than short-term hedging. While we may consider hedging strategies for our treasury or acquisitions in the future, there is no guarantee they will significantly reduce digital asset volatility or increase the treasury's value.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Furthermore, changes in U.S. political leadership and economic policies may create uncertainty that materially affects the price of SOL and the Company&#8217;s Share Price. For example, on March 6, 2025, President Trump signed an Executive Order to establish a Strategic Bitcoin Reserve and a United States Digital Asset Stockpile. Pursuant to this Executive Order, the Strategic Bitcoin Reserve will be capitalized with Bitcoin owned by the Department of Treasury that was forfeited as part of criminal or civil asset forfeiture proceedings, and the Secretaries of Treasury and Commerce are authorized to develop budget-neutral strategies for acquiring additional bitcoin, provided that those strategies impose no incremental costs on American taxpayers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>There are numerous companies announcing their intention to build a digital asset treasury and specifically SOL treasury.&#160; This concentration of SOL holdings within a few treasury companies could cause the price of SOL to rapidly decline based on one or more of these treasury companies liquidating their position and could have a material adverse effect on the value of the Shares and the Shares could lose all or substantially all of their value</em></strong><em>.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">There are currently a number of public companies that have announced intentions to accumulate Solana tokens, in addition to certain public companies that have already amassed Solana tokens as part of digital asset treasury strategies. This pool of buyers or potential buyers can significantly affect volume of transactions that would not otherwise exist and lead to concentrations of Solana tokens. The potential effect of such scale is a concentration of holdings that may lead to a wide range of price movements, whether that be increases to the upside or decreases to the downside. We cannot assure stability of prices of Solana tokens and to the extent the market price of our common stock moves in alignment with the price of Solana, we cannot assure stability with respect to the market price of our common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">29</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Our Solana holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalents.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Historically, the crypto markets have been characterized by: significant volatility in price, limited liquidity and trading volumes compared to sovereign currencies markets; relative anonymity; a developing regulatory landscape; potential susceptibility to market abuse and manipulation; compliance and internal control failures at exchanges; and various other risks inherent in its entirely electronic, virtual form and decentralized network. During times of market instability, we may not be able to sell our Solana at favorable prices or at all. Further, Solana which we hold with our custodians does not enjoy the same protections as are available to cash or securities deposited with or transacted by institutions subject to regulation by the Federal Deposit Insurance Corporation or the Securities Investor Protection Corporation. Additionally, pursuant to the asset management agreement we entered into with the asset manager, we are currently and may generally be unable to enter into term loans or other capital raising transactions collateralized by our unencumbered Solana or otherwise generate funds using our Solana holdings, including in particular during times of market instability or when the price of Solana has declined significantly. If we are unable to sell our Solana, enter into additional capital raising transactions using Solana as collateral, or otherwise generate funds using our Solana holdings, or if we are forced to sell our Solana at a significant loss, in order to meet our working capital requirements, our business and financial condition could be negatively impacted.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisers.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Mutual funds, exchange-traded funds and their directors and management are subject to extensive regulation as &#8220;investment companies&#8221; and &#8220;investment advisers&#8221; under U.S. federal and state law; this regulation is intended for the benefit and protection of investors. We are not subject to, and do not otherwise voluntarily comply with, these laws and regulations. This means, among other things, that the execution of or changes to our Treasury Reserve Policy or our Solana strategy, our use of leverage, the manner in which our Solana is custodied, our ability to engage in transactions with affiliated parties and our operating and investment activities generally are not subject to the extensive legal and regulatory requirements and prohibitions that apply to investment companies and investment advisers. Consequently, our board of directors has broad discretion over the investment, leverage and cash management policies it authorizes, whether in respect of our Solana holdings or other activities we may pursue, and has the power to change our current policies, including our strategy of acquiring and holding Solana. See &#8220;Use of Proceeds.&#8221;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>If we or our third-party service providers experience a security breach or cyberattack and unauthorized parties obtain access to our Solana, or if our private keys are lost or destroyed, or other similar circumstances or events occur, we may lose some or all of our Solana and our financial condition and results of operations could be materially adversely affected.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Substantially all of the Solana we own is held in custody accounts at U.S.-based institutional-grade digital asset custodians. Security breaches and cyberattacks are of particular concern with respect to our Solana. Solana and other blockchain-based cryptocurrencies and the entities that provide services to participants in the Solana ecosystem have been, and may in the future be, subject to security breaches, cyberattacks, or other malicious activities. For example, in October&#160;2021 it was reported that hackers exploited a flaw in the account recovery process and stole from the accounts of at least 6,000 customers of the Coinbase exchange, although the flaw was subsequently fixed and Coinbase reimbursed affected customers. Similarly, in November&#160;2022, hackers exploited weaknesses in the security architecture of the FTX Trading digital asset exchange and reportedly stole over $400&#160;million in digital assets from customers. A successful security breach or cyberattack could result in:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">a partial or total loss of our Solana in a manner that may not be covered by insurance or the liability provisions of the custody agreements with the custodians who hold our Solana;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">harm to our reputation and brand;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">improper disclosure of data and violations of applicable data privacy and other laws; or</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">significant regulatory scrutiny, investigations, fines, penalties, and other legal, regulatory, contractual and financial exposure.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">30</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Further, any actual or perceived data security breach or cybersecurity attack directed at other companies with digital assets or companies that operate digital asset networks, regardless of whether we are directly impacted, could lead to a general loss of confidence in the broader Solana ecosystem or in the use of the Solana network to conduct financial transactions, which could negatively impact us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Attacks upon systems across a variety of industries, including industries related to Solana, are increasing in frequency, persistence, and sophistication, and, in many cases, are being conducted by sophisticated, well-funded and organized groups and individuals, including state actors. The techniques used to obtain unauthorized, improper or illegal access to systems and information (including personal data and digital assets), disable or degrade services, or sabotage systems are constantly evolving, may be difficult to detect quickly, and often are not recognized or detected until after they have been launched against a target. These attacks may occur on our systems or those of our third-party service providers or partners. We may experience breaches of our security measures due to human error, malfeasance, insider threats, system errors or vulnerabilities or other irregularities. In particular, we expect that unauthorized parties will attempt to gain access to our systems and facilities, as well as those of our partners and third-party service providers, through various means, such as hacking, social engineering, phishing and fraud. Threats can come from a variety of sources, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, and insiders. In addition, certain types of attacks could harm us even if our systems are left undisturbed. For example, certain threats are designed to remain dormant or undetectable, sometimes for extended periods of time, or until launched against a target and we may not be able to implement adequate preventative measures. Further, there has been an increase in such activities due to the increase in work-from-home arrangements. The risk of cyberattacks could also be increased by cyberwarfare in connection with the ongoing Russia-Ukraine and Israel-Hamas conflicts, or other future conflicts, including potential proliferation of malware into systems unrelated to such conflicts. Any future breach of our operations or those of others in the Solana industry, including third-party services on which we rely, could materially and adversely affect our financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We have limited history in generating staking revenues from Solana, which could adversely affect our business, financial condition and operating results.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Until recently, our business focus was as a brand owner specializing in the development, manufacturing, and distribution of consumer products. We reach consumers through our direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We have recently shifted the focus of our operations to a treasury policy under which the principal holding in its treasury reserve on the balance sheet will be allocated to digital assets, and specifically long term strategy of holding Solana (&#8220;SOL&#8221;) by applying a proven public-market treasury model to an asset that we believe is earlier in its lifecycle, structurally reflexive, and vastly underexposed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We have a limited operating history with the current scale of our business, which makes it difficult to forecast our prospects and future results of operations. You should take into account the risks and uncertainties frequently encountered by companies in rapidly evolving markets. Our recent revenue growth should not be considered indicative of our future performance. Further, in future periods, our revenue growth could slow or our revenue could decline for a number of reasons, including unexpected government regulation, any reduction in the value of cryptocurrency &#160;generally or Solana specifically, demand for our platform, increased competition, contraction of our overall market, our inability to accurately forecast demand for our platform and plan for capacity constraints or our failure, for any reason, to capitalize on growth opportunities. If our assumptions regarding these risks and uncertainties, which we use to plan our business, are incorrect or change, or if we do not address these risks successfully, our business would be harmed.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">31</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>If the digital asset award or transaction fees for recording transactions on the Solana network are not sufficiently high to incentivize validators, those validators may demand high transaction fees, which could negatively impact the value of SOL and the value of the Shares.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If the digital asset awards for validating blocks or the transaction fees for recording transactions on the Solana network are not sufficiently high to incentivize validators, or if certain jurisdictions continue to limit or otherwise regulate validating activities, validators may cease expending validating power to validate blocks and confirmations of transactions on the SOL blockchain could be slowed. For example, the realization of one or more of the following risks could materially adversely affect the value of the Shares:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Over the past several years, digital asset validating operations have evolved from individual users validating with computer processors, graphics processing units and first-generation application specific integrated circuit machines to &#8220;professionalized&#8221; validating operations using proprietary hardware or sophisticated machines. If the profit margins of digital asset validating operations are not sufficiently high, digital asset validators are more likely to immediately sell digital assets earned by validating, resulting in an increase in liquid supply of that digital asset, which would generally tend to reduce that digital asset&#8217;s market price.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">A reduction in the digital assets staked by validators on the Solana network could increase the likelihood of a malicious actor or botnet (a volunteer or hacked collection of computers controlled by networked software coordinating the actions of the computers) obtaining control. <em>See &#8220;If a malicious actor or botnet obtains control of the validating stake on the Solana network, or otherwise obtains control over the Solana network through its influence over core developers or otherwise, such actor or botnet could manipulate the Solana blockchain, which would adversely affect the value of the Shares or the ability of the Company to operate.&#8221;</em></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Validators have historically accepted relatively low transaction confirmation fees on most digital asset networks. If validators demand higher transaction fees for recording transactions in the Solana blockchain or a software upgrade automatically charges fees for all transactions on the Solana network, the cost of using SOL may increase and the marketplace may be reluctant to accept SOL as a means of payment. Alternatively, validators could collude in an anti-competitive manner to reject low transaction fees on the Solana network and force users to pay higher fees, thus reducing the attractiveness of the Solana network. Higher transaction confirmation fees resulting through collusion or otherwise may adversely affect the attractiveness of the Solana network, the value of SOL and the value of the Shares.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To the extent that any validators cease to record transactions that do not include the payment of a transaction fee in blocks or do not record a transaction because the transaction fee is too low, such transactions will not be recorded on the Solana blockchain until a block is validated by a validator who does not require the payment of transaction fees or is willing to accept a lower fee. Any widespread delays or disruptions in the recording of transactions could result in a loss of confidence in the Solana network and could prevent the Company from completing transactions associated with the day-to-day operations of the treasury.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">During the course of the block validation processes, validators exercise the discretion to select bundles of transactions within a block. Beyond the standard block reward and transaction fees, validators have the ability to extract what is known as Maximal Extractable Value (&#8220;MEV&#8221;) by strategically selecting bundles of transactions during block production to prioritize transactions associated with higher transaction fees and MEV capture. In blockchain networks that facilitate DeFi protocols in particular, such as the Solana network, users may attempt to gain an advantage over other users by offering additional fees to validators for effecting the order or inclusions of transactions within a block. Certain software solutions, such as Jito, have been developed which facilitate validators and other parties in the ecosystem in capturing MEV. The presence of MEV may incentivize associated practices such as sandwich attacks or front-running that can have negative repercussions on DeFi users. A &#8220;sandwich attack&#8221; involves placing two transactions&#8212;one before and one after&#8212;a large, detected trade to exploit the resulting price movement. Unlike Ethereum, Solana lacks a public mempool, making it harder to detect pending user transactions. However, validators can choose to run clients like Jito or Paladin, which support MEV strategies that may enable sandwich attacks. For instance, searchers can submit bundles of transactions with precise ordering, allowing them to surround a vulnerable trade if detected. In the context of MEV, &#8220;front-running&#8221; is said to occur when a user spots an unexecuted transaction and awaiting validation, and then pays a high transaction fee to a validator to have their transaction executed on a priority basis in a manner designed to profit from the pending but unexecuted transaction. Since Solana doesn&#8217;t have a public mempool, validators and bots have limited visibility to unexecuted, or pending, transactions. Combined with Solana&#8217;s fast block times and parallel execution model, this makes it hard to detect and exploit user trades in real time. However, that doesn&#8217;t mean front- running is impossible. If a validator colludes with a bot, for example, it could potentially observe and front-run transactions. By running Jito or similar clients, validators have access to structure MEV systems where searchers submit bundles of ordered transactions to validators through an auction system. Validators select the most profitable bundles (based on transaction fees and MEV capture). Considering searchers determine the ordering through their bundles, front-running is possible. As of 2025, up to 5 transactions can be in a bundle for Jito. The transactions in a bundle must be executed atomically and in sequence, meaning if one transaction fails, the entire bundle does not get processed. Note, these MEV technologies, in this case Jito, can also offer user protections like front-running flags and protected order flow to mitigate risks. MEV may also compromise the predictability of transaction execution, which may deter usage of the network as a whole. Any potential perception of MEV as unfair manipulation may also discourage users and other stakeholders from engaging with DeFi protocols or the Solana network in general. In addition, it&#8217;s possible regulators or legislators could enact rules that restrict practices associated with MEV, which could diminish the popularity of the Solana network among users and validators. Any of these or other outcomes related to MEV may adversely affect the value of SOL and the value of the Shares.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">32</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Our trading orders may not be timely executed.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our investment and trading strategies depend on the ability to establish and maintain an overall market position in a combination of financial instruments. Our trading orders may not be executed in a timely and efficient manner because of various circumstances, including, for example, trading volume surges or systems failures attributable to us or our counterparties, brokers, dealers, agents or other service providers. In such an event, we might only be able to acquire or dispose of some, but not all, of the components of our positions, or if the overall positions were to need adjustments, we might not be able to make such adjustments. As a result, we would not be able to achieve our desired market position, which may result in a loss. In addition, we can be expected to rely heavily on electronic execution systems (and may rely on new systems and technology in the future), which may be subject to certain systemic limitations or mistakes, causing the interruption of trading orders made by us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Competition from other companies staking and utilizing Solana in their treasury plans.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We expect to contend with other companies also focused on developing digital asset staking operations. Market participants with sufficient knowledge and capital has the ability acquire tokens on the open market and start staking, which would increase competition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Competition from central bank digital currencies (&#8220;CBDCs&#8221;) and emerging payments initiatives involving financial institutions could adversely</em></strong><strong> affect the price of SOL and other digital assets.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Central banks in various countries have introduced digital forms of legal tender (&#8220;CBDCs&#8221;). China&#8217;s CBDC project, known as Digital Currency Electronic Payment, has reportedly been tested in a live pilot program conducted in multiple cities in China. Central banks representing at least 130 countries have published retail or wholesale CBDC work ranging from research to pilot projects. Whether or not they incorporate blockchain or similar technology, CBDCs, as legal tender in the issuing jurisdiction, could have an advantage in competing with, or replace, SOL and other cryptocurrencies as a medium of exchange or store of value. Central banks and other governmental entities have also announced cooperative initiatives and consortia with private sector entities, with the goal of leveraging blockchain and other technology to reduce friction in cross-border and interbank payments and settlement, and commercial banks and other financial institutions have also recently announced a number of initiatives of their own to incorporate new technologies, including blockchain and similar technologies, into their payments and settlement activities, which could compete with, or reduce the demand for, SOL. As a result of any of the foregoing factors, the price of SOL could decrease, which could adversely affect the value of the Company&#8217;s Stock Price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Competition from the emergence or expansion of other digital assets may negatively influence the price of SOL and have an adverse impact on the value</em></strong><strong> of the Shares.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Currently, SOL ranked as the sixth largest digital asset by market capitalization, according to CoinMarketCap.com. SOL encounters competition from a broad spectrum of digital assets, including Bitcoin and Ether. Additionally, numerous consortiums and financial institutions are investing in private or permissioned blockchain platforms rather than open networks such as the Solana Network. SOL is currently supported by fewer trading platforms compared to more established digital assets like Bitcoin and Ether, which may affect its liquidity. The Solana Network also competes directly with other smart contract platforms, including Ethereum, Polkadot, Avalanche, and Cardano. The emergence or growth of alternative digital assets or other smart contract platforms may diminish demand for, and the price of, SOL, thereby adversely affecting the value of the Shares.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Investors have the option to gain exposure to SOL through mechanisms other than the Company&#8217;s Shares, such as direct investment in SOL or through other financial vehicles, including securities or products backed by or linked to SOL. Specifically, the Company faces competition from other exchange-traded spot SOL products and similar digital asset vehicles, several of which have pending applications before the SEC or have already secured SEC approval. The Company&#8217;s ability to maintain its scale and achieve its intended competitive positioning may depend on various factors, such as its timing relative to competing products and its ability to raise additional capital.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Furthermore, if other financial vehicles tracking SOL constitute a significant portion of overall demand, substantial transactions involving these vehicles or private funds holding SOL could adversely affect the Index Price, NAV, NAV per Share, value of the Shares, Principal Market NAV, and Principal Market NAV per Share. Therefore, there can be no assurance that the Company will be able to preserve its scale or attain its intended competitive position relative to peers, which could negatively affect both the performance of the Company and the value of the Shares.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">33</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We may fail to develop and execute successful investment or trading strategies.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The success of our investment and trading activities will depend on the ability of our investment team and Asset Manager to identify overvalued and undervalued investment opportunities and to exploit price discrepancies. This process involves a high degree of uncertainty. No assurance can be given that we will be able to identify suitable or profitable investment opportunities in which to deploy our capital. The success of the trading activities also depends on our ability to remain competitive with other over-the-counter traders and liquidity providers. Competition in trading is based on price, offerings, level of service, technology, relationships and market intelligence. The success of investment activities depends on our ability to source deals and obtain favorable terms. Competition in investment activities is based on relationships. The barrier to entry in each of these businesses is very low and competitors can easily and will likely provide similar services in the near future. The success of our venture investments and trading business could suffer if we are not able to remain competitive.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>We may make, or otherwise be subject to, trade errors.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Errors may occur with respect to trades executed on our behalf. Trade errors can result from a variety of situations, including, for example, when the wrong investment is purchased or sold or when the wrong quantity is purchased or sold. Trade errors frequently result in losses, which could be material. To the extent that an error is caused by a third party, we may seek to recover any losses associated with the error, although there may be contractual limitations on any third party&#8217;s liability with respect to such error.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Risks Related to the CBD Industry</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Laws and regulations affecting the CBD industry are evolving under the Farm Bill, and changes to applicable regulations may materially affect our future operations in the CBD market.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The CBD used by the Company is derived from hemp as defined in the Agriculture Improvement Act of 2018 (United States) (the &#8220;Farm Bill&#8221;) and codified at 7 USC 1639o means &#8220;the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis.&#8221; The&#160;<em>Cannabis sativa&#160;</em>plant and its derivatives may also be deemed marijuana, depending on certain factors. &#8220;Marijuana&#8221; is a Schedule I controlled substance and is defined in the Federal Controlled Substances Act at 21 USC Section 802(16) as &#8220;all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin.&#8221; Exemptions to that definition provided in 21 USC Section 802(16) include &#8220;the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination&#8221; or hemp as defined in 7 USC 1639o.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Substances meeting the definition of &#8220;hemp&#8221; in the Farm Bill and 7 USC 1639o may be used in clinical studies and research through an Investigational New Drug (&#8220;IND&#8221;) application with the Food and Drug Administration (the &#8220;FDA&#8221;). Substances scheduled as controlled substances, like marijuana, require more rigorous regulation, including interaction with several agencies including the FDA, the DEA, and the NIDA within the National Institutes of Health (&#8220;NIH&#8221;).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Accordingly, if the CBD used by the Company is deemed marijuana and, therefore, a Schedule I controlled substance, the Company could be subject to significant additional regulation, as well as enforcement actions and penalties pertaining to the Federal Controlled Substances Act, and any resulting liability could require the Company to modify or cease its operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">34</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Furthermore, in conjunction with the Farm Bill, the FDA released a statement about the status of CBD use in food and dietary supplements, noting that the Farm Bill explicitly preserved the FDA&#8217;s authority to regulate products containing cannabis or cannabis-derived compounds under the Federal Food, Drug, and Cosmetic Act (the &#8220;FDCA&#8221;) and Section 351 of the Public Health Service Act. Any difficulties we experience in complying with existing and/or new government regulation could increase our operating costs and adversely impact our results of operations in future periods. The FDA has issued guidance titled &#8220;FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)&#8221; pursuant to which the FDA has taken the position that CBD is prohibited from use as an ingredient in a food or beverage or as a dietary ingredient in or as a dietary supplement based on several provisions of the FDCA. In the definition of &#8220;dietary supplement&#8221; found in the FDCA at 201(ff), an article authorized for investigation as a&#160;new drug, antibiotic, or biological for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, is excluded from the definition of dietary supplement. A similar provision in the FDCA 301(ll) makes it a prohibited act to introduce or deliver into commerce any food with a substance that was investigated as a new drug prior to being included in a food. There are no similar exclusions for the use of CBD in non-drug topical products, as long as such products otherwise comply with applicable laws. The FDA created a task force to address the further regulation of CBD and other cannabis-derived products and is currently evaluating the applicable science and pathways for regulating CBD and other cannabis-derived ingredients.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As a result of the Farm Bill&#8217;s recent passage, we expect that there will be a constant evolution of laws and regulations affecting the CBD industry which could affect the Company&#8217;s plan of operations. Local, state and federal hemp laws and regulations may be broad in scope and subject to changing interpretations. These changes may require us to incur substantial costs associated with legal compliance and may ultimately require us to alter our business plan. Furthermore, violations of these laws, or alleged violations, could disrupt our business and result in a material adverse effect on our operations. We cannot predict the nature of any future laws, regulations, interpretations or applications, and it is possible that regulations may be enacted in the future that will be directly applicable to our business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Changes to state laws pertaining to industrial hemp could slow the use of industrial hemp, which could impact our revenues in future periods. Approximately 40 states have authorized industrial hemp programs pursuant to the Farm Bill. Additionally, various states have enacted state-specific laws pertaining to the handling, manufacturing, labeling, and sale of CBD and other hemp products. Compliance with state-specific laws and regulations could impact our operations in those specific states. Continued development of the industrial hemp industry will be dependent upon new legislative authorization of industrial hemp at the state level, and further amendment or supplementation of legislation at the federal level. Any number of events or occurrences could slow or halt progress all together in this space. While progress within the industrial hemp industry is currently encouraging, growth is not assured, and while there appears to be ample public support for favorable legislative action, numerous factors may impact or negatively affect the legislative process(es) within the various states where we have business interests.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Unfavorable interpretations of laws governing hemp processing activities could subject us to enforcement or other legal proceedings and limit our business and prospects.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">There are no express protections in the United States under applicable federal or state law for possessing or processing hemp biomass derived from lawful hemp not exceeding 0.3% THC on a dry weight basis and intended for use in finished product, but that may temporarily exceed 0.3% THC during the interim processing stages. While it is a common occurrence for hemp biomass to have variance in THC content during interim processing stages after cultivation but prior to use in finished products, there is risk that state or federal regulators or law enforcement could take the position that such hemp biomass is a Schedule I controlled substance in violation of the CSA and similar state laws. In the event that the Company&#8217;s operations are deemed to violate any laws, the Company could be subject to enforcement actions and penalties, and any resulting liability could cause the Company to modify or cease its operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Costs associated with compliance with various laws and regulations could negatively impact our financial results.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The manufacture, labeling and distribution of CBD products is regulated by various federal, state and local agencies. These governmental authorities may commence regulatory or legal proceedings, which could restrict our ability to market CBD-based products in the future. The FDA regulates our products to ensure that the products are not adulterated or misbranded. We may also be subject to regulation by other federal, state and local agencies with respect to our CBD-based products. Our advertising activities are subject to regulation by the FTC under the Federal Trade Commission Act. In recent years, the FTC and state attorneys general have initiated numerous investigations of dietary and nutritional supplement companies and products. Any actions or investigations initiated against the Company by governmental authorities or private litigants could have a material adverse effect on our business, financial condition and results of operations. Any actions or investigations initiated against the Company by governmental authorities or private litigants could have a material adverse effect on our business, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The shifting regulatory environment necessitates building and maintaining robust systems to achieve and maintain compliance in multiple jurisdictions and increases the possibility that we may violate one or more of the legal requirements applicable to our business and products. If our operations are found to be in violation of any applicable laws or regulations, we may be subject to penalties, including, without limitation, civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, injunctions, or product withdrawals, recalls or seizures, any of which could adversely affect our ability to operate our business, our financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">35</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Uncertainty caused by potential changes to legal regulations could impact the use and acceptance of CBD products.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">There is substantial uncertainty and differing interpretations and opinions among federal, state and local regulatory agencies, legislators, academics and businesses as to the scope of operation of Farm Bill-compliant hemp programs relative to the emerging regulation of cannabinoids and the Controlled Substances Act. These different opinions include, but are not limited to, the regulation of cannabinoids by the DEA and/or the FDA, and the extent to which manufacturers of products containing Farm Bill-compliant cultivators and processors may engage in interstate commerce. The existing uncertainties in the CBD regulatory landscape in the United States cannot be resolved without further federal, and perhaps state-level, legislation and regulation or a definitive judicial interpretation of existing laws and regulations. If these uncertainties are not resolved in the near future or are resolved in the manner inconsistent with our business plan, such uncertainties may have an adverse effect upon our plan of operations and the introduction of our CBD-based products in different markets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>If we fail to obtain necessary permits, licenses and approvals under applicable laws and regulations, our business and plan of operations may be adversely impacted.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We may be required to obtain and maintain certain permits, licenses and regulatory approvals in the jurisdictions where we sell or plan to sell our products. There can be no assurance that we will be able to obtain or maintain any necessary licenses, permits or approvals. Any material delay in obtaining, or inability to obtain, such licenses, permits and approvals is likely to delay and/or inhibit our ability to carry out our plan of operations and could have a material adverse effect on our business, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Potential future international expansion of our business could expose us to additional regulatory risks and compliance costs.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Although we have no plans to expand internationally for at least two or more years, if the Company intends to expand internationally or engage in the international sale of its products, it will become subject to the laws and regulations of the foreign jurisdictions in which it operates, or in which it imports or exports products or materials, including, but not limited to, customs regulations in the importing and exporting countries. The varying laws and rapidly changing regulations may impact the Company&#8217;s operations and ability to ensure compliance. In addition, the Company may avail itself of proposed legislative changes in certain jurisdictions to expand its product portfolio, which expansion may include unknown business and regulatory compliance risks. Failure by the Company to comply with the evolving regulatory framework in any jurisdiction could have a material adverse effect on the Company&#8217;s business, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>The market for health and wellness products is highly competitive. If we are unable to compete effectively in the market, our business and operating results could be materially and adversely affected.</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The market for CBD products is a competitive and rapidly evolving market. There are numerous competitors in the industry, some of whom are more well-established with longer operating histories and greater financial resources than the Company. We expect competition to continue to intensify following the recent passage of the Farm Bill. We believe the Company will be able to compete effectively because of the quality of our products and customer service. However, there can be no assurance that the Company will effectively compete with existing or future competitors. Increased competition may also drive the prices of our products down, which may have a material adverse effect on our results of operations in future periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Given the rapid changes affecting the global, national and regional economies generally, the Company may experience difficulties in establishing and maintaining a competitive advantage in the marketplace. The Company&#8217;s success will depend on our ability to keep pace with any changes in such markets, especially legal and regulatory changes. Our success will depend on our ability to respond to, among other things, changes in the economy, market conditions and competitive pressures. Any failure to anticipate or respond adequately to such changes could have a material adverse effect on the Company&#8217;s business, financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">36</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a4">USE OF PROCEEDS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We will not receive any proceeds from the sale of the shares of Common Stock by the Selling Stockholder. All of the net proceeds from the sale of the shares of our Common Stock will go to the Selling Stockholder as described below in the sections entitled &#8220;<em>Selling Stockholder</em>&#8221; and &#8220;<em>Plan of Distribution</em>&#8221;. We will, however, receive up to approximately $13 million in cash from the exercise of the Warrants, assuming full cash exercise. We intend to use any such proceeds for working capital, general corporate purposes, and our internally managed Solana (SOL) maximum return strategy. We have agreed to bear the expenses relating to the registration of the shares of Common Stock for the Selling Stockholder.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a5">DETERMINATION OF OFFERING PRICE</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Selling Stockholder may offer and sell shares of Common Stock at the prevailing market prices or privately negotiated prices. The offering price of the shares of our Common Stock does not necessarily bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value. Our Common Stock may not trade at the market prices in excess of the offering prices for Common Stock in any public market will be determined in the marketplace and may be influenced by many factors, including the depth and liquidity.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a6">BUSINESS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Company</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Upexi is a brand owner specializing in the development, manufacturing, and distribution of consumer products. We reach consumers through our direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Our Solana Treasury Strategy</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Early in 2025, we updated and modified our cash management and treasury strategy to include holding digital currency assets directly on our balance sheet. This was a shift from before when we held excess cash primarily in FDIC-insured interest-bearing accounts. The change to adopt this strategy results from our intention to obtain the highest yield on excess cash. Under our new approach, our treasury policy focuses primarily on Solana (&#8220;SOL&#8221;). The approach involves applying a public-market treasury model to an asset that is considered earlier in its lifecycle with respect to both development and usage as well as institutional adoption compared to Bitcoin.&#160;Management will focus its resources to this digital asset strategy and a significant portion of the balance sheet will be allocated to holding Solana in the Company&#8217;s digital asset treasury.&#160;Currently our treasury is exclusively dedicated to the SOL digital asset and currently we do not intend to dedicate any of the treasury allocated capital to other digital assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our treasury is intended to bring value to our shareholders in these ways:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We plan to utilize intelligent capital markets issuance &#8211; including the issuance of both equity and convertible debt - where we may issue capital in an accretive fashion for the benefit of shareholders to purchase and hold more Solana.&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We will stake the majority of the Solana in our treasury to earn a staking yield and turn the treasury into a productive asset.&#160;Currently we are staking approximately 95% of our SOL treasury, and intend to maintain a similar or higher percentage going forward.&#160;We do not hedge our SOL and do not have plans to hedge our SOL in the future.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We will purchase locked Solana at a discount to the current spot price, which will provide higher gains for our shareholders as the discount moves to par over time.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Note that we are underpinned by Solana, which we believe is the leading high-performance blockchain and may see its price rise in the future - if this occurs, our Solana treasury will move up in value, also benefitting shareholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">37</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Our Staking Program</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pursuant to our treasury strategy, we will use our SOL in the treasury to generate a return through various opportunities with the most significant portion being allocated to our Staking Program. We will utilize several Validators in the Staking Program to reduce our risk with a single Validator and maximize the overall yield from the Staking Program. We will also dedicate a portion of the SOL in our staking program to utilize smaller Validators to help improve the overall Solana ecosystem. These Validators are scrutinized through our due diligence program and are initially only given a small amount of SOL for the Company to be able to verify the expected performance and yield, and to ensure that the Validator should be included in our future allocation of SOL to Validators. Management evaluates the validators on a routine basis around performance, yield, and economics, and makes monthly adjustments on the overall allocation of the SOL in the treasury based on our evaluation. Currently we have approximately 95% of our SOL treasury staked, and target a similar or higher percentage in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We maintain possession and control of the SOL when it is staked at all times. Native staking is generally considered a safe activity, as it is done in-protocol (i.e.. is built into Solana itself), and as, unlike other networks, Solana has not implemented &#8220;slashing&#8221; penalties for validators that either intentionally misbehave or perform their duties poorly. As such, the major risk with staking is that we choose a validator with poor performance who realizes a low staking yield. Additionally, as part of the &#8220;activating&#8221; and &#8220;exiting&#8221; processes of SOL staking, any staked SOL will be inaccessible for a period of time determined by a range of factors, resulting in certain liquidity risks that we manage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Process of Staking</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Management has bi-weekly meetings to evaluate treasury operations, including the staking of the Company&#8217;s SOL. Based on these meetings, management determines the allocation of the SOL treasury to the Staking Program and determines the amount of allocation to each Validator, ensuring that no single validator has such a large percentage of our stake that it represents concentration risk.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If it is determined to reduce the amount of the SOL dedicated to the Staking Program or it is determine to change the allocation of SOL to a Validator we will initiate an unstaking process and notify the Validator of the change, which effectively reverses the delegation of the SOL from the applicable validator node.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana has a cooldown period known as the &#8220;deactivation period,&#8221; which is the time it takes for the unstaked SOL to become fully liquid. During this period, the tokens are not actively earning rewards, but they are also not yet available for transfer or use. The length of this period can vary based on network conditions but is generally expected to be 48 hours or less. Once the cooldown period is complete, the Company will have complete control over the SOL, including the ability to sell the SOL or transfer it as determined by management.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Liquidity Management</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company&#8217;s staking program involves the temporary loss of the ability to transfer, assign a new Validator or otherwise dispose of the SOL. Under normal conditions, the Company will regain complete control over its unstaked SOL within two days of initiating the unstaking. However, there can be no guarantee that such process will result in the Company regaining complete control of its SOL in time to satisfy its current obligations. We maintain a certain amount of liquid SOL in the treasury and a certain amount of cash to ensure that the Company is able to satisfy its current obligations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">How We Earn Staking Rewards</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To earn staking rewards, we delegate our SOL to leading Solana validators via Solana&#8217;s in-protocol delegation system. This means we deposit our SOL tokens into a stake account, which is then delegated to a validator&#8217;s vote account. We utilize native staking only, and stake to top validators who have demonstrated a track record of high performance, high yield generation, and attractive delegator economics. We use multiple validators to both maximize the return on our Solana treasury and to mitigate the risk of having only one or two validators for our treasury staking.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">38</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">SOL and the Solana Network</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">SOL is a digital asset that is created and transmitted through the operations of the peer-to-peer Solana network (the &#8220;Solana blockchain&#8221; or &#8220;Solana network&#8221;), which is a decentralized network of computers operating the implementation of the Solana protocol. While certain entities such as Solana Labs, Inc. (&#8220;Solana Labs&#8221;) and the Solana Foundation have influence over the Solana network&#8217;s development and governance (which was particularly true during the network&#8217;s early years), no single entity owns or operates the Solana network, the infrastructure of which is collectively maintained by a decentralized user base. The Solana network allows the creation and exchange of tokens, including SOL, which are recorded on the Solana network. SOL can be used to pay for goods and services, including to send a transaction on the Solana network, or it can be swapped to other tokens or converted to fiat currencies, such as the U.S. dollar, at rates determined on digital asset trading platforms or in individual end-user-to-end-user transactions under a market-based system. Furthermore, the Solana network allows users to write and implement general purpose code known as smart contracts or programs that create decentralized applications, and for users to openly interact with said decentralized applications. Using programs, users can create decentralized applications covering a variety of categories and subsectors, including borrow/lend protocols, decentralized exchanges, social applications, web3 gaming, tokenized assets, AI agents, decentralized physical infrastructure networks, and many more. As such, the Solana network expands blockchain use well beyond just a peer-to-peer money system.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Solana protocol introduced the proof-of-history timestamping mechanism. Proof-of-history is not a consensus mechanism, but a cryptographic clock that enables greater organization without extensive communication, thereby increasing throughput. Proof-of-history enables leaders to know when its their turn to produce a block, rather than requiring the entire network to first come to an agreement on the prior block before the leader can begin their work.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In addition to the proof-of-history mechanism, the Solana network uses a proof-of-stake consensus mechanism to incentivize SOL holders to validate transactions. Unlike proof-of-work, in which miners expend computational and energy resources to be the miner to propose a block and receive the block reward, in proof-of-stake, validators pledge or &#8220;stake&#8221; coins, perform duties such as proposing or validating blocks, and receive staking rewards generally in proportion to the amount of coins staked. A validator that performs its duties poorly, whether maliciously or unintentionally, would receive lower or no rewards. Proof-of-stake is viewed as more energy efficient and scalable than proof-of-work. Together proof-of-history combined with a proof-of-stake consensus model are some of the components on Solana that enable high throughput and low-latency transaction processing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Overview of the Solana Network</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In order to own, transfer or use SOL directly on the Solana network on a peer-to-peer basis (as opposed to through an intermediary, such as a custodian or centralized exchange), a person generally must have internet access to connect to the Solana network and set up a wallet, which is the software that safeguards a user&#8217;s keypair (public key plus secret key). SOL transactions may be made directly between end-users without the need for an intermediary. To transact on the Solana network, a user, typically through an application such as a wallet or smart contract, will broad the transaction to the current leader, who will organize the transactions into shards before the network processes and validates such transactions. Using cryptography and its proof-of-stake consensus mechanism, the Solana network can come to a shared state of the network in a decentralized fashion and without a centralized leader. Blocks are built on top of prior ones by subsequent leaders, continuing the process.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Prior to transacting on Solana, a user generally must first install on its computer or mobile device a software program that will allow the user to generate a private and public key pair such as a wallet. The wallet also enables the user to connect to the Solana network, interact with decentralized applications, and transfer or swap tokens with other users or applications.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Each user has their own key pair that is stored in such software, like a wallet. To receive SOL in a peer-to-peer transaction, the SOL recipient must provide its public key to the party initiating the transfer. This activity is analogous to a recipient for a transaction in U.S. dollars providing a routing address in wire instructions to the payor so that cash may be wired to the recipient&#8217;s account. The payor approves the transfer to the address provided by the recipient by &#8220;signing&#8221; a transaction that consists of the recipient&#8217;s public key with the private key of the address from where the payor is transferring the SOL. The recipient, however, does not make public or provide to the sender its private key (though the network can still verify the validity of the signature &#8211; i.e., that it was signed by the holder of the private key &#8211; using cryptography).With cold storage our Custodian maintains all of the private keys.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Neither the recipient nor the sender reveal their private keys in a peer-to-peer transaction because the private key authorizes transfer of the funds in that address to other users. Therefore, if a user loses their private key, the user may permanently lose access to the SOL contained in the associated address. Likewise, SOL is irretrievably lost if the private key associated with them is deleted and no backup has been made. When sending SOL, a user&#8217;s Solana network software program must validate the transaction with the sender&#8217;s associated private key. In addition, since every computation on the Solana network requires processing power, there is a mandatory transaction fee involved with the transfer that is paid by the payor. The resulting digitally validated transaction is sent by the user&#8217;s Solana network software program to the Solana network validators to allow transaction confirmation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana network validators record and confirm transactions when they validate and add blocks of information to the Solana blockchain. When a validator is selected to validate a block, it creates that block, which includes data relating to (i) the verification of newly submitted and accepted transactions and (ii) a reference to the prior block in the Solana blockchain to which the new block is being added. The validator becomes aware of outstanding, unrecorded transaction requests through peer-to-peer data packet transmission and distribution discussed above.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">39</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Upon the addition of a block of SOL transactions, the Solana network software program of both the spending party and the receiving party will show confirmation of the transaction on the Solana blockchain and reflect an adjustment to the SOL balance in each party&#8217;s Solana network public key, completing the SOL transaction. Once a transaction is confirmed on the Solana blockchain, it is irreversible.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Some SOL transactions are conducted &#8220;off-blockchain&#8221; and are therefore not recorded on the Solana blockchain. These &#8220;off-blockchain transactions&#8221; involve the transfer of control over, or ownership of, a specific digital wallet holding SOL or the reallocation of ownership of certain SOL in a pooled-ownership digital wallet, such as a digital wallet owned by a digital asset trading platform. If a transaction takes place through a centralized digital asset exchange or a custodian&#8217;s internal books and records, it is not broadcast to the Solana network or recorded on the Solana blockchain. In contrast to on-blockchain transactions, which are publicly recorded on the Solana blockchain, information and data regarding off-blockchain transactions are generally not publicly available. Therefore, off-blockchain transactions are not truly SOL transactions in that they do not involve the transfer of transaction data on the Solana network and do not reflect a movement of SOL between addresses recorded on the Solana blockchain. For these reasons, off-blockchain transactions are not immutable or irreversible as any such transfer of SOL ownership is not cryptographically protected by the protocol behind the Solana network or recorded in, and validated through, the blockchain mechanism.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Validators</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In proof-of-stake, validators risk or stake coins to be randomly selected to validate transactions and are rewarded for performing their responsibilities and behaving in accordance with protocol rules. Malfunctions that cause validators to go offline and, in turn, inhibit them from performing their duties can result in financial penalties. Any malicious activity, such as making incorrect attestations or otherwise violating protocol rules results may result in lower rewards or the lost opportunity to gain rewards. The penalty varies depending on the type of offense and correlation to potential offenses by other validators.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Validators are typically professional operations that design and build dedicated machines and data centers, including &#8220;clusters,&#8221; which are groups of validators that act cohesively and combine their processing to confirm transactions. When a validator confirms a transaction, the validator and any associated stakers receive a fee. During the course of ordering transactions and validating blocks, validators may be able to prioritize certain transactions in return for increased transaction fees, an incentive system known as &#8220;Maximal Extractable Value&#8221; or &#8220;MEV.&#8221; For example, in blockchain networks that facilitate DeFi protocols in particular, such as the Solana network, users may attempt to gain an advantage over other users by offering greater transaction fees.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Validators less commonly capture MEV in the Solana network because, unlike the Ethereum network, it does not publicly expose transactions before they are accepted by a validator.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Staking rewards on the Solana network are determined by the protocol and are distributed to validators and their associated stakers based on the proportion of their stake relative to the total active stake in the network. The rewards are funded by inflationary issuance of new tokens and transaction fees collected on the network. The specific amount each validator and staker receives depends on, among other things, their share of the total stake, the validator&#8217;s uptime and performance, and the overall network conditions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The historical range of staking rewards on the Solana network has varied due to differing levels of network congestion and protocol parameters. The actual annualized reward rate has fluctuated over time, reflecting changes in network activity, inflation rates, and protocol adjustments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Staking rewards on Solana are distributed at regular intervals. At the end of each epoch, with one epoch being roughly 2 days, the reward is calculated. The reward is automatically distributed at the beginning of the subsequent epoch. This regular reward frequency ensures that participants receive their share of rewards in a timely manner, reflecting their contribution to network security and transaction validation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">How We Purchase or Sell Digital Assets</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our Management team reviews the Company&#8217;s short term obligations and excess cash available to dedicate to the Treasury Strategy. When it is determined that the Company has excess cash available to dedicate to the Treasury Strategy we deploy that capital into one of our custodians and through acquisition strategies with the custodians and our asset manager, we acquire the SOL over several days or weeks to maximize the number of SOL that is acquired with the capital deployed. If it was determined that the treasury needed to liquidate part of its SOL, the same process of selling the SOL into the market would be used. The Company has not reduced its treasury or sold any of its SOL staking rewards to date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">40</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Use of Custodians and Storage of SOL Tokens</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We do not self-custody and only utilize third-party qualified custodians to hold our Solana. We use qualified custodians that utilize risk management and operational best practices around items like hot vs. cold storage, access controls, custody technology, insurance, etc.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our primary custodian is BitGo Trust Company, Inc. (&#8220;BitGo&#8221;). We also maintain a custodial relationship with Coinbase, Inc. and are in the process of distributing our treasury to different custodians and onboarding other qualified custodians to ensure that we mitigate our Solana treasury risk through the use of several qualified custodians.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">Storage of Our Digital Assets in our SOL Treasury</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>The Custodians</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Custodians&#160;are responsible for safekeeping all of the SOL owned by the Company. We maintain multiple Custodians to reduce the risk of a single failure and we plan to expand to additional custodians as our Treasury grows. The Custodian accounts are all opened by the Company, this segregates our assets into an individual custodian account owned by the Company and access is monitored and controlled by the Company. Our Asset Management Company is given access to the Custodian accounts with established controls to ensure transactions require consensus of a minimum of two individuals when assets are being transferred between wallets and additional controls if an asset of the Treasury is moved out of the Custodians control. The assets go through the Custodians Trust Company, which maintains its own insurance and is regulated by their respective state where the trust is incorporated in.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our primary custodian is currently BitGo Trust Company, Inc. a South Dakota corporation (&#8220;BitGo&#8221;) and is regulated by the state of South Dakota.&#160; On May 1, 2025, we entered into a Custodial Services Agreement with BitGo (the &#8220;BitGo Agreement&#8221;) to hold our digital currency. The term of the BitGo Agreement is for one year with successive one-year renewals unless prior notice of non-renewal is given by either party. The Company pays BitGo a monthly digital asset storage fee based upon the market value of the assets in storage, plus $500. The BitGo Agreement is terminable by either the Company or BitGo on thirty days&#8217; notice as a result of a breach of the Agreement and may be suspended by BitGo if the Company violates the intended use of the account or due to a change in the applicable law, litigation or bankruptcy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our secondary custodian is Coinbase Inc., a subsidiary of Coinbase Global, Inc., a Delaware corporation, which is primarily used for the acquisition of digital assets. On May 5, 2025, the Company entered into an Institutional Client Agreement with Coinbase (the &#8220;Coinbase Agreement&#8221;). The Coinbase Agreement is terminable at will by either the Company or Coinbase.&#160; The Company pays Coinbase its regularly scheduled fees based on the dollar trading volume over a thirty-day period. The Coinbase Agreement is terminable by either the Company or Coinbase on ten days&#8217; notice as a result of a breach of the Agreement and may be suspended by Coinbase if the Company violates the intended use of the account or due to a change in the applicable law, governmental proceeding, litigation or bankruptcy. Coinbase may also close the Company&#8217;s account if it has been inactive for more than one year.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">BitGo maintains a $250,000,000 policy against loss, theft and misuse. Currently we have approximately $192,724,750 of treasury value at Bitgo, based on the SOL price of $137.39 per token. Coinbase has an insurance policy for any cash held in the account of $250,000. We currently have less than $250,000 of cash held at Coinbase and less than $100,000 in SOL value, based on the SOL price of $137.39 per token. At the current price of SOL as of the date of this prospectus, these policies are adequate to fully cover the full loss of our SOL.&#160;&#160;There are other tokens locked tokens owned in omnibus wallets and loaned on a short term basis not included in the Company&#8217;s custodian accounts.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana, as with all digital assets, can be highly volatile.&#160; Management reviews the account balances and the total value held with a custodians to allocate the Company&#8217;s holdings between multiple accounts and custodians to mitigate risk.&#160;We do not use self-storage for any of the SOL treasury assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Private keys are generated by the Custodians in key generation ceremonies at secure locations using offline devices that have never been connected to a network. Private keys are generated according to detailed procedures using specialized offline devices and within these secure facilities to mitigate risk of hacks, errors, or other unintended external exposure. Key ceremony processes are highly controlled, require segregation of duties across multiple parties and are reviewed and witnessed by designated oversight personnel. Thorough validations and signoffs are performed to verify the integrity and security of key generation ceremonies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">41</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Custodians hold a majority of SOL in cold storage and provides a user interface for the Company to manage the allocation of SOL between cold and hot storage for the wallets.&#160; The Company maintains more than 98% of its SOL treasury in cold wallets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Custodians have multiple, redundant cold storage sites, which are geographically distributed including sites within the United States. Cold storage locations of the Custodians are monitored by 24x7 on-site security, video surveillance and alarms, hardened room structures, and access to these facilities is controlled by multi-person controls, multi-team access rules, and multi-factor authentication. The locations of the cold storage sites may change at the discretion of the Custodians and are kept confidential by the Custodians for security purposes. Transactions from cold to hot storage require physical access, according to the above controls, to one or more cold storage facilities, as well as systematically enforced approvals and integrity verifications, before the secure device can be used to cryptographically complete the transaction. At no point during this process is the private key removed from the secure device(s) nor the cold storage facility. Once these security processes have been completed, a transfer on the Solana network can be executed, as signed using the private keys held offline in cold storage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Custodians also maintain geographically dispersed backups of private keys, which are cryptographically generated into shards and stored in separate locations; multiple locations must be accessed to reconstruct a single key. The storage facilities are highly secured, and include 24x7 on-premises security presence, video surveillance, and alarms for unexpected entry. Access to facilities is controlled by multi-person controls, multi- team access rules, and multi-factor authentication.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">All of our Custodians have SOC type 2 reports that the Company has reviewed and we get regular bridge reports from our Custodians to help ensure the controls are being maintained. Our Custodians maintain their own insurance policies to cover our loss, which is in addition to the policies that we maintain ourselves. We currently have two qualified Custodians that we have approved for our treasury use and we are in the process of onboarding a third as part of our risk management process.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company is charged for storage fees, staking fees and transaction fees for services specifically requested by the Company or the Asset Management Company. Except as set forth above, the contract terms of the agreements are typically for one to three years and can be terminated upon 30 day notice and payment of all fees due and one month of additional fees.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">SOL &#8211; the Token of the Solana Blockchain</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Solana (SOL) is the native token of the Solana blockchain. According to Solana Compass &#8211; a popular website covering the Solana ecosystem that also runs a Solana validator &#8211; Solana was created with an initial supply of 500m SOL, though much of the initial supply was locked or earmarked for various use cases such as for the community, investors, foundation, team, etc. New Solana tokens are brought into existence primarily through inflationary rewards distributed to validators (and delegators). Solana currently has a total supply of 615.1m SOL, a circulating supply of 559.5m, and no maximum supply. The Solana staking yield is made up of three primary components: inflationary rewards, transaction/priority fees, and maximal extractable value (MEV). Inflationary rewards started out at 8.0%, currently sit at 4.2%, and will fall 15% every epoch-year until it reaches a long-term floor of 1.5%. There are currently 26.9m locked SOL, representing 4.4% of the total SOL supply with various vesting schedules. Historically, 50% of all transaction fees were burned (with the other 50% going to the validator), but now all transaction fees go to the validator after the passage and adoption of Solana Improvement Document 96 (SIMD-96).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">How SOL is Used</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">SOL is used as part of Solana&#8217;s proof-of-stake consensus mechanism. In general, proof-of-stake blockchains have block producers called validators that run nodes, bond or stake the protocol&#8217;s native token, propose blocks when chosen to do so, and validate/sign the transactions and blocks of others when not. Validators are chosen to produce a block in proportion to their stake, which makes it extremely costly for bad actors to attempt to control the network and add invalid transactions to the blockchain. Validators receive staking rewards for the work they perform, which further incentivizes validators to behave properly, as they would otherwise miss out on such rewards. Other proof-of-stake networks often &#8220;slash&#8221; some or all of a validator&#8217;s stake if it intentionally or unintentionally performs its duties poorly, for example, by double-signing a transaction, though Solana has not implemented slashing at this time.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In addition to its use within consensus, SOL is also a &#8220;gas token&#8221;, meaning that users of the Solana blockchain pay SOL to validators (and delegators) as compensation for processing their transactions. As such, the value of SOL may increase if/as the Solana blockchain sees greater usage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We see three particularly notable items giving Solana a technical advantage compared to many smart contract blockchain peers. First, Solana&#8217;s proof-of-history gives validators a notion of time and enables them to produce blocks when it&#8217;s their turn without requiring the network to first agree upon the current block. This results in immense speed advantages. Second, unlike peer blockchains that often use single-threaded virtual machines, Solana enables parallel transaction execution to increase throughput and advantage of future hardware improvements resulting from an increasing CPU core counts. Lastly, Solana optimized for speed and security, and is naturally growing into decentralization as hardware and bandwidth costs fall over time, optimally positioning it well along the Blockchain Trilemma.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">42</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><span style="text-decoration:underline">The Solana Ecosystem</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As one of the first &#8220;second-generation&#8221; high performance blockchains, Solana uniquely enjoys both the best-in-class technology described above, as well as strong network effects that have attracted a large, growing, and vibrant ecosystem of users, developers, and decentralized applications. Indeed, while Solana is focused on bringing global finance onchain (commonly referred to as &#8220;onchain Nasdaq&#8221; or &#8220;Internet Capital Markets&#8221;), Solana&#8217;s performance and technical capabilities enable a plethora of use cases from decentralized finance (&#8220;DeFi&#8221;) to decentralized physical infrastructure networks (&#8220;DePIN&#8221;), AI agents, social media, gaming, stablecoins, real-world assets (&#8220;RWA&#8221;s), and more. Moreover, according to Electric Capital&#8217;s 2024 Developer Report, Solana is the #1 ecosystem for new developers, growing 83% in 2024, with this metric often considered a leading indicator of blockchain growth. Lastly, we note that Solana often leads all blockchains in key metrics such as daily active users, decentralized application revenues, and decentralized exchange volumes, sometimes putting up better metrics than all other chains combined.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Asset Management Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">On April 23, 2025, the Company entered into an Asset Management Agreement (the &#8220;Asset Management Agreement&#8221;) with GSR Strategies LLC (the &#8220;Asset Manager&#8221;), pursuant to which the Asset Manager shall provide discretionary investment management services with respect to the Company&#8217;s cryptocurrency treasury (the &#8220;Account Assets&#8221;). According to the Asset Management Agreement, the Asset Manager will invest the Account Assets, including any funds raised in accordance with the funding allocation provided in the Asset Management Agreement, principally with a long-only strategy primarily in Solana, including staking (and restaking0 Solana to improve returns (the &#8220;SOL Treasury Strategy&#8221;).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">The Company shall pay the Asset Manager an asset-based fee (the &#8220;Asset-based Fee&#8221;) equal to 1.75% per annum, of the assets under the Asset Manager&#8217;s management, which shall be calculated and paid in advance as of the first business day of each calendar month, as determined by the Asset Manager in a commercially reasonable manner and in good faith, by reference to, where applicable, available prices on Coinbase as of 12:00 UTC on such day. For any asset prices not available on Coinbase, the Asset Manager shall determine the value of such assets in a commercially reasonable manner and in good faith by reference to reputable industry sources.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">As compensation for services rendered by the Asset Manager, the Company issued warrants (the &#8220;GSR Warrants&#8221;) to the Asset Manager to purchase 2,192,982 shares of Common Stock at various prices per share of common stock as follows: (i) 877,193 shares of Common Stock at an exercise price of $2.28 per share of Common Stock; (ii) 438,596 shares of Common Stock at an exercise price of $3.42 per share of Common Stock; (iii) 438,596 shares of Common Stock at an exercise price of $4.56 per share of Common Stock; (iv) 438,597 shares of Common Stock at an exercise price of $5.70 per share of Common Stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">The Asset Management Agreement will, unless early terminated in accordance with its terms, continue in effect until the twentieth (20th) anniversary of April 23, 2025. The Asset Management Agreement may be terminated by the Company without cause solely upon a two-thirds majority vote of the Company&#8217;s common stockholders to terminate the SOL Treasury Strategy. If the Company terminates the Asset Management Agreement for any other reason other than for cause, the Company shall pay the Asset Manager an early termination fee (the &#8220;Termination Fee) in the amount equal or greater of (i) five (5) times the aggregate amount of the management fees paid by the Company to the Asset Manager over the prior ten (10) year period, or (ii) $15 million. The Asset Management Agreement may be terminated for Cause (i) by the Company upon at least thirty (30) days prior written notice to the Asset Manager and (ii) by the Asset Manager upon at least sixty (60) days prior written notice to the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>The Brands</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img6.jpg" alt="upxi_s1img6.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">LuckyTail, where at-home care meets innovation. We connect pet owners with the products they need to simplify and improve at-home wellness and grooming care for their beloved pets, empowering pet parents to provide their cherished furry companions with the pampering they deserve in the comfort of their own space.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">43</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img7.jpg" alt="upxi_s1img7.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At PRAX, we fuel modern go-getters to achieve their best selves through innovative energy solutions. Powered by paraxanthine&#8212;an advanced alternative to caffeine, our mission is to support your hustle and power your ambitions. Energize better, perform smarter, fuel different.&#160; We are launching this new brand in October of 2024 with several innovative products to follow.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img8.jpg" alt="upxi_s1img8.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At Cure Mushrooms, we have harnessed the extraordinary benefits of nature&#8217;s most powerful superfood: functional mushrooms. Our suite of premium mushroom extracts are meticulously crafted to elevate overall well-being, offering a wide spectrum of health benefits and a holistic approach to everyday wellness. From fortifying your immune system, to sharpening cognition, to combating the rigors of daily stress, our products are designed to deliver full-body wellness and convenience with every serving.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img9.jpg" alt="upxi_s1img9.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At Moonwlkr, we craft cannabinoid experiences that take you beyond the ordinary. By combining award-winning natural flavors and one-of-a-kind blends, we invite you to feel the thrill of the unknown, the calm of weightless relaxation, or the anticipation of a new adventure.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_s1img10.jpg" alt="upxi_s1img10.jpg"/></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">At Gumi Labs we manufacture gummies and other products supporting our health and wellness products, including those products manufactured with hemp ingredients.&#160; Our manufacturing facility has been moved to Florida and is at full capacity as of August of 2024.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">44</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our History</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company operates manufacturing and/or distribution centers in Nevada supporting health and wellness products, including those products manufactured with hemp ingredients and our overall distribution operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">July 2020 &#8211; the Company purchased Infusionz LLC. Infusionz was a similar business in the manufacturing and distribution of products and owned certain product brands that we believe could be expanded through the merger.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">June 2021 &#8211; Upexi Inc. became a listed company on the Nasdaq stock exchange.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2021 &#8211; The Company purchased the assets of VitaMedica Corporation, a California corporation (VitaMedica). VitaMedica is a leading online seller of supplements for surgery, recovery, skin, beauty, health and wellness.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">October 2021 &#8211; The Company purchased Interactive Offers, LLC, a Delaware limited liability company. Interactive provides programmatic advertising with its SAAS platform which allows for programmatic advertisement placement automatically on any partners&#8217; sites from a simple dashboard.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">April 2022 &#8211; The Company purchased 55% of Cygnet Online, LLC, a Delaware limited liability company (&#8220;Cygnet&#8221;). Cygnet operates a warehouse and distribution center for the management of day-to-day operations for product liquidation through Amazon and other on-line resellers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2022 &#8211; The Company purchased the assets to the brand LuckyTail. The acquisition of LuckyTail provided the Company with a foothold in the pet care industry and a strong presence on Amazon and its eCommerce store, offering nutritional and grooming products domestically and internationally.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">October 2022 &#8211; The Company purchased E-Core Technology, Inc. d/b/a New England Technology, Inc. (&#8220;E-Core&#8221;), a Florida corporation. E-Core distributes non-owned branded products to national retail distributors and has branded products in the toy industry that E-Core sells direct to consumers through online sales channels and to national retail distributors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">October 2022 &#8211; The Company sold all rights to Infusionz brands and the manufacturing of certain private label business. Infusionz was originally purchased by the Company in July of 2020.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">July 2023 &#8211; The Company notified the Buyer of the Infusionz brands and the manufacturing business of the defaults and notified the Buyer that all obligations and undertakings to the Buyer are terminated. The Company started manufacturing again for brands owned by the Company to ensure there was no interruption to the supply chain of the products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2023 &#8211; The Company purchased the remaining ownership of Cygnet.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">August 2023 &#8211; The Company sold one hundred percent (100%) of the issued and outstanding equity of its wholly owned subsidiary Interactive Offers, LLC.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">May 2024 &#8211; The Company sold its equity interest in the wholly owned subsidiary VitaMedica, a Nevada corporation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">June 2024 &#8211; The Company sold its equity interest in the wholly owned subsidiary E-Core Technology, Inc. d/b/a New England Technology, Inc. a Florida corporation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">January 2025 &#8211; The Company announced the strategy of establishing a digital currency holding company to invest and capitalize on the opportunities of cryptocurrency.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">April 2025 &#8211; The Company consummated a $100 million private placement offering and used the net proceeds from the offering to fund its treasury strategy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">July 2025 &#8211; The Company consummated a $50 million private placement offering and a $151.2 million convertible note offering in consideration for the exchange of Solana to continue to build its SOL treasury strategy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">November 2025 &#8211; The Company consummated a $10 million private placement offering and used the net proceeds from the offering to further fund its treasury strategy.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">45</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Regulations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In the United States, hemp products that are manufactured by Upexi are regulated by the U.S. Food and Drug Administration, the Federal Trade Commission, the United States Department of Agriculture (&#8220;USDA&#8221;), and various state agencies within the individual states. As an initial matter, the hemp products manufactured and distributed by Upexi must meet the requirements of the Agricultural Improvement Act of 2018 (the &#8220;Farm Bill&#8221;). Under the Farm Bill, all hemp products must contain no more than 0.3% of 9-delta-tetraydrocannabidiols (&#8220;9-delta&#8221;) on a dry weight basis.&#160;To ensure compliance with this provision, Upexi requires all hemp products it manufactures and distributes to contain no more than 0.3% of all tetraydrocannabidiols not simply 9-delta.&#160;The Farm Bill also requires that Upexi only use hemp [manufacturers/producers] that are duly licensed under state law or pursuant to the regulations issued by the USDA.&#160;Consequently, the Company processes, develops, manufactures, and sells its products pursuant to the Farm Bill. CBD products manufactured and distributed by Upexi Inc. must also meet the requirements of the federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and the federal Food and Drug Administration&#8217;s (the &#8220;FDA&#8221;) regulations implementing the FDCA. While neither the FDCA nor FDA has specific provisions that relate to the marketing of hemp products, the products are subject to the general adulteration and labeling provisions of the FDCA and FDA&#8217;s regulations depending on whether the product is marketed as a cosmetic, dietary supplement or food. The permissibility of hemp products containing cannabinoids remains in a state of flux. The FDA has issued guidance titled &#8220;FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)&#8221; pursuant to which the FDA has taken the position that cannabidiol (&#8220;CBD&#8221;) is prohibited from use as an ingredient in a food or beverage or as a dietary ingredient in or as a dietary supplement based on several provisions of the FDCA. In the definition of &#8220;dietary supplement&#8221; found in the FDCA at Section 201(ff), an article authorized for investigation as a&#160;new drug, antibiotic, or biological for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, is excluded from the definition of dietary supplement. A similar provision in the FDCA at 301(ll) makes it a prohibited act to introduce or deliver into commerce any food with a substance that was investigated as a new drug prior to being included in a food. There are no similar exclusions for the use of CBD in non-drug topical products, as long as such products otherwise comply with applicable laws. The FDA created a task force to address the further regulation of CBD and other cannabis-derived products and is currently evaluating the applicable science and pathways for regulating CBD and other cannabis-derived ingredients. Additionally, various states have enacted state-specific laws pertaining to the handling, manufacturing, labeling, and sale of CBD and other hemp products. Compliance with state-specific laws and regulations could impact our operations in those specific states. It is important to note that FDA has not taken any specific positions regarding the regulatory status of other cannabinoids, for example CBDA, CBDG, and CBDN. Finally, the Federal Trade Commission is the agency that is vested with ensuring that all marketing claims for hemp products are truthful and non-misleading.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Products</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Upexi is a brand owner specializing in the development, manufacturing, and distribution of consumer products. We reach consumers through our direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The market, customers and distribution methods for eCommerce products are large and diverse. While Amazon remains the largest eCommerce channel, others are carving out a big chunk of the market, including Walmart, eBay, and Etsy. More opportunities are popping up for sellers as well. Being able to navigate multiple marketplaces is a key to our success and helps reach different demographics and consumers with specific buying behaviors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our target customers are first and foremost end consumers via internet sales; however, we see growth opportunities in direct-to-consumer retail stores, cooperatives, affiliate sales and master distributors. As we continue to develop our business, these markets may change, be re-prioritized or eliminated as management responds to consumer and regulatory developments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Competitive Strengths</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We attribute our success to our consumer products by controlling each phase of the process from manufacturing to order fulfillment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As the manufacturer of our primary products, we are able to control our costs and improve profitability at each step of the process, starting with the development of new products.&#160;Our products take priority in manufacturing give us a higher inventory turnover rate and accelerates the timeline for new product launches.&#160;In addition, we are able to adjust to market demands and change production schedules to ensure we maintain optimized inventory levels.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our primary sales channel is our ecommerce site and our marketing team is led by an expert in the online direct to consumer sales as she has been with the brand since its inception. We have the ability to direct product manufacturing and increase sales with special promotions and product variations with little or no delay in bringing the product to market.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our direct to consumer focus reduces the overall supply costs as we do not have retail outlets or maintain distribution networks for small retail operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our executive team comes from a background in logistics, with CEO, Allan Marshall, the founder of XPO Logistics (formerly known as Segmentz, Inc.). With increased shipping costs affecting online retailers, our strength is understanding this and finding ways to lower our costs and overhead, thus increasing profit margins on all of our products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">46</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Our Growth Strategy</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our growth will focus on the expansion of our brands portfolio through organic growth and optimization of our supply chain.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Direct-to-Consumer expansion.&#160;</em>Our direct-to-consumer business is expected to be our growth driver for the next several years with additional brands and products.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;"><em>Talent acquisition.&#160;</em>A large part of our acquisition process is to not only evaluate the brand/product offerings, but to understand the team that has been responsible for its success. In a tough market for hiring, this has proven to be a strategic method for bringing on talent. We not only get a great brand, but look to retain the personnel, often the heartbeat of said brand, give them resources, and even utilize them for other brands that we have launched internally or acquired. We strongly believe that continued success relies on a growing team of experts across various industries.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Competition</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">There is heavy competition in our products and we are able to carve out certain niche markets within the industry and there are few competitors that control their manufacturing to distribution as we do.&#160; Our goal is to compete through our product delivery and introduction of new products that we manufacture and deliver directly to the consumer giving us an advantage on our competitors.&#160; We will focus on profitability, and grow efficiently, without the requirement of additional capital.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Government Regulation&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Treasury Strategy</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The laws and regulations applicable to Solana and digital assets are evolving and subject to interpretation and change.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Governments around the world have reacted differently to digital assets; certain governments have deemed them illegal, and others have allowed their use and trade without restriction, while in some jurisdictions, such as the U.S., digital assets are subject to overlapping, uncertain and evolving regulatory requirements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As digital assets have grown in both popularity and market size, the U.S. Executive Branch, Congress and a number of U.S. federal and state agencies, including the Financial Crimes Enforcement Network, the CFTC, the SEC, the Financial Industry Regulatory Authority, the Consumer Financial Protection Bureau, the Department of Justice, the Department of Homeland Security, the Federal Bureau of Investigation, the IRS and state financial regulators, have been examining the operations of digital asset networks, digital asset users and digital asset exchanges, with particular focus on the extent to which digital assets can be used to violate state or federal laws, including to facilitate the laundering of proceeds of illegal activities or the funding of criminal or terrorist enterprises, and the safety and soundness and consumer-protective safeguards of exchanges or other service-providers that hold, transfer, trade or exchange digital assets for users. Many of these state and federal agencies have issued consumer advisories regarding the risks posed by digital assets to investors. In addition, federal and state agencies, and other countries have issued rules&#160;or guidance regarding the treatment of digital asset transactions and requirements for businesses engaged in activities related to digital assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Depending on the regulatory characterization of Solana, the markets for cryptocurrency in general, and our activities in particular, our business and our Solana acquisition strategy may be subject to regulation by one or more regulators in the United States and globally. Ongoing and future regulatory actions may alter, to a materially adverse extent, the nature of digital assets markets, the participation of industry participants, including service providers and financial institutions in these markets, and our ability to pursue our Solana strategy. Additionally, U.S. state and federal and foreign regulators and legislatures have taken action against industry participants, including digital assets businesses, and enacted restrictive regimes in response to adverse publicity arising from hacks, consumer harm, or criminal activity stemming from digital assets activity. U.S. federal and state energy regulatory authorities are also monitoring the total electricity consumption of cryptocurrency mining, and the potential impacts of cryptocurrency mining to the supply and dispatch functionality of the wholesale grid and retail distribution systems. Many state legislative bodies have passed, or are actively considering, legislation to address the impact of cryptocurrency mining in their respective states.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The CFTC takes the position that some digital assets fall within the definition of a &#8220;commodity&#8221; under the Commodities Exchange Act of 1936, as amended, or CEA. Under the CEA, the CFTC has broad enforcement authority to police market manipulation and fraud in spot digital assets markets in which we may transact. Beyond instances of fraud or manipulation, the CFTC generally does not oversee cash or spot market exchanges or transactions involving digital asset commodities that do not utilize margin, leverage, or financing. In addition, CFTC regulations and CFTC oversight and enforcement authority apply with respect to futures, swaps, other derivative products and certain retail leveraged commodity transactions involving digital asset commodities, including the markets on which these products trade.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In addition, because transactions in Solana provide a degree of anonymity, they are susceptible to misuse for criminal activities, such as money laundering. This misuse, or the perception of such misuse, could lead to greater regulatory oversight of Solana and Solana platforms, and there is the possibility that law enforcement agencies could close Solana platforms or other Solana-related infrastructure with little or no notice and prevent users from accessing or retrieving Solana held via such platforms or infrastructure.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">47</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">As noted above, activities involving Solana and other digital assets may fall within the jurisdiction of more than one financial regulator and various courts and such laws and regulations are rapidly evolving and increasing in scope.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Consumer Products Business</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We are subject to laws and regulations affecting our operations in a number of areas. These laws and regulations affect the Company&#8217;s activities in areas, including, but not limited to, the hemp business in the United States, the consumer products and nutritional supplement markets in the United States, consumer protection, labor, intellectual property ownership and infringement, import and export requirements, federal and state healthcare, environmental and safety. The successful execution of our business objectives will be contingent upon our compliance with all applicable laws and regulations and obtaining all necessary regulatory approvals, permits and registrations, which may be onerous and expensive. Any such costs, which may rise in the future as a result of changes in such applicable laws and regulations and the expansion of the Company&#8217;s business, could make our products less attractive to our customers, delay the introduction of new products, and require the Company to implement policies and procedures designed to ensure compliance with applicable laws and regulations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We operate our business in markets that are both highly regulated and rapidly evolving. We are subject to numerous federal and state laws and regulations affecting the manufacturing, packaging, labeling and sale of food, beverages, dietary supplements, and personal care products/cosmetics, as well as the use of hemp and hemp-derived ingredients like CBD in such products. The FDA regulates hemp and hemp-derived ingredients in FDA-regulated products pursuant to the provisions of the FDCA and regulations promulgated pursuant to it, in particular those related to adulteration and labeling of cosmetic, food, and dietary supplements. The FDA has issued guidance on the subject and issued letters to companies regarding claims made for products and the use of such ingredients in various products. The FDA also initiated a task force to evaluate pathways for further regulation of hemp and hemp-derived ingredients. At various times, bills pertaining to the regulation of hemp and hemp-derived ingredients have been introduced in both the U.S. Senate and the U.S. House of Representatives, and additional proposed legislation is expected to be introduced in the future to clarify the regulatory status of cannabinoids from hemp generally and CBD generally. Future legislation approved by Congress and signed by the President, or rulemaking promulgated by the FDA, could either positively or adversely impact the future sale of products by the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We are currently not subject to any foreign regulations as we do not currently distribute or export any products, including hemp or CBD related products outside the U.S. Additionally, we are not aware of any foreign regulations that we had to comply with in regard to the sale of our flavoring products to one end user customer in the U.S. who distributed such products to Europe where it had operations. The responsibility for compliance with any European regulations would be on such customer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Additionally, numerous states have passed forms of hemp legislation governing the cultivation of hemp, as well as the further processing and sale of hemp and products with hemp or hemp-derived ingredients. Those states that have not yet enacted laws or issued regulations pertaining to hemp and hemp-derived ingredients may do so in the near future. Unless Congress specifically enacts laws preempting the state regulations of hemp products, we will continue to be subject not only to federal law but various state laws. Presently, Upexi only distributes hemp-products in states that it is legal to do so. Changes in the state laws and regulations could again either positively or adversely affect our ability to sell products in those states.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Employees</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company has 59 full-time employees working out of its headquarters in Tampa, Florida, its Odessa, Florida, manufacturing facility, its distribution warehouse in Tampa Florida or individuals&#8217; home-based offices</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a7">SELLING STOCKHOLDER</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="text-decoration:underline">November 2025 PIPE Offering</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">3,289,474 shares of Common Stock being offered by the Selling Stockholder were previously issued to such Selling Stockholder pursuant to that Purchase Agreement dated November 26, 2025 (the &#8220;PIPE Offering&#8221;). In connection with the PIPE Offering, we provided registration rights within that certain Securities Purchase Agreement dated November 26, 2025 (the &#8220;Purchase Agreement&#8221;) with the investor whereby we agreed to register for resale the shares of Common Stock sold in the PIPE Offering. We are registering the PIPE Shares and the Warrant Shares in order to permit the Selling Shareholder to offer the shares of Common Stock for resale from time to time. Except for the ownership of the shares of common stock and warrants, the Selling Stockholder has not had any material relationship with us within the past three years.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The table below lists the Selling Stockholder and other information regarding the beneficial ownership (as determined under Section 13(d) of the Exchange Act, and the rules and regulations thereunder) of the shares of common stock held by the selling stockholder.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The following table sets forth, based on information provided to us by or on behalf of the Selling Stockholder or known to us, the name of the Selling Stockholder and the number of shares of our Common Stock beneficially owned by each Selling Stockholder before and after this offering. The table below lists the Selling Stockholder and other information regarding the beneficial ownership of the shares of common stock by the Selling Stockholder. The second column lists the number of shares of common stock beneficially owned by the Selling Stockholder, based on its ownership of the shares of common stock, as of November 26, 2025, without regard to any limitations on exercise. The third column lists the shares of Common Stock being offered by this prospectus by the Selling Stockholder. The fourth column assumes the sale of all of the shares offered by the Selling Stockholder pursuant to this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">48</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 34.55pt; text-align:justify;">The Selling Stockholder may sell all, some or none of their shares in this offering. See &#8220;<em>Plan of Distribution</em>.&#8221;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Name of Selling Stockholder</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of Shares of Common Stock Owned Prior to Offering</strong></p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Number of shares of Common Stock Owned After the Offering</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Polar Multi-Strategy Master Fund (1)(2)</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">6,578,948</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">6,578,948</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">0</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Consists of 3,289,474 shares of common stock and 3,289,474 shares of common stock underlying common stock purchase warrants. Andrew Ma, the Chief Compliance Officer of Polar Multi-Strategy Master Fund (the &#8220;Selling Securityholder&#8221;), has voting and investment control of the shares held by the Selling Securityholder and may be deemed to be the beneficial owner of such shares. Mr. Ma, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The registered address of the Selling Securityholder is at c/o 16 York Street, Suite 2900, Toronto, Ontario, Canada M5J 0E6.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a8">PLAN OF DISTRIBUTION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Selling Stockholder and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal trading market or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Stockholder may use any one or more of the following methods when selling securities:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"/><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">an exchange distribution in accordance with the rules of the applicable exchange;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">privately negotiated transactions;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">settlement of short sales;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">in transactions through broker-dealers that agree with the Selling Stockholder to sell a specified number of such securities at a stipulated price per security;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">a combination of any such methods of sale; or</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">any other method permitted pursuant to applicable law.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Selling Stockholder may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;), if available, rather than under this prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Broker-dealers engaged by the Selling Stockholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In connection with the sale of the securities or interests therein, the Selling Stockholder may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholder may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholder may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Selling Stockholder and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">49</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholder against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholder without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the shares of Common Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholder will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the shares of Common Stock by the Selling Stockholder or any other person. We will make copies of this prospectus available to the Selling Stockholder and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>DESCRIPTION OF CAPITAL&#160;STOCK&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>General</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">The following is a description of the material terms of, and is qualified in its entirety by, our certificate of incorporation and bylaws, each of which will be in effect upon the consummation of this offering, the forms of which are filed as exhibits to the registration statement of which this prospectus forms a part. Under &#8220;Description of Capital Stock,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; and &#8220;our company&#8221; refer to Upexi Inc. and not to any of its subsidiaries.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.35pt; TEXT-INDENT: 0.5in; text-align:justify;">We are authorized to issue up to 300,000,000 shares of Common Stock at a par value of $0.00001 per share. As of December 1, 2025, there were 63,208,083 shares of Common Stock outstanding. The holders of Common Stock will have the right to vote on all matters on which stockholders have the right to vote, and holders of Common Stock shall be entitled to one (1) vote per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">Holders of Common Stock are entitled to receive proportionately any dividends as may be declared by our board of directors, subject to any preferential dividend rights of outstanding Preferred Stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">In the event of our liquidation or dissolution, the holders of Common Stock are entitled to receive proportionately all assets available for distribution to shareholders after the payment of all debts and other liabilities and subject to the prior rights of any outstanding preferred stock. Holders of Common Stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of Common Stock are subject to and may be adversely affected by the rights of the holders of shares of any series of Preferred Stock that we may designate and issue in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Preferred Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">Our bylaws authorize the Board of to provide for the issuance of shares of Preferred Stock in series and, by filing a certificate pursuant to the Delaware General Corporation Law (&#8220;DGCL&#8221;), to establish from time to time one or more classes of Preferred Stock or one or more series of Preferred Stock, by fixing and determining the number of shares to be included in each such class or series, and to fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations and restrictions thereof.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">We are authorized to issue up to 10,000,000 shares of Preferred Stock at a par value of $0.00001 per share. As of December 1, 2025, there were 150,000 shares of Series A Preferred Stock outstanding which is convertible into 138,889 shares of the Company&#8217;s common stock at the holder&#8217;s option. The holders of Series A Preferred Stock will have the right to vote on all matters on which stockholders have the right to vote, and holders of Series A Preferred Stock shall be entitled to ten (10) votes per share and shall vote together as a separate class on stock on all matters which impact the rights, value, or ranking of the Common Stock or Series A Preferred Stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">50</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">In the event of our liquidation, consolidation, merger or dissolution, the holders of Series A Preferred Stock are entitled to receive an amount on such date equal to the Stated Value of Series A Preferred Stock, which is $0.05 per share.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Anti-Takeover Provisions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The following is a summary of certain provisions of Delaware law, our Certificate of Incorporation and our bylaws. This summary does not purport to be complete and is qualified in its entirety by reference to the corporate law of Delaware and our Certificate of Incorporation and bylaws.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Effect of Delaware Anti-Takeover Statute.</em> We are subject to Section 203 of the Delaware General Corporation Law, an anti-takeover law. In general, Section 203 prohibits a Delaware corporation from engaging in any business combination (as defined below) with any interested stockholder (as defined below) for a period of three years following the date that the stockholder became an interested stockholder, subject to certain exceptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Section 203 defines &#8220;business combination&#8221; to include the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any merger or consolidation involving the corporation and the interested stockholder;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">subject to limited exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation, or who beneficially owns 15% or more of the outstanding voting stock of the corporation at any time within a three-year period immediately prior to the date of determining whether such person is an interested stockholder, and any entity or person affiliated with or controlling or controlled by any of these entities or persons.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Our Charter Documents.</em>&#160;Our charter documents include provisions that may have the effect of discouraging, delaying or preventing a change in control or an unsolicited acquisition proposal that a stockholder might consider favorable, including a proposal that might result in the payment of a premium over the market price for the shares held by our stockholders. Certain of these provisions are summarized in the following paragraphs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Cumulative Voting.&#160;</em>Our Certificate of Incorporation does not provide for cumulative voting in the election of directors, which would allow holders of less than a majority of the stock to elect some directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Special Meeting of Stockholders and Stockholder Action by Written Consent.</em>&#160;A special meeting of stockholders may only be called by the Board of Directors, the Chairman of the Board or the Chief Executive Officer at any time.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Indemnification of Officers and Directors.</em>&#160;The Company shall indemnify its officers and directors under the circumstances and to the full extent permitted by law. A director of the Company shall not be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director&#8217;s duty of loyalty to the Company or its stockholders, (ii) for acts or omissions not in good faith or which involved intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL for unlawful payment of dividends or improper redemption of stock, or (iv) for any transaction from which the director derived an improper personal benefit. If the DGCL is hereafter amended to authorize the further elimination or limitation of the liability of directors, then the liability of a director of the Company, in addition to the limitation on personal liability provided herein, shall be limited to the fullest extent permitted by the DGCL, as amended. Any repeal or modification of this paragraph by the stockholders of the Company shall be prospective only, and shall not adversely affect any limitation on the personal liability of a director of the Company existing at the time of such repeal or modification.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">51</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Authorized but Unissued Shares</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">The authorized but unissued shares of our Common Stock are available for future issuance without shareholder approval, subject to any limitations imposed by the listing standards of The Nasdaq Capital Market. These additional shares may be used for a variety of corporate finance transactions, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved Common Stock and preferred stock could make more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Transfer Agent and Registrar</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">The transfer agent and registrar for shares of our Common Stock is Vstock Transfer, LLC.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Listing</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.75pt; text-align:justify;">Our Common Stock on The Nasdaq Capital Market under the symbol &#8220;UPXI.&#8221;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>AND FINANCIAL DISCLOSURE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">None.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>LEGAL MATTERS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Lucosky Brookman LLP serves as our legal counsel in connection with this offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>EXPERTS</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The consolidated financial statements of Upexi, Inc. (the Company) as of June 30, 2025 and 2024 and for each of the two years in the period ended June 30, 2025 incorporated by reference in this Prospectus and in the Registration Statement have been so incorporated in reliance on the report of GBQ Partners LLC, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a9">WHERE YOU CAN FIND MORE INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This prospectus is part of a registration statement on Form S-1 that we filed with the SEC. Certain information in the registration statement has been omitted from this prospectus in accordance with the rules and regulations of the SEC. Whenever a reference is made in this prospectus to any of our contracts, agreements or other documents, the reference may not be complete and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into this prospectus for a copy of such contract, agreement or other document. Because we are subject to the information and reporting requirements of the Exchange Act, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the internet at the SEC&#8217;s website at http://www.sec.gov.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">52</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span class="atag" style="display: inline" id="a10">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The SEC allows us to &#8220;incorporate by reference&#8221; into this Prospectus the information in documents we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this Prospectus, and information that we file later with the SEC will automatically update and supersede this information. Any statement contained in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Prospectus to the extent that a statement contained in or omitted from this Prospectus or any accompanying prospectus supplement, or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We incorporate by reference the documents listed below and any future documents that we file with the SEC (excluding any portion of such documents that are furnished and not filed with the SEC) under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after the date of the initial filing of the registration statement of which this Prospectus forms a part prior to the effectiveness of the registration statement and (ii) after the date of this Prospectus until the offering of the securities is terminated:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"/><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">our Annual Report on Form 10-K for the year ended June 30, 2025 as filed with the SEC on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1775194/000147793225006996/upxi_10k.htm">September 24, 2025</a>.</p></td></tr><tr style="height:15px"><td/><td/><td/></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our Quarterly Report on Form 10-Q for the three months ended September 30, 2025 as filed with the SEC on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1775194/000147793225008025/upxi_10q.htm">November 12, 2025</a></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td/><td/></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">our Current Reports on Form 8-K filed with the SEC on&#160;<a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005090/upxi_8k.htm">July 16, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_8k.htm">July 18, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005253/upxi_8k.htm">July 25, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006136/upxi_8k.htm">August 20, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006234/upxi_8k.htm">August 26, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006575/upxi_8k.htm">September 8, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006234/upxi_8k.htm">September 26, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225007346/upxi_8k.htm">October 3, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225007473/upxi_8k.htm">October 9, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225007749/upxi_8k.htm">October 24, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225007931/upxi_8k.htm">November 5, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225007982/upxi_8k.htm">November 7, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008089/upxi_8k.htm">November 12, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008305/upxi_8k.htm">November 14, 2025</a>, <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008662/upxi_8k.htm">November 28, 2025</a>, and <a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_8k.htm">December 1, 2025</a>.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">all reports and other documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Prospectus and prior to the termination of this offering.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We also incorporate by reference any future filings (other than information furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including those made after the date of the initial filing of the registration statement of which this Prospectus is a part and prior to effectiveness of such registration statement, until we file a post-effective amendment that indicates the termination of the offering of the common stock made by this Prospectus and will become a part of this Prospectus from the date that such documents are filed with the SEC. Information in such future filings updates and supplements the information provided in this Prospectus. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Notwithstanding the foregoing, information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits, is not incorporated by reference in this Prospectus.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The information about us contained in this Prospectus should be read together with the information in the documents incorporated by reference. You may request a copy of any or all of these filings, at no cost, by writing or telephoning us at: Upexi, Inc., 3030 North Rocky Point Drive, Suite 420, Florida, FL 33607, (701) 353-5425.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">53</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Up to 3,289,474 Shares of Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Up to 3,289,474 Shares of Common Stock Underlying Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>UPEXI, INC.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong><span style="font-size:18pt">PROSPECTUS</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 1, 2025</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PART II</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>INFORMATION NOT REQUIRED IN PROSPECTUS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Item 13. Other Expenses of Issuance and Distribution</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The following table sets forth the costs and expenses, other than underwriting discounts and commissions, to be paid by the Registrant in connection with the issuance and distribution of the securities being registered. All amounts other than the SEC registration fees and FINRA fees are estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">SEC Registration Fee</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,544</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accounting Fees and Expenses*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">20,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Legal Fees and Expenses*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">25,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Transfer Agent and Registrar Fees*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Miscellaneous Fees and Expenses*</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Total*</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">54,544</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">* Estimated expenses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Item 14. Indemnification of Directors and Officers</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our Certificate of Incorporation provides that all of our directors, officers, employees and agents shall be entitled to be indemnified by us to the fullest extent permitted by Section 145 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;). We are incorporated under the laws of the State of Delaware. Under Delaware law, a corporation may indemnify any person who was or is a party or is threatened to be made a party to an action (other than an action by or in the right of the corporation) by reason of his or her service as a director or officer of the corporation, or his or her service, at the corporation&#8217;s request, as a director, officer, employee or agent of another corporation or other enterprise, against expenses (including attorneys&#8217; fees) that are actually and reasonably incurred by him or her expenses, and judgments, fines and amounts paid in settlement that are actually and reasonably incurred by him or her, in connection with the defense or settlement of such action, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation&#8217;s best interests, and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful. Although Delaware law permits a corporation to indemnify any person referred to above against such expenses in connection with the defense or settlement of an action by or in the right of the corporation, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation&#8217;s best interests, if such person has been judged liable to the corporation, indemnification is only permitted to the extent that the Court of Chancery (or the court in which the action was brought) determines that, despite the adjudication of liability, such person is entitled to indemnity for such Expenses as the court deems proper. The DGCL also provides for mandatory indemnification of any director, officer, employee or agent against such expenses to the extent such person has been successful in any proceeding covered by the statute. In addition, the DGCL provides the general authorization of advancement of a director&#8217;s or officer&#8217;s litigation expenses in lieu of requiring the authorization of such advancement by the board of directors in specific cases, and that indemnification and advancement of expenses provided by the statute shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any by law, agreement or otherwise.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our Bylaws and Certificate of Incorporation provide for indemnification of our directors and officers and for advancement of litigation expenses to the fullest extent permitted by current Delaware law. In addition, the Company has entered into indemnification agreements with certain of its directors and officers that provide for indemnification and advancement of litigation expenses to fullest extent permitted by the DGCL.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We maintain a policy of directors&#8217; and officers&#8217; liability insurance which reimburses us for expenses which we may incur in connection with the foregoing indemnity provisions and which may provide direct indemnification to directors and officers where we are unable to do so.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-1</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the above, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Item 15. Recent Sales of Unregistered Securities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The following sets forth information regarding all unregistered securities sold by us in transactions that were exempt from the requirements of the Securities Act in the last three years. Except where noted, all of the securities discussed in this Item 15 were all issued in reliance on the exemption under Section 4(a)(2) of the Securities Act. Unless otherwise indicated, all of the share issuances described below were made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On November 26, 2025, the Company issued: (i) 3,289,474 shares of Common Stock, at an offering price of $3.04 per share, and (ii) warrants to purchase 3,289,474 shares of Common Stock (the &#8220;Warrants&#8221;) at a combined purchase price of $3.04. Each of the Warrants is exercisable for one share of Common Stock at the exercise price of $4.00 per Warrant, are immediately exercisable, and may be exercised at any time until all of the Warrants are exercised in full.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On October 27, 2025, the Company issued 33,334 shares of Common Stock for $100,000 pursuant to certain exercises of warrants at $3.00 per share.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On October 14, 2025, the Company issued 678,352 shares of Common Stock pursuant to certain exercises of warrants at prices between $2.28 to $5.70 in connection with the Asset Management Agreement entered into on April 23, 2025 with GSR Strategies LLC (the &#8220;Asset Manager&#8221;).&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On July 16, 2025, the Company issued secured convertible notes in the aggregate, principal amount of approximately $151.2 million, convertible into 35,569,224 shares of Common Stock at $4.25 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On July 11, 2025, the Company issued 12,457,186 shares of Common Stock, at an offering price of $4.00 per share and $4.94 per share for certain members of the Company's management and members of the board of directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On April 24, 2025, the Company issued: (i) 35,970,383 shares of Common Stock, at an offering price of $2.28 per share, and (ii) pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase 7,889,266 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;) at an offering price of $2.279 per Pre-Funded Warrant. Each of the Pre-Funded Warrants is exercisable for one share of Common Stock at the exercise price of $0.001 per Pre-Funded Warrant Share, are immediately exercisable, and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">On April 24, 2025, the Company issued 214,228 shares of Common Stock as repayment of $550,000 of the Company&#8217;s debt.&#160;The shares were valued at $550,000 or $2.28 per share.&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In February of 2025, the Company issued 125,000 shares of Common Stock to two different investors for the repayment of $250,000 of outstanding debt.&#160;The average share price for the repayment of debt was approximately $2.00 per common share issued.&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="font-size:10pt;font-family:times new roman;margin:0px">In January of 2025, the Company issued 260,000 shares of Common Stock to two different investors for the repayment of $550,000 of outstanding debt.&#160;The weight average share price for the repayment of debt was approximately $2.12 per common share issued.&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-2</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In September of 2023, the Company was to issue 4,505 shares of Common Stock for the acquisition of the remaining 45% of Cygnet Online, LLC.&#160;The shares were valued at $162,727 or $35.80 per common share. &#160;&#160;These shares were held and not issued due to an ongoing dispute.&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In January of 2024, the Company issued 25,081 shares of Common Stock as repayment of $500,000 of the Company&#8217;s long-term debt.&#160;The shares were valued at $500,000 or $19.94 per share.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended June 30, 2021, the Company issued 526,404 shares of Common Stock for the acquisition of Infusionz. The shares were valued at $1,235,124 and the Company issued 306,935 of the Company&#8217;s stock on September 1, 2021 for the remaining acquisition liability of $1,764,876. In addition, the Company issued 83,334 shares of Common Stock valued at $127,500 for acquisition costs.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended March 31, 2022, the Company issued 306,945 shares of Common Stock for the acquisition of Infusionz. The shares were valued at $1,764,876 or $5.75 per share, as this was the remaining acquisition liability for the Infusionz purchase.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended March 31, 2022, the Company issued 100,000 shares of Common Stock for the acquisition of VitaMedica and 7,000 shares of Common Stock as a finder&#8217;s fee for the completion of the transaction. The shares were valued at $515,740 or $4.82 per share, as this was the closing price of the stock on August 4, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended March 31, 2022, the Company issued 35,000 shares of Common Stock for a consulting agreement. The shares were valued at $175,000 or $5.00 per share, based on the price of the services to be rendered.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the nine months ended March 31, 2022, the Company issued 666,667 shares of Common Stock for the acquisition of Interactive, the shares were valued at $4,000,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subsequent to the nine months ended March 31, 2022, the Company issued 555,489 shares of Common Stock for the acquisition of Cygnet Online, LLC valued at $2,550,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subsequent to the nine months ended March 31, 2022, the Company issued 119,792 shares of Common Stock for the cashless exercise of a warrant, valued at $651,668.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">On October 31, 2022, the Company issued 1,247,403 shares of Common Stock for the acquisition of E-core Technologies Inc. a Florida corporation, valued at $6,000,000.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-3</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Item 16. Exhibits and Financial Statement Schedules</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>(a)</strong> <strong>Exhibits</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We have filed the exhibits listed on the accompanying Exhibit Index of this registration statement and below in this Item 16:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Exhibit</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Reference</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td/><td/><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Filed or</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Furnished</strong></p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Number</strong></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exhibit Description</strong></p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Form</strong></p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Exhibit</strong></p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Filing Date</strong></p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Herewith</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006419/upxi_ex31.htm">3.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006419/upxi_ex31.htm">Certificate of Incorporation</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">3.1(e)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006419/upxi_ex32.htm">3.2</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006419/upxi_ex32.htm">Bylaws</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">3.2(b)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex46.htm">4.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex46.htm">Common Stock Specimen</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">S-1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4.6</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/15/21</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex41.htm">4.2</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex41.htm">Form of Pre-Funded Warrant</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex42.htm">4.3</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex42.htm">Warrant Issued to GSR Strategies LLC dated April 23, 2025</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex41.htm">4.4</a></p></td><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex41.htm">Form of Common Stock Purchase Warrant dated November 26, 2025</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4.1</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">12/1/25</p></td><td/><td/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex51.htm">5.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex51.htm">Legal Opinion of Lucosky Brookman LLP</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">X</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex101.htm">10.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex101.htm">Upexi, Inc. 2019 Incentive Stock Plan (Amended and Restated as of February 8, 2021)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">S-1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/15/21</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex102.htm">10.2</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex102.htm">Form of Nonqualified Stock Option Agreement</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">S-1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/15/21</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793224003725/upxi_ex101.htm">10.3</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793224003725/upxi_ex101.htm">Stock Purchase Agreement, dated June 1, 2024</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">6/17/24</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793224004547/upxi_ex101.htm">10.4</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793224004547/upxi_ex101.htm">Agreement to Unwind Securities Purchase Agreement, dated July 31, 2024</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8/5/24</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex105.htm">10.5*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793221002410/grove_ex105.htm">Employment Agreement, dated April 24, 2025, between Registrant and Andrew J. Norstrud</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/25/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002989/upxi_101.htm">10.6*</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002989/upxi_101.htm">Employment Agreement, dated April 24, 2025, between Registrant and Allan Marshall</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/25/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223006654/upxi_ex2.htm">10.7</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223006654/upxi_ex2.htm">Equity Interest Purchase Agreement, dated August 31, 2023, between Registrant and Amplifyir Inc.</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/06/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1023.htm">10.8</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1023.htm">Exercise of Option to Acquire Cygnet Online, LLC, dated September 1, 2023, between Registrant and Eric Hanig</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.23</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10/3/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223005846/upxi_ex47.htm">10.9</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223005846/upxi_ex47.htm">Upexi, Inc. 2019 Amended and Restated Stock Incentive Plan, effective May 24, 2022</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">S-8</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4.7</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8/9/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex101.htm">10.10</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex101.htm">Form of Securities Purchase Agreement, dated as of April 20, 2025, between Upexi, Inc. and each Purchaser (as defined therein)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex102.htm">10.11</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex102.htm">Placement Agency Agreement, dated April 20, 2025, between Upexi, Inc. and A.G.P/Alliance Global Partners</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex103.htm">10.12</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex103.htm">Form of Registration Rights Agreement, dated as of April 20, 2025, between Upexi, Inc. and each Purchaser (as defined therein)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.3</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex104.htm">10.13</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002944/upxi_ex104.htm">Asset Management Agreement, dated April 23, 2025, between Upexi, Inc. and GSR Strategies LLC</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.4</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005090/upxi_ex101.htm">10.14</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005090/upxi_ex101.htm">Form of Securities Purchase Agreement, dated as of July 11, 2025, between Upexi, Inc. and each Purchaser (as defined therein)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/16//25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005090/upxi_ex102.htm">10.15</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005090/upxi_ex102.htm">Placement Agency Agreement, dated July 11, 2025, between Upexi, Inc. and A.G.P/Alliance Global Partners</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/16/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005090/upxi_ex103.htm">10.16</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005090/upxi_ex103.htm">Form of Registration Rights Agreement, dated as of July 11, 2025, between Upexi, Inc. and each Purchaser (as defined therein)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.3</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/16/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex41.htm">10.17</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex41.htm">Form of Secured Convertible Promissory Note</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/18/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-4</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:8%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex101.htm">10.18</a></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex101.htm">Form of Securities Purchase Agreement, dated as of July 2025, between Upexi, Inc. and each Purchaser (as defined therein)</a></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:8%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/18/25</p></td><td style="width:1%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="width:8%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex102.htm">10.19</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex102.htm">Form of Security Agreement, dated as of July 2025, between Upexi, Inc. and Seller</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/18/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex104.htm">10.20</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005150/upxi_ex104.htm">Form of Registration Rights Agreement, dated as of July 2025, between Upexi, Inc. and each Purchaser (as defined therein)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.4</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/18/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005253/upxi_ex101.htm">10.21&#160;</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005253/upxi_ex101.htm">Common Stock Purchase Agreement, dated as of July 25, 2025, between Upexi, Inc. and A.G.P./ Alliance Global Partners</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/25/25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005253/upxi_ex102.htm">10.22&#160;</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225005253/upxi_ex102.htm">Registration Rights Agreement, dated as of July 25, 2025, between Upexi, Inc. and A.G.P./ Alliance Global Partners</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">7/25/25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006234/upxi_ex101.htm">10.23</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006234/upxi_ex101.htm">Waiver and Amendment to that certain Securities Purchase Agreement, dated as of July 11, 2025</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8/26/25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006234/upxi_ex102.htm">10.24</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006234/upxi_ex102.htm">Form of Greenshoe Instrument</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8/26/25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006741/upxi_ex1025.htm">10.25</a>&#160;&#8224;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006741/upxi_ex1025.htm">BitGo Custodian Services Agreement</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.29</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/24/25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006741/upxi_ex1026.htm">10.26</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006741/upxi_ex1026.htm">BitGo Prime LLC Master Lending Agreement</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.30</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/24/25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1025.htm">10.27</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1025.htm">Audit Committee Charter</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10/3/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1026.htm">10.28</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1026.htm">Compensation Committee Charter</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.26</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10/3/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1027.htm">10.29</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex1027.htm">Nominating Committee Charter</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.27</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10/3/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006741/upxi_ex1030.htm">10.30</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006741/upxi_ex1030.htm">Coinbase Custodian Services Agreement</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.31</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/24/25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex41.htm">10.31</a></p></td><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex41.htm">Form of Common Stock Purchase Warrant dated November 26, 2025</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4.1</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">12/1/25</p></td><td/><td/></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex101.htm">10.32</a></p></td><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex101.htm">Form of Securities Purchase Agreement, dated as of November 26, 2025, between Upexi, Inc. and each Purchaser (as defined therein)</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.1</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">12/1/25</p></td><td/><td/></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex102.htm">10.32</a></p></td><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex102.htm">Placement Agency Agreement, dated November 26, 2025, between Upexi, Inc. and A.G.P./Alliance Global Partners</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.2</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">12/1/25</p></td><td/><td/></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex103.htm">10.33</a></p></td><td/><td><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225008713/upxi_ex103.htm">Form of Lock-Up Agreement dated November 25, 2025</a></p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">8-K</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10.3</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">12/1/25</p></td><td/><td/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex141.htm">14.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex141.htm">Code of Business Conduct and Ethics</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">14.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10/3/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex142.htm">14.2</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793223007307/upxi_ex142.htm">Whistleblower Policy</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">14.2</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10/3/23</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006996/upxi_ex191.htm">19</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006996/upxi_ex191.htm">Upexi, Inc. Insider Trading Policy</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">19.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006996/upxi_ex211.htm">21.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225006996/upxi_ex211.htm">List of Subsidiaries of Registrant</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">21.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">9/24/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex231.htm">23.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex231.htm">Consent of GBQ Partners LLC</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">X</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex51.htm">23.2</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex51.htm">Consent of Lucosky Brookman LLP (included in Exhibit 5.1)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">X</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#POA">24.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="#POA">Power of Attorney (included in the signature page of this Registration Statement)</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">X</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex107.htm">107</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="upxi_ex107.htm">Filing Fee Table</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">X</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002895/upxi_ex971.htm">97.1</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><a href="http://www.sec.gov/Archives/edgar/data/1775194/000147793225002895/upxi_ex971.htm">Clawback Policy</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">10-K/A</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">97.1</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">4/22/25</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">*</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Indicates a management contract or compensatory plan or arrangement.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&#8224; Confidential portions of this exhibit were redacted pursuant to Item 601(b)(10) of Regulation S-K, and the Registrant agrees to furnish to the SEC a copy of any omitted schedule and/or exhibit upon request.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>(b) Financial Statement Schedules.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">All schedules have been omitted because either they are not required, are not applicable or the information is otherwise set forth in the financial statements and related notes thereto.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-5</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Item 17. Undertakings</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The undersigned registrant hereby undertakes:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(1)</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</p></td></tr><tr style="height:15px"><td style="width:4%;"/><td style="width:4%;"/><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(i)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</p></td></tr><tr style="height:15px"><td/><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(ii)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and</p></td></tr><tr style="height:15px"><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(iii)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(2)</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">That for the purpose of determining any liability under the Securities Act of 1933 each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(3)</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(4)</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-6</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"/><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(5)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:8%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(i)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(ii)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(iii)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(iv)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(6)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(7)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described in Item 14 above, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(8)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The undersigned Registrant hereby undertakes:</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:8%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">That for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(2)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">That for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and this offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-7</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#TOCMF">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Tampa, Florida, on December 1, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td/><td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Upexi, Inc.</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"/><td style="width:3%;"/><td style="width:35%;"/><td style="width:12%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">By:</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>/s/ Allan Marshall</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td/><td/><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Name: Allan Marshall</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Title: President and Chief Executive Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span class="atag" style="display: inline" id="POA">POWER OF ATTORNEY</span>: KNOW ALL PERSONS BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Allan Marshall, his true and lawful attorneys-in-fact and agents with full power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to sign any registration statement for the same offering covered by the Registration Statement that is to be effective upon filing pursuant to Rule 462(b) promulgated under the Securities Act, and all post-effective amendments thereto, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his, her or their substitute or substitutes, may lawfully do or cause to be done or by virtue hereof.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:35%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Signature</strong></p></td><td style="width:2%;"/><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Title</strong></p></td><td style="width:2%;"/><td style="BORDER-BOTTOM: 1px solid;width:15%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Date</strong></p></td></tr><tr style="height:15px"><td/><td/><td/><td/><td/></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>/s/ Allan Marshall</em></p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">President, Chief Executive Officer and Director&#160;</p></td><td/><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 1, 2025</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Allan Marshall</p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Principal Executive Officer)</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td/><td/><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>/s/ Andrew J. Norstrud</em></p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Chief Financial Officer and Director</p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 1, 2025</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Andrew J. Norstrud</p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">(Principal Financial Officer and Principal Accounting Officer)</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td/><td/><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>/s/ Gene Salkind</em></p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Director</p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 1, 2025</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Gene Salkind</p></td><td/><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td/><td/><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>/s/ Thomas C. Williams</em></p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Director</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 1, 2025</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Thomas C. Williams</p></td><td/><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td/><td/><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>/s/ Laurence H. Dugan</em></p></td><td/><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Director</p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">December 1, 2025</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Laurence H. Dugan</p></td><td/><td/><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">II-8</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>upxi_ex51.htm
<DESCRIPTION>LEGAL OPINION
<TEXT>
<html><head><title>upxi_ex51.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 5.1</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_ex51img1.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">December 1, 2025</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Upexi, Inc.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">3030 Rocky Point Drive, Suite 420</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Tampa, Florida 33607</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Ladies and Gentlemen:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We have acted as counsel to Upexi, Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the Registration Statement on Form S-1 (as amended or supplemented, the &#8220;<strong>Registration Statement</strong>&#8221;), filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), for the registration for resale by the selling securityholders listed therein (the &#8220;Selling Securityholders&#8221;) of up to 6,578,948 shares of the Company&#8217;s common stock, par value $0.00001 per share (the &#8220;Shares&#8221;). Of the Shares being registered, there are (i) 3,289,474 shares are presently issued and outstanding and owned by the Selling Stockholder (the &#8220;Outstanding Shares&#8221;) and (ii) 3,289,474 shares (the &#8220;Warrant Shares&#8221;) issuable to such Selling Stockholders underlying common stock purchase warrants (the &#8220;Common Warrants,&#8221; and, collectively with the Outstanding Shares, the &#8220;Shares&#8221;) issued pursuant to those certain Securities Purchase Agreement &nbsp;dated November 26, 2025, by and between the Company and the Selling Stockholder (the &#8220;Purchase Agreement&#8221;) and collectively with the Warrants, the &#8220;Offering Documents&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The Shares may be offered from time to time, pursuant to Rule 415 of the General Rules and Regulations of the Commission promulgated under the Securities Act, as set forth in the Registration Statement, any amendment thereto, the prospectus contained in the Registration Statement (the &#8220;Prospectus&#8221;) and one or more supplements to the Prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">In connection with this opinion, we have examined and relied upon the Registration Statement and the Offering Documents. We have also examined originals or copies, certified or otherwise identified to our satisfaction, of the Company&#8217;s certificate of incorporation and bylaws, and such corporate records of the Company and other certificates and documents of officials of the Company, public officials and others as we have deemed appropriate for purposes of this letter. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, and the conformity to authentic original documents of all copies submitted to us as conformed and certified or reproduced copies.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">UPEXI, Inc.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">December 1, 2025 &nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Page 2 of 2</p></td> <td style="width:5%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:30%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><img src="upxi_ex51img2.jpg"></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">Based upon the foregoing and subject to the assumptions, exceptions, qualifications and limitations set forth hereinafter, we are of the opinion that:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Outstanding Shares have been duly and validly issued and are fully paid and nonassessable; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Warrant Shares have been duly authorized for issuance and, when issued and paid for in accordance with the terms and conditions of the Warrants, will be validly issued, fully paid and nonassessable.</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The opinions expressed herein are limited to the Delaware General Corporation Law and the laws of the State of New York, as currently in effect, and no opinion is expressed with respect to any other laws or any effect that such other laws may have on the opinions expressed herein.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This opinion letter is furnished in connection with the filing of the Registration Statement and may not be relied upon for any other purpose without our prior written consent in each instance. Further, no portion of this letter may be quoted, circulated or referred to in any other document for any other purpose without our prior written consent. &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our firm under the caption &#8220;Legal Matters&#8221; in the Prospectus forming a part of the Registration Statement. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission promulgated thereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Very truly yours,</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="upxi_ex51img3.jpg"></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>upxi_ex231.htm
<DESCRIPTION>CONSENT
<TEXT>
<html><head><title>upxi_ex231.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 23.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="upxi_ex231img1.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><u>Consent of Independent Registered Public Accounting Firm</u></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated September 24, 2025, relating to the consolidated financial statements of Upexi, Inc. (the Company) appearing in the Company&#8217;s Annual Report on Form 10-K for the year ended June 30, 2025. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We also consent to the reference to us under the caption &#8220;Experts&#8221; in the Prospectus.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">/s/ GBQ Partners, LLC</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Columbus, Ohio</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">December 1, 2025</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>upxi_ex107.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><head><title>upxi_ex107.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="From2025-12-01to2025-12-01" id="ixv-369">EX-FILING FEES</ix:nonNumeric><ix:nonNumeric name="ffd:SubmissnTp" contextRef="From2025-12-01to2025-12-01" id="ixv-370">S-1</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-12-01to2025-12-01" id="ixv-371">0001775194</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-12-01to2025-12-01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001775194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-01</xbrli:startDate><xbrli:endDate>2025-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Scties424iAxis_From2025-12-01to2025-12-01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001775194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ffd:Scties424iAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-01</xbrli:startDate><xbrli:endDate>2025-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="OfferingAxis_From2025-12-01to2025-12-01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001775194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-01</xbrli:startDate><xbrli:endDate>2025-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 107</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Calculation of Filing Fee Table</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric id="fid_b87899e1" name="ffd:FormTp" contextRef="From2025-12-01to2025-12-01">S-1</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Form Type)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2025-12-01to2025-12-01" id="ixv-406">Upexi, Inc.</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact Name of Registrant as Specified in its Charter)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="text-decoration:underline">Table 1: Newly Registered Securities</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Security Type</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Security Class Title</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fee</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Calculation Rule</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Registered</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Proposed</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Maximum</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Offering </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price Per Unit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Maximum Aggregate</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Offering Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fee Rate</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Registration</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fee</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:8%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric id="fid_819a96cd" name="ffd:PrevslyPdFlg" contextRef="Scties424iAxis_From2025-12-01to2025-12-01" format="ixt:fixed-false">Fees to Be Paid</ix:nonNumeric></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:8%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_71f4cc4a" name="ffd:OfferingSctyTp" contextRef="OfferingAxis_From2025-12-01to2025-12-01">Equity</ix:nonNumeric></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_e5a841a9" name="ffd:OfferingSctyTitl" contextRef="Scties424iAxis_From2025-12-01to2025-12-01">Common Stock, par value $0.00001 per share</ix:nonNumeric></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:8%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_70cbf21d" name="ffd:FeesOthrRuleFlg" contextRef="OfferingAxis_From2025-12-01to2025-12-01" format="ixt:fixed-false">457(c)</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"/><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:8%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_53eaf3f8" name="ffd:AmtSctiesRegd" contextRef="OfferingAxis_From2025-12-01to2025-12-01" format="ixt:num-dot-decimal" unitRef="USD" decimals="0">6,578,948</ix:nonFraction></td><td style="width:3%;vertical-align:bottom;white-space: nowrap;"><sup style="vertical-align:super">(1)(2)</sup></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:8%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_d9a5ac74" name="ffd:MaxOfferingPricPerScty" contextRef="OfferingAxis_From2025-12-01to2025-12-01" format="ixt:num-dot-decimal" unitRef="USD" decimals="INF">2.80</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><sup style="vertical-align:super">(3)</sup></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:8%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_9eb473f0" name="ffd:MaxAggtOfferingPric" contextRef="OfferingAxis_From2025-12-01to2025-12-01" format="ixt:num-dot-decimal" unitRef="USD" decimals="INF">18,421,055</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:8%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_bf1e0cd6" name="ffd:FeeRate" contextRef="Scties424iAxis_From2025-12-01to2025-12-01" unitRef="Pure" decimals="INF" scale="-2">0.00013810</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:8%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_5692a200" name="ffd:FeeAmt" contextRef="Scties424iAxis_From2025-12-01to2025-12-01" format="ixt:num-dot-decimal" unitRef="USD" decimals="INF">2,544</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="6" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Total Offering Amounts</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_bce6ae62" name="ffd:TtlOfferingAmt" contextRef="From2025-12-01to2025-12-01" format="ixt:num-dot-decimal" unitRef="USD" decimals="INF">18,421,055</ix:nonFraction></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">&#8212;</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_97e183de" name="ffd:TtlFeeAmt" contextRef="From2025-12-01to2025-12-01" format="ixt:num-dot-decimal" unitRef="USD" decimals="INF">2,544</ix:nonFraction></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="6" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Total Fees Previously Paid</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>&#8212;</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="6" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Total Fee Offsets</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>&#8212;</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>&#8212;</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;"><strong>&#8212;</strong></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="6" style="vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Net Fee Due</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>&#8212;</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>&#8212;</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_7ba93d01" name="ffd:NetFeeAmt" contextRef="From2025-12-01to2025-12-01" format="ixt:num-dot-decimal" unitRef="USD" decimals="0">2,544</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_d8436ac9" name="ffd:OfferingNote" contextRef="OfferingAxis_From2025-12-01to2025-12-01" escape="true"><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the securities being registered hereunder include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or other similar transactions.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;Consists of 3,289,474 shares of Common Stock registered for sale by the selling stockholder named in this registration statement and 3,289,474 shares of Common Stock issuable upon the exercise of Warrants for $4.00 per share registered for sale by the selling stockholder named in this registration statement.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to Rule 457(c) under the Securities Act of 1933, and estimated solely for the purpose of calculating the registration fee, the proposed maximum offering price per share of the Common Stock covered by this Registration Statement is estimated to be $2.80, which is the closing price per share of Common Stock as reported on Nasdaq as of November 26, 2025.</p></td></tr></tbody></table></ix:nonNumeric><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>upxi-20251201.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/01/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-types="http://fasb.org/us-types/2025" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:cyd="http://xbrl.sec.gov/cyd-af-sub/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:upxi="http://upxi.com/20251201" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://upxi.com/20251201">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://upxi.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251201_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251201_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251201_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="upxi-20251201_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
 <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
 <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
 <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
 <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>upxi-20251201_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/01/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>upxi-20251201_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/01/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://upxi.com/role/Cover" xlink:href="upxi-20251201.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://upxi.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>upxi-20251201_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/01/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://upxi.com/role/Cover" xlink:href="upxi-20251201.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://upxi.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>upxi-20251201_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 12/01/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://upxi.com/role/Cover" xlink:href="upxi-20251201.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://upxi.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>upxi_s1img3.jpg
<TEXT>
begin 644 upxi_s1img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !/ *P# 2(  A$! Q$!_\0
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H*Y :A::YKEG_ &>I\VTD\R65AM*KM^[_ +5=6WF[C\O_ (]51)/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>upxi_s1img4.jpg
<TEXT>
begin 644 upxi_s1img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !L 3$# 2(  A$! Q$!_\0
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MZM__ $!J^5OBM_R67Q?_ -A6X_\ 0S0!]/?M1_\ )N/PX_[=_P#TEJG^P_\
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M_P#1CT =E\*(O+_8-\829SYBWS8],!1_2O /V>?^3B/!O_7X?_0&KZ$^%?\
MR81XJ_ZYWW]*^>_V>?\ DXCP;_U^'_T!J /9/VW_ /D;/!__ %Y3_P#H:UT?
M[+7_ ";;X\_ZZ7/_ *3"N<_;?_Y&SP?_ ->4_P#Z&M=%^RU_R;;X]_ZZ7/\
MZ3"@#Y@^#O\ R6[P=_V%(/\ T,5]*?MO_P#'KX,_WKC^25\U_!W_ )+=X._[
M"D'_ *&*^E/VW_\ CU\&?[UQ_)* #]CW_DFOQ"^J_P#HIZ^8/AZ<?%_PP?\
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MC:W-?*WQ0D2;XO\ BR2%@Z-JMQ@CO^\- 'U!^U)_R;E\./\ MW_]):I_L/\
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MK[DH **** "BBB@ HHHH *QM<\/:'XDTU]-U[2;74[-^L-S&'7\,]/PK9HH
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MI#A8U##))]*][_:U\;>$_%]OX6'ACQ#9:L;9I_.%K)O\O(7&?K@U@:K^Q_\
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MT#D8XZ5]*6?@G4&_9VB^']]Y(U+^PO[/<!MR"7RMHY]-V.: /B?]E34ET_\
M:'TB-LD7EO/;#GN4+#_T&OTCKX:^%_[-OQ6\%_%3P[XFOK733::?>+),([T%
MMG1L#'/!-?<M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>upxi_s1img6.jpg
<TEXT>
begin 644 upxi_s1img6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !E 2D# 2(  A$! Q$!_\0
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MP^(]I%6^8YQ<78L44Q6#*&4@@\@CO3Z] S//;KY99?9C_.MGPWUE^@K%N?\
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C445Z! 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>upxi_s1img2.jpg
<TEXT>
begin 644 upxi_s1img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !" 2T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[+HHHH **
M*2@!,BF;E_O"O+_CMXPD\&?"#6+ZUF,=]=I]CM65MK+))\NY?]U=S?A7P"OB
M/Q(J[?\ A)-6_P# Z3_XJMJ=)S.BG0<US'ZG^8O]Y:-Z>HK\M%\4>*%^[XHU
MC;_U_2?_ !5._P"$H\6?]#5K'_@=+_\ %5I]69I]6\S]2<I_>HW)ZU^6G_"5
M>+/^AJUC_P #I?\ XJI%\7>+%^[XJUI?]V^E_P#BJ/J\A_5GW/U(W4M?EU'X
MT\91LLD?C#6E9?NM]ND_^*KW/X&_'3Q4WC?3?"/B[4GUBPU*3[/!<S?ZV"3^
M'YOXE;[M3*A**,Y4)1/M#Y5H\Q?4?G7SA^U-XTGT+P'I_AO3[R6WO-7GW221
M/M988_F;[O\ >;;7QZOB#Q J_P#(P:HO_;Y)_P#%40I.8X4'-<Q^J/F+_>%-
MW+ZC\Z_++^W_ !%_T,&J?^!DG_Q5-_X2+Q!_T,6J?^!DG_Q57]6\R_JTC]4=
MR^H_.C<O]X5^6"^(_$2_=\2:M_X&2?\ Q5.;Q+XD_P"ADU;_ ,#I/_BJ7U?S
M)^K2/U.X(ZT97'45^6]KXO\ %UG,LUKXLUB&3^\M])_\57TW^S_\:_$GB3Q(
M/!/BNZ_M&66%I+.^9=LNY/O1R?WN/XJB5"4?>(E0E'4^KZ*:GRJJT-(J_P 5
M8'.)N7^]1N7U%?*OQX^/GV%KGP7X%O/],^:.^U*%O]1_>CC;^]_>;^&OES_A
M(_$B_P#,S:M_X&2__%5O&DY'3"A*2/U.W+_>I<U^7FF>-O%&DZU8ZM'X@U29
MK.>.X\N2ZD96VM]W;NK]*]#UBWUWP_8:Q9MYEO?01W$>/[K+NJ)T^0BK2E U
M=T?]Y?\ OJDW+_>!_P"!5\^?'[X8ZWX@TAO%GA&^OX=8LHO](M(+F1%NXE_N
MJK?ZQ?\ QZOC/_A(/$7_ $,&J+_>7[9)_P#%5<*7M"J=+GZGZI*R_P!X4FU?
M6OS*\)?$;Q;X1\4V>O6>L7MXUNW[RVN;EGCGC_BC96;_ ,>K]"O!7C'2?'GA
M*R\1Z)-OM[D<HWWHG_BC;_:6IG3E F=*5,ZP]*0LN*H7^H6.GV$M]?7,=M;0
MKODFE?:JKZYKY.^*W[3EQ=M/H7PWD:.+_5RZPX^9O^N*_P#LU1&$I$PIRDS[
M!W+3?,2ORU;Q9XJ^9F\5:Q_>9OMTG_Q5>L_##X:_%;XC-#J$GB36M&\/,W-]
M/=R[IE_Z91[OF_WONUK*ER[FDJ/+\1]Y[E_V:<O2N8\)^$=-\&Z&NEZ;)=W'
M\3SW=PTTTK?WF9JZ=>%K YQ:2EI* %HHHH *8]/JA?7=OI]C<7MU(J6]NC2.
MQ_A55YH ^.OVLO%G]H>,M*\'6\FZ+3(OM4Z_]-9/N_\ CO\ Z%7S8S;5W?[-
M;GB_Q#<>+?&^M>);@L6U"Z:9=W\,?_+-?^^=M8L<C121R1[=T;*R_P"\M>I3
M5H'KTX\L3[%\$_LR>"K[P3I%YXECOVUBXMUFN?*NMJAF^;;BNA;]E'X6M]U=
M57_=O/\ ZU?,B_'SXN(I6/QC*JCHOD1\?^.T]?V@?C IS_PF,K#_ &K:/_XF
ML90JG/*%4^EO^&4?A;_U%O\ P,K*U_\ 9C^%NE>'-2U/[9JMFMI;O,TWVK=Y
M>U=W3%> _P##0GQ@_P"AM/\ X"1__$UA^(_BW\1O%NF'2M=\43SV3C$D$:K&
MLG^]M^]1&%3N.-.IW.(W*WS*VY?X?]VO4_@!X:F\1_&S1BJM]GTMFU"=O]W[
MO_CU>7;?FC559F9MJJJ[F9J^NOAKX;G^"?P2\0^.O$%OY.N7UOYB0/\ >A'W
M88_]YF;<U:3E:/*:U96CRGC7[0'BS_A+/C)J@AD\RSTE?[/@V_[/^L_\>KS3
M3-,NM8UJQT>Q7==7L\=O$O\ M,VVJLDDTLDDUQ)YDTK-)(W]YF^]4EM=75G=
M0W5G</;W$3;DEC;:T;?WE:M(QY8FD8\L3[EA_99^%JVT(N+._DF5%WNMXR[F
M[M4O_#+'PE_Y\=0_\#6KXO\ ^$X\;?\ 0Y:Y_P"!TG_Q5._X3KQQ_P!#IK?_
M ('2?_%5S^SE_,8>SJ?S'V?_ ,,L_"7_ )\-1_\  YJ\\^+GP+^%O@GX;ZGX
MALVU"SOX%5;4R77F>;*WW8]K5\Y_\)UXX_Z'37/_  .DK/U#7->UKR_[8UR_
MU)8_]7]KN6FV_P"[NIJG.^X1I3O\1GU]%?LF>&?[1\>:IXJEC9K?2K?[/$V/
M^6LGWO\ QU:\%T'P_K7BC6[?1/#UC+J-_.VU8T7[J_WF;^%?]JOT(^$_@&V^
M&_@&TT)0)KV1O.O9U_Y:3-][_@*_=HK3M'E)KSLN4]&\Q4^]]ZOE/X\_'S[/
M]J\$> [S]^VZ._U*%O\ 5_WHXF_O?WF_AJO\=_CV0USX,\!WFUOFCO\ 4X6^
M[_>CB;_T)J^4_NK][;M^]65*E]J1%*A]J0?*OS?]]-NK9U;POK^A:-I.KZO8
MO:6FKHSVC/PSA?XMO\->]_ OX$_VT]OXV\<6ACTU2LECITR_\?/]V21?[O\
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M_P"A;TO_ ,!8_P#XFMZB@#$MO#GA^SG%Q9Z'I]K<+]V:&V167_@6VMI:*6@
MI&Z4M% &'J'AW0]6D274M'L[Z2,;4-Q LA4?\"JL?!/@]?\ F5=)_P# ./\
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<0 4444 %%%% !1110 4444 %%%% !3:** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>upxi_s1img10.jpg
<TEXT>
begin 644 upxi_s1img10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !& 3X# 2(  A$! Q$!_\0
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M^U2ZO-/A@BN8HKB0R>7(6*DJ3TR,9'M7IW[6G_)N^H_]?MK_ .C!7C7[$O\
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M;F$0Y< [FV@G&>/RKV_]CFQCU2\^(6F3-MCN].A@8CL&\Q3_ #H ^4O^6/\
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MBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@
MS1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FB
*B@ S29HHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>upxi_s1img1.jpg
<TEXT>
begin 644 upxi_s1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !5 /H# 2(  A$! Q$!_\0
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MG95^9OE6J,VKV,/WIMW^[\U6;RU^UVK0LV-U<U_8-]YK+N3;_>S7DXJ=:/\
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>upxi_ex51img3.jpg
<TEXT>
begin 644 upxi_ex51img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  S 0\# 2(  A$! Q$!_\0
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MJI*2TL*DVTTQU!Z4FX>HHW+C[PJ38;T%8ECKFG:CJ-W8VL_F36C;9.#MSG!
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? **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>upxi_ex51img2.jpg
<TEXT>
begin 644 upxi_ex51img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !# +\# 2(  A$! Q$!_\0
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M6X&2^MHK4:E87,9Y1QT(]."5(^HZBAI(9%!\3/$WBSX\2>"_!0L_^$>T4?\
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D !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>upxi_ex51img1.jpg
<TEXT>
begin 644 upxi_ex51img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" "Q FD# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 G
M48KY=_:?\>>,?!^N^&H/"_B"ZTJ.YMIGF6 @!R&4 G(]S7U$?NU\=?MB?\C)
MX2_Z])__ $-:<%=B>Q1\.?$WQ]=_ +QEK]SXJO9-4LM1M(K>Y)&Z)&/S*..A
MKD-%^)GQGUZ^6PT?Q+K.HW9!<0VX#N0.IQBG^$_^36O'W_84LOYBM']F^=;;
MXP+<L"5AT^Y=@O4@+G%==-)1;:V.6I=M*YNP:K^T=_RT7Q-^,'_UJ6S^+'Q4
M\/:GY&J:I=--&?GM=0@'/Y@''N#7ID?[4GA27A?#FK@^YC_^*KR[QYXUD^*'
MC"QETG1W@,<?V>&,D&64DYR3T^@KOPL?:24:D$H]SSL2^1.4)NY],_#OQQ!X
MZ\-#4_(%M=0OY5Q #D(^,Y![@CI7FE_XT\51_MD6G@Z/6YU\/O;*[6(V["?(
MW9Z9Z\]:[+X0^#;_ ,&>%94U)E%]?R>?+$ASY6!A5SW/K7E7CC3?&FB?M4CQ
M_H_@35?$.FVUM$JFT3"R'R=I ;GIGTKS:T8*K)0VZ'J4'-THN>Y[%\;=:U7P
M[\&M=UC0[Z2QU"W2,Q3QXW)F10<9]C4GP7UG4_$7P8\/:SK=[)?:A<Q.9IY,
M;G(D8#./8"N+U+5/%WQ@\*Z]X&U/X;ZMX16[LFD@U#4'#1>:K*40@ =3^@-<
MM\/_ !A\3OACX.@\%:[\(=9U4Z>SK;76GD-'(I8M@D @\D\_I6'0W+NE?$+Q
M%%^U1XIT'5==N&\,Z9:SW'V0@;(U2)6R.,\<GK67X8\2_%SXYZEJ.H^'O$B>
M"O"EI,88FAB$DTIQG&[J3C!)R ,XYJY\-?AMXO\ $7Q*\4?$7Q]H_P#8,&M6
MTUHFG%LRE95V'/H @[\DFJ?@[3OBA\!;[4M#M_!L_C3PI<S&>"?3F_>QGIDK
MR0<8R".HX-&G01V_A[P_\;_"7C.V2^\8V/BOPHX+74VH#RIH%'7;@$ENXYP<
M<XKC=*\;_$[XW>+=5LO!&OIX/\*:7)Y9O%A$D\V2=O7N0,X& !ZUV6@>./BU
MXR\9VT8^':>'/"(4I>RZRQ$SJ>#LQ@[NP&,<\FN(T+PW\2/@)XNUD^'_  K-
MXR\'ZI+YBK9N!/!@G;D=00#@\$' Z4 3>,;GXR_!:R@\42>-?^$T\/B98KJV
MOH0LB;CQ\W49Z9!X..*I_%3XV:_-K/A*Q\/:TWA+PUKEE%>R:R8/.D <D$#_
M '2,$#G//2I_'%Y\5OC;9P>#]+^'UWX3T2299+R]U9MI8+R!C .!G. "3Q72
M>*K/Q5X+L-$\(6'PIM_'?@?3[%("3M>Y:4?><*0=GY'.>HIH#-\%MXVO/%&F
MR>%?C_I7BW3'E'VRUO45IO+ZG8G4GCU&,UGM\8-0\,_M)^+;/Q1XDE3PMIEM
M*\5D0""X5-BH,9+$DX&?6N)U3X>ZMXW\9:++\//A#J7@&6UG#W6H74S1H!D'
M(!Z$8/W>3FNL/PAN?%7[4'B*;Q?X8OY_#4\+O'>,"D<D@C158,#USN(]Q3T
MW_!D_P 5OBSJMUXONO$%[X,\(RHR:;9V@7S9L9VR$L.1GDGOT'K5+PK\8-<^
M'/B37/!'QFOY+B:U1KNPU79_Q](!D( !SN_A]\@U8\$VGQ'^#OC8^#[O2M1\
M5>!+AMUG?6T?F/8@GN.P'\2_B/2K/[3W@W7?%6D>%W\.^';C5KB"[?SC;0[W
M2(J.I[#.:5U>P="Y\(=3^(WQ$\27GQ!U[4KG2_"<CLNF:/'M"R@<!FXR5'KW
M;V%?0-9>CVT=GHEA9QP+;I!;QH(D7:$PH&,=L5J5#*"BDR,9SQ2Y% !1110
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MRL<8SOP"#SD8Z5O^+K^:_P#VG=8\/^)/B)JGA715@1GEM;]H8XI?(C.U03M
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M'VHR?V[<V0&JZU=3G?$!DLJL3N) ZD<]AZUT/QJT:^^&?P#L[/2O%&L3W_\
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MM*%4=!2T4K -V+G..:/+3^[3J*8#=B^E!C0XRN<4ZB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH JW,\%O$TUS+'#"@RTDC!57ZD\55.HV*F4/?
M6R^4JNX,J_(K=">> >Q[U8O[&VU*PN+"\B$MM<QM%*C#(92,$5Y[:?#_ %&"
M:VN)]5CDF>W-G>R"+/GQ1G-KP>,ICYL]<F@1Z8$4#@54N[NSL8A+=W,5LK,$
M#2,%!8]!S7#0^%O%"3V<LNM,\-NL2W%IY\FV^90P:1GZH264[1Q\O-1OX-\4
M36,=G?ZS%J02YM[A7G9AY2QL2T8&/FSGACSZ]J=@._MYH;JWCGMI%EBD4.DB
M'<K C@@]Q4,E]9P6DUU+<PQP09$LC. L>.NX]L=\UPMMX)U^UMM,M(M6$5I:
M+:1S017$JB81%O,;/4%U(7;TXZTZ\\'^([G3=7T\ZE#):7T5U##!)+)MA\QL
MHY.,L57Y<?D:8CT5=CHK<$$9!J&:6.""25F2-44L7<X5<=R?2O-/[!\976IW
MZ_:)[(2%OL\OVIMD2!T.T@<'<JE01RH)XS776VFZBFCWND^6K1- RPR3W+3$
MN^[<K$KG:N0![<8XI6*.=;0[E=5MM7EUZQ@A6:.]:U2=EBFVA]\VXG/S>8OJ
MHVBKGAK0'\*R6LMSK%J;8V9@9 Q599?-:0.,G'W6Q6%?>!]3TO1[O3=,47>G
MW.ER65O9*,_8YW W%6/2$D9Q_">G!P.BUKPQ>:E>?:[>XC!;2IM+:&7.Q/,V
M_O5P#R,8QW&.:9)CV_A%[/0H=,&O6\=[;WOVQWW96!-[M^[4_=/SC/8D#UH@
MT&[BN-.E?Q-9O'$D2-9&=O*U!E#*TKDG.XLPZ9&5P<]H7^&NI[[DIJRR+-"8
M&\UF(D7$8# ?\LY,1\N#R<''%6AX(UE=.AL1?6DL4<JR++<)OE %QYI$C8_>
M\ ==OS<F@9>\,:!/8:[+->ZV-3GCMXH57S&+0LI;<2I/<,%SUPHSS7?5PNA^
M#[S2]1TB::_$D>E1W2!U)WW7G2!LR9_NX]3D\\5W5)@@HHHI#"BBB@ HHHH
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MM1U>VETBPG3R[-KFW,I^2!99F65$7/RG?&<_3CBO0:0(****!A1110 4444
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M[F8YZG)K?K)M;/58KA7N=7%Q$.L8MU3/IR#6M0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %-9\,!CK3J0J"<XYH XN
MU\9M=#3O^)4ZF^%Y@&9?D:W)!!X_BQU[5)/XO2W\-Z%K:Z>Q75W@C$1?F$R*
M2,X!SC&.!6K%X6T&#[.(=-C3[/YWE89OD\W_ %F.?XN]#^'-%.G6-E]B46VG
M,KVL89@(6484CGM3$8MK\0M$FTR"[NEGM'>V^URQE-_D)O*'<PXSN&,=<D<5
M=N?&.B6BSFZ>:)[:58ITDC(:%FVE=P]#N7!&?T-<MH^I>$I[Z?3;O0(M.N9S
M]ADLY4;S2))6(WJ1AE9LMYBDC)ZYI9KGP/?7%O&VFM<_;615E:.0RN\DIB^8
MGL&A'.3C:.,4P-VX\=:;;:C"&4OITMF;H7J D<2B/IC[N6SG/3GIS4[^./#Z
MV<]['<O/:VX8RS11EECVE@V3V(V-Q[5DV,G@W4+2^ETW3OM%O#8RQX<,L,L!
M8AXU+':%+*?3UZ&L73]7\*Z\MOIEOX7@^TW]Q,QBE5H@"MLN]G! 8$HP0<<]
M1Q0([W3_ !%I>I7GV.UEE>82R1,IB9=A0 DG/0$,,'H<\5T%>:>#]6CO=:CN
M['2T$.K6B7'G23@S0P(-B*RA>F[*@[B3@GM7I=24%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 >?OXZ:#6+C2KW3UM+A;SR+62
M64^5>1!PKLK <.F<E#SCD9%6/^%A:"MC%>$WJVD_,5P]LPCD!5F&#W)"G ZD
MX'>NA?0]*=45]/MWV7/VM0R;MLW_ #T&>C<]:9%HNDPVD5FFGP^1'()8XR,J
MC*<@J#]W!)QCI5 8]_XMBCT!M?TVV:^TR"4?:)02I$& 7FC&/G"@YQWP<=*9
M;^--.5)?MBR0*EPMOO12RAG7?$I]&9"IP.!N S70C2=/.C-HXL(5T]D,9MMN
M$VGJN!VJFV@Z.9UF?3X"ZJH!V\?*NT<=,A> 3R!2T$8-OX[L[G7M,LX[69+?
M5;07-H9$*RS$LH^X?X=K9)Z\5K>)=;NM$LK:[M-+DU82S^7+! ^) FUF9D'\
M9 4G;W[59?PYH$H@632;=A;(L<&5_P!6JL&4+Z $ U-#I.FQ06L,=OE;1S+#
MN))1B3E@?7DTM!G OJV@/;6^I1:';WN@O=+9I>P3.[PGY6AVKU4&1MN 1M;&
M:NZE!H_AZ/2)+GP[;QM)'-(_V>5BUL84>X"IZ_,&].2?6NM?0=(:TEM#IEO]
MGEG^UO$$PK2[@V\@?Q9 /UYJW<6%E=W-O<W%K')/:EC$[#)C+##8^H)!IW)/
M/8?$VFVDMEH2Z!&CZ[%!+%"KEK<)<%R0X/"XVL2 /F)XJNOBK1)+;51'X=7=
MHD3W-X6D(8^6[08B?J?E1L=L87O7?#0])BB=$TZ!$.PD!>FTY3!ZC;V QCM0
M=$T9TB1K"W*QC:HV<8+;B#Z@M\V#GGFBZ YKPKXAT?4=:*:=I\-@ERLD,.Y&
M229+9A&0!C;M7=TSQD=<UZ'6-!I6F6^H->P6,4=RY.9%7GYCEL>F2 3CJ1S6
MS2&@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
-BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>upxi_ex231img1.jpg
<TEXT>
begin 644 upxi_ex231img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" #2 Q<# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_+\W3TYQGIUJ$FI)7U-)N+@Y-75A!X=L1:16MPTDL:1RHRYV!_,<.WW<8Y'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU8AU[3[BYMK:&7=-<ARJ @E-G7<,\56.AQF\D\N\ECM)9Q<-;*%VE]VX\XR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)IV;O?\  ]&\,^)]1;5G\/\ B*/9?+_JY, >9@9P<<9QR".M>A_2O+/$#O\
MV_X1NI 5U"01^=QAOO)U'U+?K7J*?=%=^#G)\T)._*]&][/:_F=E&3UBW>Q+
M1117I'0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
E10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>upxi_s1img7.jpg
<TEXT>
begin 644 upxi_s1img7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !+ 58# 2(  A$! Q$!_\0
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M-;_5Y=SH^K2[GZ,;A2U^<W_"_/C!_P!#G/\ ^ \/_P 31_POSXP?]#G/_P"
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MQ$V@^(K>**\$:S*89 Z2(<X8'Z@]:^Q;C]JWX716[R6[:M<N!\L:6)4L?JQ
MKY!^(7C*Z^('C_4O%5Q";<7+*L,!;=Y,2C"KGN>Y]R:UIRJ-^\C>E*I)^\M#
ME:^O/V44;1?A[XN\2:BWDZ:;D,'/3$,9+M^OZ5\BQ0S7$\=O;1-+/,XCCC49
M+L3@ >Y)KZ[^*6SX3_LL:1X%MI!'J6J(MI(5ZDG]Y<-_[+_P*G5UM'N.MK:/
M<^6?%'B"X\5^,-7\2W1/FZE=/<8/\*D_*OX+@?A6?96=QJ.I6NG6<9DN;J9(
M(D'\3LP4#\S4%=/X!\2V/@_Q[I?B;4-,?4XM/<S):I((RTFTA3D@]"<UKLM#
M;:.AZY_PR;\1.,:UH)_[:2__ !%-_P"&2_B)_P!!K0_^_DO_ ,17;_\ #8UG
M_P!$_N?_  8)_P#$4O\ PV/8_P#0@W?_ ('I_P#$5S7J=CDYJW8X?_ADOXB?
M]!K0_P#OY+_\12G]DWXC8/\ Q.=!/_;67_XBNX_X;'L?^B?W?_@>G_Q%5[C]
ML6W-M(+7P#.)]IV&6_78#[X3.*+U.P<U;L?,_BCPOJW@WQ/>>&]<2)-0M"HD
M\E]Z$, P(/N#6+6IXBU[4/$WB74?$6J.KWVH3-/*5&%!/11[ 8 ^E1:+HNH^
M)/$%AH&DPM-?7\RP1(OJ>I/L!DD^@KI6D=3J6D=3[3_91T.ZTSX1W&J7&Y5U
M:^DGA1O[B@1@_B5-?0587A?0K7PQX3TKP_9J!!I]LENN.^U<$_B<G\:\S^,W
MQFTOX:Z0;&W9+[Q-<QDVUIG(B!X\R3T7T'4_K7F.\Y:'E.]2>G4L?&/XR:7\
M,]'^SP%+[Q'=(?LEGGA!_P ])/11^9Z#N:^#-:UK5?$6MW6M:Y?27VH7;[Y9
MI#R3Z#T Z #@4W5]7U+7M:NM:UJ]DOM0NW,DT\AR6/\ 0#H . *M^&?#.M>,
M/$EMX?\ #]FUW?7!X'18U[NY_A4=S7;""IH[Z=-4U=F+GG'>EK[#\4?L_P"C
M^'?V=M6TW3(OMWB&!5U&:_*?/-)'RR+_ '4V[@%_/FOCL'<H8=#6D)J>QI"H
MIWL>V?LT^+/^$=^,$.ESR;++7HC9L#T\T?-&?Q.5_P"!5]\5^45G>7.G7]MJ
M-E(8[JTE6>)AU#J01^HK]/?!OB.V\6^"-'\26A'E:A;)-@?PL1\R_@<C\*Y<
M1&SYCCQ,;-2,#XG?#O1_B9X0FT34%$-TF9+*\"Y:VEQP1['H1W'X5^>/B3PY
MK'A+Q+>^'=>M3:ZA9OMD4]&'9U/=2.0:_4ZO%OCE\'[?XE>'/MVF*D/B73T)
MM)3P)UZF%SZ'L>Q^IJ:-7E=GL30J\KL]CX$KZ/\ V=/C-_PCU[#X!\37@72+
MA\:=<RMQ;2'_ )9,3T1CT]#[&OG6ZM;JQO)K*]MY+:Z@<QRPRKM:-@<$$>M0
MD9&#R*[914U9G?."G'4^Q_BQ^TU8Z*UQH/P_:/4M34F.746&ZWMSWV?\]&_\
M='O7R+JNJZIKFK3ZMK6H3ZA?SMNDN)VW,Q_H/8<"J7 'H!7MOPM_9Y\3>.C!
MJVO"70/#S88/(F+BY7_IFI^Z#_>;\ :CEA21FHPHJYY7X:\+^(/&&N1Z+X;T
MN;4;U^JQCY8Q_>=NBCW-?8_PK_9MT'PB;?6O%WEZ[KJX=(RN;:U;_94_?8?W
MF_ 5ZYX/\$^&? NAIH_AG2X[*W&"[#F25O[SL>6/UKJ&KEJ5G+1')4KN6BT0
MH  Z8IU%%<YRA1110 AHH-% "T444 %%%4[NZ@L;&>]N9!'!!&TLCGHJJ,D_
MD* /CO\ :X\7?;O%VC^#;>3,.G0F\N .GFR<(#]%!/\ P*OFFMWQEXDG\8>.
M=:\37!.[4;IY4!_ACSA%_!0!6-;VUQ>W<%E:H9+BXD6&)!U9V. /S->E!<L3
MUJ:Y((A+H#@NH/UI/,C_ .>B_G7Z0^&?A/X)T7PII>D77A?2;RXM;=(Y;B:S
MC=Y' ^9BQ&3DYK=_X5WX#_Z$W1/_   B_P#B:S>(78R^LKL?F#YD?_/1?SH\
MR/\ YZ+^=?I__P *[\!_]";HG_@!%_\ $TUOAQX!88;P7HA'_7A%_P#$TOK*
M["^M+L?F%YD?]]?SK4T70]:\17B6.@Z1>:I<N<".UA+_ )D<#\:_2>/X<> 8
MG#Q^"]$5AW^PQ_\ Q-=!:V%CI\(AL+."VB_N0QA%_("D\3V0GBNR/G#X'_L\
MR>%M0M_%WC@1RZQ%\UI8(=Z6C?WW/1G],<#W/3R;]IKQ=_PD7Q:;1K>3=9Z#
M"+8 '@S-\TA^H^5?PK[7\5:]:^&?".J>(+Q@(+"V>X;/&=HR!^)P/QK\P=0U
M"ZU;5;S5KYR]U>S/<2L>[.Q8_P Z*-YR<F%"\Y.4BM6A#H6NW$*3V^AZC-$X
MW))':2,K#U! P14GAW0[KQ-XITKP[:Y,^I726ZD=@QY/X#)_"OT\TO3;32='
ML]+LXQ';6D*01+Z*J@#]!6M6KR&U6M[.Q^87_".>(_\ H7=5_P# *7_XFHY]
M$UNU@>XNM%U"WA09:26UD15'N2,"OU3\N/\ NUD:UHMCX@T#4-#U*$2V=] \
M$JD?PL,?GWK'ZSY&'UKR/RTHZ#)K8\4>';[PCXNU3PUJ"D7.G7#0EB/OJ/NN
M/8K@_C6-U&#TKL3OJ=J=U<]#\*_!KXE>,'@;3?#-Q;6<H#+>WW[B':>C GEA
M] :^O/@_\"]%^&<3:G<3?VKXBG39)>E=J0J>J1+V'J3R?;I63^S#XV/B3X8+
MH5Y/OU#0'%J=QRS0'F)ORRO_  &KWQL^-EC\-=,.DZ28[WQ/=)F& G*6RG_E
MK)_1>_TKBG*<I<IP5)U)RY!_QJ^-6F_#;33I^FF.^\3W4>;>V)RMNI_Y:R>W
MH.I^E?"6JZKJ6N:Q=:OK%[)>WUTYDFGE.6<_T'H.@I-3U/4-:U:ZU;5KR2]O
M[MS)-/*<L['_ #P.U5*Z:=-01U4J2@O,V?"_A?7/&'B"UT#P_9FZO[@\#HL:
M]W<_PJ.YK[]^%/PIT7X7>&_LMFHNM6N0&OM09<-,W]T?W4'8?B>:^/OAW\:K
M[X;Z9+9Z#X3TF>ZN&W7%_<-(9IO0'!X4=@.*[V']K;QW<7$=M;^#])FGE;;'
M%&9F=SZ  Y)K*JIRTZ&-93EIT/LN6%)H7BD4.K*58'H0>HK\S?B-X5?P9\3=
M>\-LA6*UN6:WSWA?YD/_ 'R0/PK[L^'.K_%;Q!"NI>-M#TCP]9.N8[.+S'NF
M]"V6P@]N3]*\,_:Z\(^3J6A^-[:+Y9E.GW3 ?Q#+1D_AN'X"LJ+Y9<IC0?+/
ME/ENOL;]D?Q=]N\(ZMX-N9<S:7-]IMP3SY,G4#V#@_\ ?5?'-=U\)?'G_"N?
MB%9^(IHY9K'RY(+N&'[TD;#C&2!D,%-=56/-&QVU8<\6C]'[BXAM8'N+B5(8
MHU+/([!54#J23T%?,'Q5_:?M;'[1H?PW\N]NAE)-7D7,,1[^4O\ &?<_+]:\
M3^)WQJ\7?$F:2UGF.EZ &_=Z9;N<..QE;^,^W0>E>8$A5YX K&G0MK(YZ>'M
MK(M:AJ%]JVI7&I:I=2W=[<N9)IYFW/(Q[DU6KVSX5?L^>)/'A@U?7Q-H/AUL
M,)'7%Q=+_P!,U/W0?[Q_ &ND^/'P)L_".D0^*O!=G(NE6T:Q:A:[B[18X$^3
MR0?XO?GUK;VD4^4Z/:P4N4^<HI98)X[B"0QRQ.)$<=58'(/YU][_  +^,%M\
M2/#QT_5&C@\3:>@%U$.!<)T$R#T/<=C[$5\"UI^']?U?PMXAL_$&A7C6FHV;
M[XI!T/JK#NI'!'I14ASH*M/VB/U1XI>U>:_"OXF:3\3_  C'JEIBWOX<1WUE
MNRT$F.WJIZ@_U!KTFO-::=F>2TT[,=1112$%%%% "&B@T4 +1110 WM7CW[0
MVL:MIWP>O]/T2QN[S4-79;%5M86D9$;F1CM!P-H(_&O8Z;33L[C3L[GY:#PA
MXM P/"FLX_Z\)?\ XFO5/@#\.=9U#XP:=J&M:'?6EAHZ-?,UU;O$KR#B,#<.
M3N.<>U?>VU*7BMW7;5K'3*NVK6'=J***YSE"BBB@ HHHH ^?/VGK[7IOAU:>
M%_#^D:AJ$FK7(-R;.W>79#'AB&VCC+;?R-?'G_"#^-O^A-US_P  )?\ XFOU
M$I-B^E;PK<BLD=-.OR*R1\8?LR_#G65^)%WXF\0:)>:?#I5L5MA=V[1;YI.,
MC<!G"AOS%?:%%.[5G.;F[LRJ3<W=A1114&9\E?M3_#>^O;[2_'&@:9/>3./L
M-]%;1-(YQDQR8'/JI/\ NU\T?\(CXN_Z%36?_ "7_P")K]2OUI-H_NUT0KN*
MM8ZH8APCRV/SE\!ZE\2?AWK-]JFA^$]5>:\M'MF26QEV GE7QMY*GD"N9U#0
M?'FK:E<ZIJGA_7KV^N7,DUQ-92L\C'N3MK]/MJM[UA:]K6E^&]!N]:U:X2VL
M+*(RS2-T51_,GH!W)IJMK>Q2K:WMJ?F3?Z/K&E+&VJ:3>V"R$A#=6[1;R.N-
MP&:H$@#)X%>K^)-4\<?M ?$B:30])N;F",^59VP.(K*'/!D?[JL>I/7L.E?0
M/PT_9A\.^&O(U;QI)'XAU9<,MN5_T6!O]T_ZP^[<>U;NJDM=SH=9)>]N?.OP
MW^"?C3XD21W5K:_V5HI/S:E=H0K#_IFO5S^GO7V-\._@WX-^&]LLFEV/VS5B
MN)-2N@&F;UV]D'LOZUZ3'%'#$L<2A$4!551@ #L*L"N6=64CBG6E+T#^&O//
MB_X0_P"$V^$^NZ%''YEV8#/:\9/G1_,N/<XQ^->BTAK).SN8IV=S\LQX2\7%
M03X3UD'T^P2__$TO_"(^+O\ H5-9_P# "7_XFOU)V+Z4;%]*Z?K+['9]9?8_
M,+2_A_XZUC5+?3-/\(ZL]S.VU!):O&H]V9@ H'J37UG\*/V;=%\*FWUSQAY>
MMZXN'2#&;:U;V!^^P]3QZ#O7T5\M+43K2EH9SQ$I*VPH    Q5.XMX+RUEM[
MB)98)5*2(XRKJ1@@CN"*NT5@<Q^?OQB^">K>!?%QF\/Z;=7_ (?U%FDM?L\+
M2M;-U,+;03Q_">X]Q7F'_"->)?\ H6]6_P# &7_XFOU._&C:O]T5TQQ#2M8Z
MXXF25FC\VO .K_$#X=^+[;Q%HOA_5BR_)<VS6<H2ZBSRC?+^(/8U^@OA?Q%;
M>*/#-GKME#<0QW"9,-S&T<D3?Q(RD9!!XKH-H]*6LISY];&,ZG/K8=11169D
M%%%% "&B@T4 +1244 +1244 +1244 +1244 +1244 +1244 +1244 +1244
M+1244 +1244 %>5>/OAOJ'Q,UFUT[7]6:S\'6969K&S8B:_F_P"FC=%1>P&2
M3D\<5ZK136@[V,+P]X:T'POH\6D^'])M]-LH^D4"8R?4GJ3[GFMZDHI"W%HI
M** %HI** %HI** %HI** %HI** %HI** %HI** %HI** %HI**  T4AHH __
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>upxi_s1img8.jpg
<TEXT>
begin 644 upxi_s1img8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !4 +@# 2(  A$! Q$!_\0
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M'T'?ZUS"WGB;5I2T<UW.>XCW%1^ X%;7A;PI'>1)J>I*6B)S'&>-_N?;^?\
M/T&.*.&%8X46-%X  P!7"L-+$^])M)[(U=2-+2*NSR62+Q18CSG^V(HY+?,
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MY!]M_OM_2K_@/_D6_P#MJ?\ T%:H?$3_ )!]M_OM_2K_ (#_ .1;_P"VI_\
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MLY?^M<]&O4A%1DFK#=.,G>+/8,\5GW:V,86XO/)7R?F623'R?0FO,/[4\43
M*MQ>-G^YN_I1'H?B;5G4R6]R_/WI\C'XM6DZWM591;8E#EU;(KZ9-0\3O-I^
M<2W \LXQDD]?Q/\ .BNU\-^#X]+<7EZZRW0^ZJ_=3_$T5S?5*DM0YT<CX@AD
MTCQ9+,@V_O//C/U.[^?\J]/T^\BU"PANXN4D4-]#W'X&L/Q?H3:Q8":W7-U
M"5']]>X^OI^/K7(^'_$UQH,[6EU&SVK-\R=&0^H_PKKI_P"RU'&7PO9EM>U@
MFMT>O9IN6_NUEV.LZ9J$8:UO(W)&=A;##\#S6@TD<:[FD 'J37MQQ$''F33.
M.S3LT2TVN3UCQ=I^F(Z6TJ7-SCY54Y4'W/\ 04_PCKE]K5M<M>Q*IC8!71<
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,))/KFBBBMX[$'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>upxi_s1img9.jpg
<TEXT>
begin 644 upxi_s1img9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !L 3$# 2(  A$! Q$!_\0
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MZM__ $!J^5OBM_R67Q?_ -A6X_\ 0S0!]/?M1_\ )N/PX_[=_P#TEJG^P_\
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M_P#1CT =E\*(O+_8-\829SYBWS8],!1_2O /V>?^3B/!O_7X?_0&KZ$^%?\
MR81XJ_ZYWW]*^>_V>?\ DXCP;_U^'_T!J /9/VW_ /D;/!__ %Y3_P#H:UT?
M[+7_ ";;X\_ZZ7/_ *3"N<_;?_Y&SP?_ ->4_P#Z&M=%^RU_R;;X]_ZZ7/\
MZ3"@#Y@^#O\ R6[P=_V%(/\ T,5]*?MO_P#'KX,_WKC^25\U_!W_ )+=X._[
M"D'_ *&*^E/VW_\ CU\&?[UQ_)* #]CW_DFOQ"^J_P#HIZ^8/AZ<?%_PP?\
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MC:W-?*WQ0D2;XO\ BR2%@Z-JMQ@CO^\- 'U!^U)_R;E\./\ MW_]):I_L/\
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MK[DH **** "BBB@ HHHH *QM<\/:'XDTU]-U[2;74[-^L-S&'7\,]/PK9HH
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MI#A8U##))]*][_:U\;>$_%]OX6'ACQ#9:L;9I_.%K)O\O(7&?K@U@:K^Q_\
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MT#D8XZ5]*6?@G4&_9VB^']]Y(U+^PO[/<!MR"7RMHY]-V.: /B?]E34ET_\
M:'TB-LD7EO/;#GN4+#_T&OTCKX:^%_[-OQ6\%_%3P[XFOK733::?>+),([T%
MMG1L#'/!-?<M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>upxi_s1img5.jpg
<TEXT>
begin 644 upxi_s1img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !& 3X# 2(  A$! Q$!_\0
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M^U2ZO-/A@BN8HKB0R>7(6*DJ3TR,9'M7IW[6G_)N^H_]?MK_ .C!7C7[$O\
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M;F$0Y< [FV@G&>/RKV_]CFQCU2\^(6F3-MCN].A@8CL&\Q3_ #H ^4O^6/\
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MBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@
MS1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FBB@ S1FB
*B@ S29HHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UPEXI, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001775194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-3378978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">3030 North Rocky Point Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Tampa<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">33607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">287-2800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001775194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Upexi, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Dec. 01, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered</a></td>
<td class="nump">6,578,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 18,421,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the securities being registered hereunder include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or other similar transactions.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;Consists of 3,289,474 shares of Common Stock registered for sale by the selling stockholder named in this registration statement and 3,289,474 shares of Common Stock issuable upon the exercise of Warrants for $4.00 per share registered for sale by the selling stockholder named in this registration statement.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(3)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to Rule 457(c) under the Securities Act of 1933, and estimated solely for the purpose of calculating the registration fee, the proposed maximum offering price per share of the Common Stock covered by this Registration Statement is estimated to be $2.80, which is the closing price per share of Common Stock as reported on Nasdaq as of November 26, 2025.</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Securities, 424I - Securities, 424I: 1<br></strong></div></th>
<th class="th">
<div>Dec. 01, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Scties424iTable', window );"><strong>Securities, 424I Table</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.00014%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 2,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Scties424iTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Scties424iTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Scties424iAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Scties424iAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 01, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 18,421,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">2,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 2,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>35</ElementCount>
  <EntityCount>2</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="upxi_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://upxi.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="upxi_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="upxi_ex107.htm">
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="upxi_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995214 - Document - Securities, 424I</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/securities424iTable</Role>
      <ShortName>Securities, 424I</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="upxi_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>upxi-20251201.xsd</File>
    <File>upxi-20251201_cal.xml</File>
    <File>upxi-20251201_def.xml</File>
    <File>upxi-20251201_lab.xml</File>
    <File>upxi-20251201_pre.xml</File>
    <File doctype="S-1" isOnlyDei="true" isUsgaap="true" original="upxi_s1.htm">upxi_s1.htm</File>
    <File doctype="EX-FILING FEES" original="upxi_ex107.htm">upxi_ex107.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>upxi_s1img1.jpg</File>
    <File>upxi_s1img10.jpg</File>
    <File>upxi_s1img2.jpg</File>
    <File>upxi_s1img3.jpg</File>
    <File>upxi_s1img4.jpg</File>
    <File>upxi_s1img5.jpg</File>
    <File>upxi_s1img6.jpg</File>
    <File>upxi_s1img7.jpg</File>
    <File>upxi_s1img8.jpg</File>
    <File>upxi_s1img9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="16">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>38
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "upxi_s1.htm": {
   "nsprefix": "upxi",
   "nsuri": "http://upxi.com/20251201",
   "dts": {
    "schema": {
     "local": [
      "upxi-20251201.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "upxi-20251201_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "upxi-20251201_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "upxi-20251201_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "upxi-20251201_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "upxi_s1.htm"
     ]
    }
   },
   "keyStandard": 17,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 18,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 17
   },
   "report": {
    "R1": {
     "role": "http://upxi.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-12-01to2025-12-01",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_s1.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-12-01to2025-12-01",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_s1.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://upxi.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    }
   }
  },
  "upxi_ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "upxi_ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/ffd/2024q2": 2,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 16,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-12-01to2025-12-01",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-12-01to2025-12-01",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "OfferingAxis_From2025-12-01to2025-12-01",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "OfferingAxis_From2025-12-01to2025-12-01",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ffd/role/document/securities424iTable",
     "longName": "995214 - Document - Securities, 424I",
     "shortName": "Securities, 424I",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "4",
     "firstAnchor": {
      "contextRef": "Scties424iAxis_From2025-12-01to2025-12-01",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Scties424iAxis_From2025-12-01to2025-12-01",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2025-12-01to2025-12-01",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-12-01to2025-12-01",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "upxi_ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>39
<FILENAME>0001477932-25-008717-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-25-008717-xbrl.zip
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M@Y6=P3-N=@^IX<.C8N;@*S\SUJ"L$7J=05FY&$3*M6Q;"YFQOA2T/#,U8"V
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M2<OK7!YO0*T=DLKU-C P.->Y=?>"VH)^T2_Z9I=P^O+K]?]02P,$%     @
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MY+.(\L48;S&=Q2Z1/N:D?@*K_7]02P,$%     @ =9.!6X;*(+EV @  F0@
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MY6-G.V&TW6V_W9:'%D'SYQ#_ E!+ P04    " !UDX%;Z#HN'MX(  !F*
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MLES!0K5@<X>N;YDGIA8K:Z]8E 3V@!-%Y(G7 J=4.<#M;:[XUP;A<820 IO
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M+6#JVGMZ_W5C,RW26Z-%ML2U;2KJOQ?]^+.1R ]QCO;_ 0[_!U!+ P04
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M!62]+CAPA! E@UE((DDKI-7?6"3,QS0U5\!$LTQ%(B8S< ,2[^!0ST?'.?#
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M#PW?I\-B*+3P.X5I@4&NK^&#;@SD.XT?.4C.?!.,RDET$A5R-@2)\_,VT;E
M[D5Q?/&0;FLWVMB@&[-+"8$6U1FR#1HQZ6"^4F,A<$./]$>&#=^%V9;@D\]_
M1@\W@JS%BO5Z9_@K)G ,9BJ<L%3):0Z][V2)LB;T2>G<?//X^EYJ>5AW!Y=5
M':\O$/AIH0(KGH[KA0TPXLSKW5^B=$$;I.;"KZ A9+(G"^0@<CT=MJE]DHZU
M!6_;FOV; <@J5 <7E18)= <Y".J-6Q0[ $VD&+/@R*'W=TTT=KK4\-D*G5]T
M1,/D.4EB(<#6C'Y.[EI;Y^Z<="K?NA4BC=ZK]YK(M-PJI6$\B^7]RRH9D7%,
MCC67$,&=A9.+!#G]$VOB4ZP]3[KG;JU8%2SJ0["VYWAZ\2++'B1D&'/T*L,D
MBC\/D,(>,PV]]D-:6+)_;>##TZ*'<%HR1YS1T+P,-$#K<6GP&0]SXIP!GL,D
M1F):=>@<N4.5%BP%3=I9/9XF9FFQ;$:RKF9" $+$N>V@#Y[H]2&3+A1)#;OH
MB;3QR'+4]M^;)FFNG@M%@VD5+V:@&];@!!-7A?BMRVBP+-/PNN#$0P>([NR'
MA*:>H+@V-8]Z:,2)#)^URBV=K;EM_=CZNBOM/?TFU:ZH@DJXG=\1#0=EEX<"
M*IJ^@D,.BNOA%^$NS-W=)S&:VSG=)HV:2?@T3TA^Y>7ZEPV=NT0-7]CUC3$Z
M9&2]R*$(\R%E/?1TWLY<=M>2%\,B!R7+'LD1[UN<9M=$9.H=C<!S0_ZG<"(S
MI"F4;7=8X+6G!:9E1/;7QAV!M]:#TJ?M4#:IZV+5==$>6!M#6Y$U1OG)DGNN
MVD$L=@-!B7\0/A="0[+V.B(GT!A?!:7I\4G1OL31X?BGYTZ(-:D1/@/.!=^'
MGWZ5$ V&[L J,");-1Z55E^E?7&M+[.",PK#'FBY(Y0UMQ! [[=-VV;<268E
M7"Y-/DJP2P8J@6HRV5I% QJU2&MF%KL"5X"X8O%ZRO7':^_=&8P]R%K$=!2X
M](+P54+2'0YM)M!MFKZ%U<,-)TBN>G25AC4\?;@6R/'>[Y:PQK?R8,/@.%=5
MX;*M<%'W 7'*I?=H:7<B^+IK(5]D.$WZKB"76DJ7P-"0(HZM=&\9P'=UG/N)
MH.5(YJ3(,%3OK%T15J^Q X %'=55FI&G?%6&AWNLOW?-CTM-:\A]JO*J18\!
M@;YQX'L?,.CVF8+*$%UK[7JNV6;\J!":PSO[!_MZTHXW\;Z;X19MO:#?KYPO
M\UG84/%T\>OW=[SV_#KKK>2(6-6+6B;=LQXF+&,UXZ6>B6L^9-&>R>%HK =F
M\V&OGL]F"PDOPW2*9"B?")!H^%22OBD?1'^8=.-U4$V\--KO.?CW'FXU<F=Y
M%\J[;GOF6B$06?)RC 8!!2+O%1!9&R?V<U&U,"8EU-=UFIK>?M \?2A)!AED
M)B;))+]T&<-9\??VD(/W^[R:\WY$D5.U I^4^FP702Y"U;4A,<PQ#+ >AOQ&
M<.F.IH^11H@A<> :X. T>)] JL(BIC\4 8<QH$KR<NZR7%S=O#/LFU3>UT[E
M/;Q)Y=VD\CX%Q6\L&C\>Q!0XYZX'+/UQ]N$O!DNZ!N(HI6M&I"-X0D%5HIM;
M-4-L8ETX9"4R(54=  ,JHD9QARK#\YI;%B&YP;P#AJ1GTC$EPT+BI<Z$"XP9
MPDSEDWWEF &PF"Q*R_)(5@?1Y&X4;5K!<L%:X@$,\00"&?\XHV>W$F'EK,C*
M$!4>.69 LE$"A(:?GE=MF!P 1V^HR8@*SKR!F?*@H0MHS79:VP(%KE5:,9_"
M>5YIF*C[PKX%%J+483B"OC2HJ/HT'%T./)Y"_ GKQN,S.9G%XU]*80-"S!8<
M4&W<+N<2XIE,7*EM.WC\A0^CS2L&AJ:%7<2(&8G%AW48?I]'I4>_&7!=M# 3
MH1;$BX=J.]Z$F1/.#.SF15YD$<G2+!V?,3&6=U-$VW7*1M0[1CLJ_JK+P<,>
M"UFN<PYJ]KG\D'@?5V2W2UV7+!AC8WW>PX?3)9>_$DU=$P/5RYJN4SH(&3K/
MO H3/\H&L!21 "ZGGU/871$+$"3,HA;N$%8@_'%?E*Q!2T?OK4E<([7P=EXH
M%.Q[85K0.^'"*JYOZ(4K80L/! (HB':G]2NAQ$D7Z04*A6D/'%TR;(\'\7<P
MG:_63;XX^OO0/H5WY2Y3A+!8($7NA]7GR'I.2)63=(2$?>J>Y:&,B)'@OJ2P
M6W36AV0(@@+S!*$SF[=>&K")?)XJA1KJ'&/,!0XRNNMBXJV,I#]-W__)YB:V
M8^XE#5K/=,[I95JM7N#<O$K-67IZ3EQRQ(&PQ2R"P;0A1>Y#"N1M<-?/>#\&
M&*9R6EFLGP-%?I^O!;Q\+[-]TJMGN"*84??I,CM^OAD5/B'0L4!81DL8@*3<
M&A'4<3.C&@H):>=F\8AN._>)E+;BH-K8LQMX!EU?FRI)0WDS#! 9:AD_:HA3
M:R(==^#"3$9]85?\<"W.#0/N/,S'-K7P@R/G73DL;VURUU0[9GZ 7T'%:U9?
M>"!U"LXTIQ/>7"W$CJ3W4<3%G)F.TCZ?LF45C!QYE4_M.Q4;F'VI.>'22D_F
MVB_86;_!D:QG4RMCQF[?O1R_+%!$WLC>\),U1<-[#6KZ<T!2/YWAF*@1ISW1
MT[)<:"A81B'!&3QS4J#V4YJ/6R.8@04,&0,C%:A)4#^1!>LWL10O#[JCB2BQ
MO],U72.<K&%/3]J@?MM-H6\E?DX' I:_5 Z@0HU6C\^BFU>HH140(YE>_+<F
M53GH2+I@EPG,!IJ!X 5#@BHMH-!;R[N&;](%.=YIJP9H;U@<PD0U8QDQP4:P
M=1Z PO#L%?36$\[-HHA)&,/4\!#;(B=_MPWF6T]*V(QQ7@2KP$P"98F43+2[
MY%>< K \+FU]GZUTXT5MG0AC06A6WP8B'7XGP=)KZRM%0OX$5==/->=SP,7@
MWT ]U2<(SZ"W1\21W+IT!GA9[I1C8H7I\(P4>0*K(>:N,P8*WY4ZL(/&K7E5
MR:\T'3>FH, /']/?]BGU(&-__[.4MZFHEA;#L#Z;G"SSU,8^B6>&CF8!Q[\M
M\D;  MH+I-.UH_<SW$E2A$+_*?2\?!,%A')"!FK"VG,(T6*=@*>ZD1:!$3M2
MN9B-0B;'L%5ZPPA^9:\EKPKY)GS%%^GZR?6,2"C)$E-/V! QE\;SKIR+(D4;
M4HN>QA%*&;U2(WP 3RC^T/;;%]:! NF%3Z&\NAOYFY<J;\7O/NQND!/#O<J"
MGK*5^@V(EL_=-D+3J&C!L"5G1E02>X7&<D;F<IUM"43F-YA;$QAST1'3!N41
M4UB7=&S]C[#G[1$<@(UHV7D,%F%"PMXQ&!]*$JDQ;6>2DU_?"/C_C-[BG.R2
M&,4\,!"KXB90P*;OV+KQ65D5U91-/3IQ8L*[=CQ,((OG=3Z#^Q+J1^EX_YRW
MOU0DRH 652G88USB*XQKB8E..2\7LYWJ#8O$XHF< 6:!<5CE)1PVO6GH9&/>
MFYWQ@ Z#W=-KKBK6-3=+[@G!D@LK<^\&7;66,8DJNB\8R=LZ(CA>N)B%:R'G
MR\3HNF?<)!F_=I+QT4V2\2;)^"V3JT;Z&.*X:_);SRS6U"J(-EU7VP3"/0ZV
MR\:^;O<U-:VJB5/M=0#BA'?.S;4+7]SWPF,.(W^E2SON:5 /.YHOZAIB;*:^
MV=Z$W!MNT88Z>^GFK5@:)4.-8#>QYFUXKWH':%I7%QK#"@566FS7:'\'SJZM
MO@(,?@;F3VLFK6V"7V-LMQW&O''__FLGQF/M44G(7=]R*;.,VH<5:Z83YY+/
M8^RX1GSKVG&O4T:TYHW9\D%.F-S8YLSY1W8LD3AUH#4R$;D"KQ(Y4OELP;!O
ML,V&:=!""9TFYCUP/N&&RC^\FX(%!;/:6!V%7TX;$JJJ]%:VW_S"\MRA]@8$
M#-:6*.P#O8=&+V4PTZIC.D57]XQ,)8;R97CP )&2\Z:K,%!8F"L !A5PX'PD
MOW51%63+3P'N&PEZ=$=H&32XH77&5QKV8]^'\&H3/Y7AGM#JGB5/TW<5TM@Z
M:8A"K'4!Y#=7K$U@^(AO"A _G:AELC-(=K=W]SE2P78;+PT7#A]Z)^)$R3^3
M T\$QP=*WB/FN)5/_&6>$#;VW0Q-K;R>2]FL$F62#=V["UYK(IPAS-NJ])0+
M:0^'-GJEV^(OZ'[N H=Q4192)IPS=1;\.8[_5^667A.$!\V3UF&R\ZE24T7,
M' $:&4_J>U5V\>!6S0K8HV3"%E9JHM$0[L_M:X6]=>$=2 9Q_GE_>UN>O>;U
M)8;#MF(8;BQ>Z37E9_SD'$XT8DL:RK,I8.B\PEND^J7FH+H.+3S2&I:#JW7!
M=2VRH>09>:<=FH)JM&*;V<PR8;;UKVR*H;;D3&I=KJS(,[2.*M(+E-JWN76:
M B]3^:Y>S%O:*YLH+1JPJ&<K\L(<=98,7'>Q&#4Y4R:)*Z-?_U)4H[08^,N>
MDLM_(04G7G!$Y% BFW)$7AJ%C\D:A5@G.__1%F^\N-@W<1&O?U=NE#00>KMV
MH6KML."JYI[H\*./I8?_<$6 V*'L?]\[&T;;<>49L3NH[ED]ZOX1>>O3.<#E
MC<EH6,! X1QR)^$MY F^TN2\*A8S17RD>A:W,BE^SJOL ]_DO6_ 3T=O@<]P
MRL,D?/:#+H3>3$]>2/#)2;7CE1(@C(Y1-XA\C;F6?%T&PP:4<SS<5W2CMRC;
M*A.F@ZF5$]$4S,9)&1';$<%"\N?=_>T!^?CX_V1./OZ8YA*X)3))T+F*3_A$
MMTC><)NW]S52_O/.H]W!@]U[@P?[VU)HHT:KZ#\ZG#2.:37H'A\N:ZA50?]Y
M9^_!<.^1U#D@/!XM-W?;BZU1';90RBTE/W2&UA6VUVPW3OSKLG\6##%^";84
M>/WM*M_KB>^6MF$,3$X9KM_1"=0B-G[/CWP]37$;X9R_E)LT>&:2S+.TL02O
MV-A>R"HU.A,,\X5GEY'OHEDQZ1 X]C3[^-MW)M/HALI"ZWD"LYV3T&U$S X,
M'2>*A*;]0OD9JEF9C\AVB3V:HDJ5?#V-$XC"K2AU6:$I^;HSN^)0;BHCD:>Q
M4O\4+GE7[PZ,,!\DJ>!*8/0RRN8B;SC.X-J6U]I?C]M2Q)$<1-[5RN;:C<EK
ML>9Z6:KEG8WW8WUX(P06RGZ4WX?UN2UL$I)!T!J<$/+FLQ[C=1UQU0K9M WP
M.F9S">62D?,6.>NY4%6%MCS X**_#Y_[5L >0*<;N[YP\!@^7]C.-"'&<J]$
M\D3TH?*.68,BCXB[9H!20*!8Y\R17BF8HH0T>,90%WD\X^D4.]4?BG%)YM8[
M65]!@;FY6]U!TOF'8<JNKKDG0.6!M:4W2<"]SB6XC JE>PZ3_Z&YTPE;QF2<
MM3]<(0HU\.$?BX*952PU"^FXA@CU^Y\!/2ZNS3 ^9GG#TC&O JVIX-<]7*Q!
MG%R)84O'89M*(C4!H:-=$.AG-'\R8 4$*D@S,#KA_:<>\./1/S3P*W?.QIVI
M7DR7HPX@L_E797.AY>8=)BK%W8%>RQAR!8<V056X^4AF!S-. _)79.Y*DV83
MD/P(W!IYXUC.X6>J,[OAAF"B!:OTT<,?XAZ87BC:.]B--GTE(;/LR TXB$Y.
M,Q+0\4*2!^LZQ>Y3UZEUCL%]H2R$?Q7)HN1MF>.*$\3.&MB@T2."A%V-O^*)
M(;9-!W[WWN4#E.7C"?Y$#A)LM(J<KOK<D;_J8ZNDM6LT40&+,(?FZZJ:);[!
MB )$.]'NIB,O\Z873.<)VU+JZ8!0D(\9 *9WXS(H;5S"7])=&?&\H(>4K;+H
M:*_G_@RL+@$[9^KZ*>H(!#.UB[E.>O 83-X[-V^E)B;3VJ=53<AY&1-NVB4'
MYRB.WW/-&0^+0X_A^)ED]SU<Y/T'787&YQHT.-&<&61,/<;..X<E$',."$+0
MYG%EBT>6.I IC(6LDX0- I4<M?5B.R8L0D/N0".MJE$Y2WOMFE9+^GT3W;9?
MTGT @CER&.BAH>P[]UQ@1A\>TZ9!5R#EX!N]=P9SN[GC*>O6S<DRM.MN7+1N
M7@7SP58S1$:=#:P:BHD,U@*^=0K<)=U0?N%9"A=-H(Z.[!<V>\T&Z2F 31>>
M78#0JDR$@(# 8.:[1FFZ_=3%\G1UKP6;,*9 ETH)SZ3J *UO(]'Q8S"?@CAA
MBKR1T0+*Y@;-A%*.AC0I4^!QO<;* 8Q-.MFHV4"/&?N=7B3/:5_GV(#1GJ0M
MRA"M5?D\B 2T-,\J?9MZ4,70> Z\7/[=$CGY'2)YT[;N@:39.^2@*B5.7AU*
MX>PN;0M4&37K$<-= QQ&0"@O&-5YQGI ?L]"K?<LJ Q7S -$+:B!*+4;&OM)
MFCJZ@3]IK:<9[H6MU+F1R P>+T$W'Z7/U[07\K\SR)P]A>L\T8)^77@+>>J
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M)DHZ2_36)XP\]W1KT@0YTG-\AD0:,5Z+DR];6*(4,)OSO&9^)*->''A/3R<
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M85L =1=G)/AK!F+6V*[);;S9'4\QT30++2"J%BU)^Y+#.:CE$NI96/X7Y$!
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MEQZ2YSD^F7^+Y,32N+78.C-T!'^%)3TR:^9 UF3GT=Y])B5+9]P5E-?Y\.B
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M[<F$M7G"20NPN$H@S-J5Y'%*GU]")"%3UZO8:&G.*MZ5F)$<B&WF],?O97T
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MUM6BL6ES94,O,$P.$%!8<'5[TW9^@]"^K:=&^)A@B=R812$! O72(/C8>OB
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M@X</'_V1HW/BF-OY '5?Y%O7S)Q"/^2DYK>_S#=/VY2S>V.WAMFY-]C?N3=
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MY_^Q]ZY-;AO)MNA?8>S8<Z\4P>XCO^;E&SM"EN0].L>V'):\?>]'D 39&($
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MK<WL"_2F2&00EG1TJL_N'/N;]^7:B.8/C4V""C+-I#0TI<0D"9AY5#0J]Y5
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MH:#+^UY4ZRCWD<YR>)'$"7*?F!\N(^N9I)5UI!6N"Q2(\[1L,!'(N$OI_<0
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MJ5H+E@0+L)4\\:XC<!%Y^K)>L49O=4I?H<>NN& >>\LZ8U[TQU36!!-!NF:
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M6WO[BK]RSR9$2 /+K-Q@/N0==GMAH0:XT2K-X\@1T[+$\#B&JZ@=_^OX8GH
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M>FWQXQ7LA:@_P*SAV,$.S%FXD2M@S<=J+=T8"' 1AI_.Y0]Q2$^>QYF3JAZ
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M:"6!I4RY^B_,=ZB]D[\=C.M]18',SGO:H"G6W_,.M4XON*RNSCHI[FL2&2O
MZ#?:"V+M+067*\-ZSDYZ>'G;FPF6^F_RNI2##29ZU%3'E@;A]%<1S:__5MK<
M"/-+LZZT5-"/N#9L*L*F2Q#<A+V&YS-*.-+S(P=CTFP=L=0X0E*Y\\;YGCOR
M7#]@(O]8F,A?73/N'J%G7EGKT,Z3E!Y##-T/&7K=^7<9">$BIN2@\I^F(B6\
MV:[W?\CH$N[_82\9)GBEM&N;$)N%.ZNW?Y0(IK*PL>KZ_86E')$5=')0%G^P
M+6_3,67!/I(*:-'EE8F[:/(AO&"-%Z!LB3*5=0).?Y\T!Z-*BN(.Q!F#C5@Q
M]8W:I2_BQI<Q%I!,3+OF(+ _^S'+T?0K3]X+)U:$793=B#@^"L0BMX0:V@ K
MH;HU(49.PYCG0K6#$HB2@_0'-KC19D(NRS\VAC(TOBE:W)>-UH9('SG^P\A4
MZ-E[ALBJ^X+'.]^WW:MIO@\&\O<-CGPZSN\,K  5K[P5(!Y@TE]=JKZL8W>E
MM:FNVG8E*BA9*U)+6,FBW4-1Z5&A/<VEH$U8!5^1HR$U2]O-T!NC2RU#TQ&
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MOH.O;4."./LEZ]Y32N3\\9H7B4P%5EN);32E5EB:@4+[Y>P'0F0:=B>2+$J
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M_/7@..;^S?TZDG]LI,]G#TB?>V*T\VQ3[$AV?6!),L,UR9A!/)$YM@R^4+D
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MY"1!#0X&ZX7&WKCPY.B"Q Y37_INJJL*Q-96K]NPQV%0A2=C7#\;,E>SFJJ
M><\(K?)5P%]J3TFPJ$!+!$.6=-<'Z/L12I]/1R6\O,[1%T/_>FH;.Y5!_.F_
M#H5G9<SZ+>1:2DI_F1KWAU'E^A%X68Z46VAC4L M**X7*0>MLGE,.K]==>VD
M'OK1=ZR"[?>L]G?SN^_:*'=N!_6_E<:RE!,8K^:\:6-3MPNDG:)/IE>J.N!A
MA[=;G!HMH@^)TIE,2\V069\DB#;L7$Y5&P>FPDL,)>-,7:%I-G,C.!SPDP[B
MN+=EN9L!\JMM3\W1.RE*%\*$SWQ&@(/8=DFT#_T+^4/!.=SM]0!-M(VXAI),
M-GY\ 96XL= +X80?YU%_PWR"%,-$PFF@(5&YD]!994$9"36B>2? .1M!L2J#
M@=AK",P/MY>?MR?SQR[Y_?FAY'>_Z 3_G[#W&ML=1;!X_V%OAW9N71S_'HQ!
M'<[4?\RJ5?B-3__CO[Y__6+VZLO9M]^]>O;BQ?/7P;<,C_B%7<PX[M\B,TJ;
M*@6'92F.Y-' >+WCD]+\ ?\WR?!E>Q'B+,);&OB]!K,P! OPCU OH)907=M?
M-^7^SL]G#<&_@Z/=M):AF'B7$#[URZY:H+A;HEM%+7YO6':*SKEN?)RAB4?Q
MP%@3.<RK^_5O-4OYW,$I_>_3V;PA<\25>7\VPX>=DC"ZGJW__.B3V3;\NC99
M+XO^RFE[O8,<7?(^?RBZKFBD$[D_4.YC?:AK^2O[98Y \D8&!<?26L.RSC_Z
MRT/4+?00I,>>1Q1?DJ/;'3HD(!3=+#SDS"[A_MZ2>'QE^D:/7K_Z"DWAX=,.
MD%L,GE]CM._BX<OM!Y)PA0<5G7[F3I+M4FY-+6-PDGI'Z7?+)K1>[JE=^/,>
MK]^YK?OL/_[K^8LW+[[[^N4W3]^\?/4-K-ZK+[]\\=W+;_X[F+^7SUZ<N>U[
M<\)^D&>9C-Q$N*)@<V*O1;1PB7Q=BK=C4!5AES7%]EJ%;\J/Q=,V+O>DN?<>
M"[AJ2VE]LW)/Q>BTZ+3I(#&F1]!>V[X5-9-Y%'[;(>T\2KU,.Y9MYX@#??@?
M;"S]5R<E^FHX7.H,0DN5X&*=L7R:R!+HN?CS.1$CE3U44X3:SZ=/2[V6>[(!
M^KIX#&]BFS@QB:IYN!(5/A&C$BQ)SMH60@Y-CR5)MP<S0C/RY__XKR^^?_WR
MFQ>O?QU?Z1XD4'6/(S0[VV_]?E>^JR3)R$X':-0BHR5!>_6C:CK*X8C]T*.6
M[JF&$X!3D(1T)? ?<,47A,+*SY :5#VZ0Z?\ A?[]B+^K<I!SIW>,VABPQBI
M%3'7<_Y/>@-5M[H@Q[K3+"3IX]-M\6/;G)5?,)'OYXG6-_(W5^6R%6?J[T27
M\#AS6ZL+]P:YPT-W#.96W+9S/]HOBDY*%1\_^?@S(L\/NU5A)$Q;H]@6$9G^
M2EU>I^2C\V5NKC*9L))F FZF3K@TC775UXSL&09>H'@G?(!24O?A%-Z0\XB=
M!Q(5J$XAI150=2Y9HN<ER@&&FW,KKD'XJ"^?OWQV4;$&N8I=Y1?P&:1QB$51
M]4=4)9Q%_I9,OD!WVF=9?DDD&C4,:"Q'K[@4DCQ4FRN(W1XKC*QM_. N9]\3
MTX2_QXHQ$ JG7XI#<2YW;;C<D>)?'A 3I"^"&Z"AA@9D(>)([*]OA-:(CYPE
M;:*=\L85ZC9<J-L0WQ=6N:PEIZ<*DLS)5Z)X"Y&>,'MASNI*& Y$X75=+H^@
M#ANV;5%ISE-%4'^)=0G'$NH4<YD%5 E0KTBK8K-JI+Y.&X_^#F>'0W%5E596
M+9?#C&O(4MHI 4.L7;8!4W&D!@Y791FB**&L0S6=K\P'8!.M7Q(5D_-5-ZZR
M7HH>*Y#?>#$(R"#FSY62BSTL'(952X\SA;[V$&N[P'/B"]-W:?S+G;P?2V:?
MB<>77OAJ,.^Q91[;EZ9!)! UC&!,(C&2Y=#[L.^+8__W^Y1@ONBK'TMFF?_=
MK++^NSSETS_A2HW?.'@3_W-=;(-Y^OOP X.=V53-WY_@L>Y+F(>=> L[.I=%
MK;.P;W<_QXLS)\#_47_<+MJ:(_OK)Y_'>WX\P/>,ZY=.4QJ ,MA*<,//DH)9
M5$ZWXA*I-VG!:(G(<.ZCN?CC8 IHI@$*U5Z%8.KYH=AEJW*QGUTD+"?A,6#U
MC"]D'(H+M"M9)UJ'VPV&U))0B[(IUY6(%_C3@SXV53[B6_'O4F(7@WHYW"=W
M+RG\DH=/=\3YONU>3?,=#]X?U2#0+^DC_0AC/45DT$^(GDGF7@ 35W2-D#<S
MZRT>*KUX)*HSWX \I84%JBR.P!48>3 *A+)'YIG]OWWV)TOD4<9='SYW-#69
M2G@1F4Z S((?W9EB#;S'3<MT?]O=%-U*1_)#='JNRM6FC.]B^*T_H.2Y@5+S
M7\OY$N[I<3C?M]VK:7ZP.N^W.O'N#I'#VU3X@LP@A7(13EN\HI')K-^U>]-O
M%5B5/$JE1O6<D]>![L/(XRZDLS\^?]M>2ZRW*T1MEE\W/+UG5^-/+_RFW:<6
M&<&AAHG:54TC"7U9E3C;"?I7]4IX(&JLF/H+KP>_P+*&!8[-092$5!!U)8#G
M,C>:P4TD8!_<^J#[TH8LW1CQ/N&28^%0 @8E@A9EA#N&OB++,7[A'] [OQ)Z
MYR\/Z)U[<K)_4N9:?:]OI67[W!/6WSJ^WLS!M33?/#8.'OJ1I^?=80%[(#EF
M6 TKO1CY5ZZM'KLXMBWX:R;2B$+$G^4+V_$*18!,#.E-_.%_PL>N"@],'_RI
M@#U%5 "H8S 8FG8 )*/*] BUX,$9QQM87.9+:O7[(\3FY.A4!=XRB,-DJ<XJ
MKVM]Q"Z-,G[:%M3AG?\T>N'U#@U%4 +-QJ;W1MCLP@]D3 'NSQEO++OP@H;,
MSEF][  _0>7=XW"8]^V,EHLM8TWX_S;$+A<R1.!F#\)KC ^S/(;KY7$P^3!8
M8/ -N4,*:'^/XH6<924=&/.LI67JKZSIPPLX..E9W4XZ\PRD6C<?ES.7&5>-
M ^5"NDZ31KK0,$]ATDKC"NW(4N3&/?>#5E3V,E84(76Q#689_3#%"@=2N)(4
MLFLKF _7;93L^$7=$WRH*3.TS>4L"RT%+G67F%+B89OOX'<C/7Y[.#D1^YV1
MF63GM\;5QD"K4&GE'_7+PVJ:L+?*1-*E![$U1G%)6;[K%.97#JKO:T1AQHMU
M:81\1\J%R%-7X-VJF@OPZK9+R/94E^7E)7X$HK"])!PL=<'VO\=**!HVX*%A
MT5IJ$UH #_^LOP[I%Y8]MLJ;E^"-?5VP+2#J T4-.AQP=SYX,,MJ+QS>6MD3
MC%_50T[^FC!W/2R8MPK61N3LVK:KCY>SIZ*),D]9&6>@W=29Y[Z\:M%87*1Q
MR*_B>9DYN;F"U0?X .6\&7"=60YGR%0?YB,I&D>%*JX*04\3P,[R7>5_HDPF
M L3"!M'W"7^7;A%N'*V154W!1@6FC]GAJRTO'$381!Z<1/WYCM76\-.(/$JT
ML:ZQ,\*.M,DZ<;K!Z)W=L27 5B:?4R_3KA[P>7VJN[8HWE1=W)3E6YPXD7"5
M-EZ]T)*ASVGH,HUN/1-MUD >:[)ANU[.OK![1VIX]JJYQS7$G2JWZ/2%YAW)
M*4>-"<C!@Z*'X1[)M&R(TN.%/A=?(>KB4;B)KETR$U<FOQ2, >XZ?ZWIY6CY
M8=3Q@7"GBIZ07WJ5<!RJLSM$+]=VZR2;DQSG?"EB97U4;A\L*%KY\X=&N9]R
M8I^HGU8X3\_"$F,S107MT#C?>6F=P>$V,_\R_;D.5MX86]A=FR1D4CKCP5R5
M=;D9[=KH]#M6G;2MFG9U?A;5.0GH!6QK-'C:Y22=_II@-#6]TF[*UGYO;O=B
MU."F,XMK+>R)/5WC**76N.N180,))M"E<-3;['+VW YXU=LKY)'MV[)QY,NV
MM*C<"%H9M8_>Z/O+(W^5@1I^_PBO%XCLPJ[A<,Z;'HANT0(0C%!=-AMP8ZW]
M -B;"U:(Y)NKI^7[ _'>S/N+\8]$2)_^=1;B&:7-A_K1[%6C9VXX]Y5T8M?A
M..7MGCPD]+CLY\EEO5;FYC"Y0_/O^B$)7;<][V<!4GW]P!5)EO_L]CZ\B:^B
M Y4NW+/T)R:[=P>)B0B*XV%3U8MP+-L$P7?;R+8-FP= ^2+BB\XD=T[W$"CQ
M-G4JT=T0N%\#1][U%?03^[TK-Y'U>+3CD8#/[(HIZMRTLQ7$"BF<Q%O%3D.\
M6&[IP=\<"C13E>HGI/XH:SA.$FY^O#)4X909CE9H=BSBAX'$<0S#ZL-]AA]9
M5:A=U$;OK4SRL0ALKG^ZI,5L3B82!-,W_A-B02<2+TXZW;(Y[QO>N1V4#TTR
MA_V#%7H!](!Y1=_)173NR>8W"IHP.Q+OWYOH8:44,YES"X\.=0F&ZZK0?XW&
MR:=#G+N6$I]ACVY+X!;X-LK,N)?14U"<AGC[BF>>9VY*$P>Z^O_9>Q/FMK$T
M6_"O(+(S8^P.B":U*_-U32AE.4O5WMJ2*ZMC8F(")$$*91)@ J!DUJ^?>[[E
M+B HR5FR+%-\\3K+DDC@KM_^G<,&J1V4'<@5\HGR9;J,&KS-P[ /HJ:QLA]\
M8DC88N;/$I$*TMS#= J&SU))7DLDIDH<+XH((!H71A[I-QR9EK@\X4/1]:[Q
M=1J)3 7X61J>Y '#EU.(>#^L(^7(01Q<@OT2?&QF*B5@.\V8=)>_@3 .AIU<
MZ3HHD#Q$L/="36 '<4E(X4TN\V%RF8>;7.8CD9U?JF:T;,NK87O+#LBZ:QFR
M:Y@@/F@;T"8,Y<JF?ANC#XQLJKW$%V5?'.B0V)^SU-S[NMC"_^IZJD/WS'-W
MY4^N]$-]72/)PH_(M[7?Q%,SP(7FH-*$4G+Z'NIYF\[F-0%KVY[;FF$*&TR=
MWKZK6E1>.37O"+T (7<.?E7Z^==)W^CDLWS0<8TQ[B\ZX.;I>H7\%[]>6'ND
M*]9S,Y=FSNT=C>X6II^A6/TS*;J1&#QPBJC#JBZ1FG1<>LU'IO0I@L T*^N"
M?C3E!9H0F914H"5;1L=.A9E$F2A[1^JH-LC;GDQLL$CM;0W'AQMH]&E)<0 .
M&#2.#R)=USP$.IN:6$H_2S@,NTGVB>^CD\O.@V$(;Q@#-AC;>$>'C!QQ58BL
M@.J]&#UT7!2",B\X8V$H&/Y_+E9'7B4"R]WVEEBB>O*>ZAK<J4/7!B-&%ICI
MN#J>_S@R?I8VLQ$8OQY'O.%CY[P3#<U2)_ ;ZXBWRPLY%/E2>Q ;C:Y%DV%#
M,^,N7F7#.2"R\N$6]@076O_M3\^"94LG@$"/JRD9\'PO+X-N*)Y*-M,UVMNY
M2E>OJ87&$$ ,LR+#U,7/JBD23N0&)H)F:BD$2(ZQ$&L<LV5J;N&LY&&8PYY/
M& $63Y5$6I(-;WB,\;DKS^-'\I >ARV^=0QF E?<?Y]0#4C*5=6("X\=KA\8
M']*E;GEC:97%]8M)RD0 )+_ MA.\3&\(SDQ!8 /A$ERG_9UHG$PIU4:GC\<H
MV 7'9\0 42\]=W:YJ% ;VKS^+E?*.7R J15@A@MRE8W3P-"IE5\-"/N:.O?Z
MZ0(P7]!=E.+S=(PQ^-.%'KEU4]$7R\K)POZG0P'#*(K1EOG_C *YX%?6R71&
M^!@I=CZKS&U\W_R@,CI3*AT!B\I]7(@PS-E=S&H<Z9F1H,;8!A@$)ZT)@[2R
M:)-%.39?%$)M)8 @RHLJXY#J=)[+B9.04'^A)%JLG<BL,%J[9:CZ-CBZ<DLA
M [2 H)+,.%=3%=(_@!PW':88TI"!Z9)<(.E5(4+1N1/+8K:L" TSU=Y4 .<P
M1U4N2PZV5WJT]@5K?2NX84FJCSEBE#':S]H=3 ]-63-72P?1.TPMUYUZC!/W
M+?;M6XZBM'9CHZ[@2T-#>WU=X@6G@5Y"")1J-^SC6>]:5&SHQ+)B *2A6(L^
M2B2T#K=?NQ[?OC2^X*MRRF9<2<%'@?$ &7&*FM'HMQR[H5>'<XU]!]ZH.VH0
ML<8O?41M8O0C,_H_E8%( 8BJ?QZ'8)/*,TDUX/TB@W5<C8B2EU'A\6FQG>RI
M%]C$$*0$P\AQ+WU'XD"&QIW108$*C"\FJ9^:KPQ0X,C@Z48<^!4OYG/"/LHC
M-:8!YX_R0D?K"08^+1D"7.DUJ2INYY-]2P'5F:F=7!D5Q5%7W/_@2!A#LQCS
M\);.KSD5?3*=I-1Q]5&E1G8J$!087TX\36=&-TFMFL9[G.SDV),3>T*]=+T%
MPD# %?AVI".B7CM1\L7%QU>POLW;0N?MB3CM9X"'&K( (LC@1JI5^O4=PD6+
MZ*6JS,"(XM+,9PG7'E=:CL".?B),4M-TF"4$5BV")V'D9?/;G&FTERU.5--!
M.%3FG4[63&''B?,+5#ODCQEPEH&G<X\3H>DSD/L%@B3SX&L4^38"S^8.CNKK
M1),OJ Q$P@F>&]GDUO7]E"YFB='/SP35ROQLQ+"YSL;*+LT;S,_/.U)TXWD\
M@F4U!;J67>>^&5V:YM9AJJP)Q$YWRBY&8R4A?.S#5[F*/&JSSXL93&WX]&Y?
M/#/>VQ5>%B+ #/RC6.KFRB(92CK+29A&^Q0;,P3WP]\2 R]M?E&2 >B@@?'N
MS"'=,5?4A[U3=2WJJZ&T28MY-B?'Q85-X18[H=7*(/]+33EN\U$298>.:5D0
M&NZ-=I<33+_L9Q(<<UZE3O0KJ5I2 5Q72@LZ8RH)&(L%JK'Z"W;B_IB[%09,
M,B.MJT4JZ[5V<OX]+43M3CSG-&S;&!_TII1@:QRP+:@++MC:U^@><[CT,\(.
M0$0&>ZS7WW8%4.EF)C7BUYRFKEB">KT8RM=,5%Z>1("(:%XM#D_)-:,R&'50
M_(??*,CB1GSAM@B%+^81,-(@$=/-D0'#@J<HP\#$NAVC4Y0MTA)?)NKW(1ID
M-TOCUS#BN*N!MD_/1<Q(9-Y6%M;FE$Q_0SEZ,BJVY3WF*]F,+$PZIMI62J+*
MG1YUC0@+K5$JH3LJ*5>M7J? MK&(BW$AW$_>N[C$V1?;9KA>Z*^2@7 LB1LO
MQO#4@*=.WD]&#2D<JE'2&A[B B>KD+ 98VZ1IKM6_C9.8LI0K!JU"=P+^Q1F
M)M-R%SVXZE+(8&3%AHIB["9I?J%.$)J=O,+Q4&'10)EXT:8?EL?G[8;MI-*[
MCE]J_8T,BTH5&8'$+0LL"YF&#1Q0H<V%_TH/>-ABAJ)_18? P4DZ)LJ.FE+X
M5!I=[9">";N5KYX&9!M#BGE=0*1,/0P&K%="$3@+Q-)).[&MQT5Z )]QJRX0
MK)J\\0:A3Y@OZ>3GG=^QD -@J."2)8)L<&*-08WR5]3,L?SP]9-*;Z6)(SS)
MN11GRCZC4C:9B,SRE^-FH6.I4)I;E,S-02FI/<.I!V$+FR.4FLDMT<-M,PRD
M*H2E9D3A^6RD"GA22#%O.,C8Z38(!C 1)CFW3$TH"F(->!610F/K8&&3BJ+/
ME%3D$76BUT88HXXMCB0=F1G[$X1A5T:ATJ-KI68+INX>I;=ZRE72* P;2CFS
M\6L&GXRG0(7^L,]AM2.[9_Z)/;'YH89KT# BETP*$ODN\-2PI*V8X6UWDM*-
MV9M*@YFL0J@K@A19^&&I%9Z<T&M67GP@FB%PHE5WE"4U&S5DD@]_F".TV'-A
MHEM$3UR+&ITA\2'2@J2A2CWMFI&LDMDL79%AJ*'@4;%8UQ-TYX5N]P'#2ANQ
MZKPWFH-GS,8IM_:MFZ19O192YR2]=EB!T$^C8#E5;]NCRRQ?0PD5<CTG%4?Y
M+N%2JEYND-]!1IL\L279[@4:@<\T%R>).?FU>.[<@FJN;U(G 1C]L^PY:SHH
MO<SU.9CEFY W)44)CA0^/'WL=#[+S&/P8&)!'J0N9.T"^5G>/EE'V,WJ^%H_
M7VG?]7"(D.C%I=_3P.7WYNUTG*DYI@83.7,KSG.;AO;/+6YS6M4.BS?0"+0V
M,R/0.'>+>@S77!E@_@*R9%XABI/TC1VV*0)[H"*PHTT1V",1DA]GHB]MD@KM
M;W)SM4W*DQ*ML:,E;:3PA:3;9V(_L&^G-3[L2;K?,VB:\0L"I>0P45=5BC0@
M<<SF0K@R4;SVP/NVED+(HEH)#C*]?96:=2Y1K+7TGE?CCTKZ:)*F0I?)+)71
MN&''TK8&<P[]8>C074-=/%U:,HX"HNEB/O!:PHO1:&NYV$TA(FHUQ)48J*U&
MR5? %]1'VOKL8##Z(C'T0A./L>%MOP>5)1'L/)%9%"/8Q01 ;S2O+1Z2J)<%
M))96)SK[82^B_RA;2^="+$4Q28=;[D/A"_PL0^/5^(J6C]U8T42<J8V@ 37-
M,3.%C:,'(=WPD:ZVK/33'5XQ/;/R$.>'<O9B]RJ] -A0BK@/B'BZU: E)KM;
M]_PLET@^/Z?(5VVZ7^_&=YW:-&]Y01S8?F14L#4V3LHA-SBO/&;T*A>YQ9SM
MBVUG8.!OWO:PG"A,YN;[2_=+O5HR92WV=/OY]O>>IM/N1WFXC5;4$FX8EWVP
MPM DC_BN:76737O%EZ.BZU'1YMQEZMET.F=C"L:U)T/I1BBKE#]3NHCV,LG!
M"\IW:&M01L1FNOIT6E?43R^SL%*U[7AFTAWA^7I\C6)7\\#S<J5'ZR;VOS1C
M[5!SGD!V^H8B%^YG49  KBCANAHPGA13>'1M3N22/\>%O*@)D<2JE)^(%9,I
M,:BY,>BJU I* E01H ^$K<LAXYP0^HE> R-S4D(WFHSFN<;(.2:.&%P8>Q@7
MN,W89;R BGQ0@X9_7)IWUQR7HICRTA"E2F9 )6G:\.CHH"QF#%.@VN(9#^9&
M->14,%YR,Z629)?QB:M:"_/];M&KK!#G.IRP)9I ;,\-AXMPM%A(]#S%Y!Q&
M&8.:X<;;,AU*!=#X%US06@F)K*3\2$HO9NP8CT;@H).P1:E\6E1@55!]4#+1
M#U$*E2.8;A_63KPT0,=<XM]LV8@!E; DKO6"CN<PY5YAG/-Y-AEZT!)3XQ$0
M'(A5ZNRS!H7$8DN""8+^%&(/D'XW<GY6"?=8@&"4$'VXT7)<Y"]LOGT"JY X
ML@U/<F)T*3K5$E.2CU6A"1>[S(?%FX-"]**K)%\X(,8$FXAU>N@'D#WSDGNF
M*49!OVX*F99*.F_>DAS39EZ*)!E)\R_7-=*T6:3_;T15]DH6W@C(4K+75CNF
M4M;LZMUED]Z@K]"<@=//5-=!@_@[H$V7FVC>G/Z]H[^%+9)^3N#PD:CRE+56
M;/-^CI(!Y"9D[\OT5>8*RZE*T/:7A!T(S?PVIZ.) ;U&SWMMY01YL<J(34TO
M?@*[OW!\=%I=W%RF=;[S$Z+M(?8]P)PE,TKHF7ULA"C5.I/LD(4KPT=.R:&<
M3[UJ@]HE):UIGGZF M;@I+H*'D'YT*@J.5SV!JPIA]=YHSYVA;M0-H'% DM:
M310;E WL&9+K;&AG99O8ZGM@47Y-+@>-,K6?6%->V6!V79#;.K"]TQ9KT#8W
M<>*&9X8!(DO(XT<3&M<_EXN KP,KJ? P^;*\TNXN-^#@939Z((7$%)L*93?/
M6F6U&@I8^792>5F"2XFKNYF+O1EH!^NGSV>$"I$TD2<U;J<PDLO8,VLG:K O
M7.),K3L6$*]9&MY^])%*)9-N2*BG('O*5%I/T)]8\:FQRS@VEJ@&%.P-,3HD
MF>("B;$( D.JO,_G$H;A45 ;&[US-$%O$=T3B[T>J[-.%0K<X10Y9>99RO9X
M<U]<'([&@Q5=N]UN$6B*GM^04&@:3,?0ZQS5,I<(O@>7L*)+PNPKW=]T5J"%
MBRO/C(E'/TLRC$(!1K-L$T!,+'%!VDJ$C9,)#(=:\V7N+\F\+A!Y8D.W,2P*
M+*"C)O=P]KQ*2AJ E%'I%.31(\JIH9J>$5G$P&$;)IN!T]OOV? EBZX812NQ
M"\R\G3.QN#UW_"T*S&G^S5P*FT-(!_-2N8Y\X:G6Y1IFJ/\DT,M[)7DPB@$T
MT=%+B<0>4QOBNH=.@*GN85/6:0(N=S0ZL'F]A#%U:<R""#:(CQJD#=&6E]+A
MLOF\?&(R+-&.BA>V#&/8Q#&"2/[SKQ%DF4FQT-"*TGM17-NB2=IXNUI,$K ?
M_#'/*L[K"?QZ )3>^!J>Q-%\QEPK"4>''B)5?A0[A5911'1&MP)V8OJI8K(@
M#\DEGT_[+NBJA3+R0*^61J?%4X708XC(ZZ1]<2UZ"QH&V&9D""JLI4+K"M 5
MB];*:%&+G04=+O3J.BE:4/R@E-T*^HW>=I;!_HYR_)M[2ZFKTJ*?HC1T,E0^
M1P7;:IH,V'LSUDW!P<,4'.QV-P4'CT1Z?ZG.^\C1IY-04IUK-2U+E@ORN]9=
M\3DN-<"O;['P9H.)(B"*"N;3BO\!-X$8HCU9+S2Y'KR6!>EJ_SSDKCZ=<A,-
MEFD;8D5^-Z4J?UAO: <6%H.L3I7:_-),X,H8S'Y9=*Q5L9)F1[./3*].!Y=Y
M,2G&Y)T8(<O^:%H/UC2R ON&*:477MN@T9N_9O5OA;$14%,KRJ@!JD.?<'S3
MOPOTK(_=* ^<1)H_H"PH:>*3(LL14I&'.E8.C:^H\G0U=/ R&B2&[.42^6G#
MNLC[A2;(*5"QZFSZD)! DE>DMS8T.#J-/M#2G.6%VB=M[WCR?H0G/7'80O=!
MV4U(KLHRK[MDU04D,\^>D[6=;CA-?CUGBB47+.#4: G^E*8S(4WR@<IM:9'G
MZX0XL1;N\22XW![(NZ(V6FZDD7&-B%$';:2.6)GQ;JB"W=)H!,*EH@-KG:=Q
M65Q+N,QUVDCW526 W)067)X"G 6JT!Z7!,E9.9](L3P#W*=!\_FM"V.+KM%:
M1B0]&;?<>6PODY;EQ.6D2^G[NQY KA D!?TD+3,FX8XTM_%^J\O4OC(0MGYF
M0YHEO-YAVB7CA&73.55W E73+8-4S,LR46]O:C.%: 7#W*0FB$O3*BVHM]NI
M0T)[C3Q*SYO=6%H[-&&@OUA9)-PYD&=(H)0',RX"[>!]NJ%'!>W$]F/!<T,N
MT9H<W&"M<3-7%R0U%*E-)]2IUQ97TUN(PMY(8L!9UU0;M'8Z:*75,K"$4:OM
M%T#OSLTA?9E\*I!TEY5"V*+5M%FU%ZYAW7^>V(G1N]S<HT74BZ/M[O8>Q3;(
M0:0-H?[1$VL=G0MP771L,8WH&O$<?'Q&_HW]F!VB;V1KJ:1@TBWXB')(BH]Q
MXRF8W(B[X0ES4*#5YLSA ZZC/-VB/YCGI=>X@O-\PMVB&4'!P/JF!$.1;\EG
MG,@PJR5M>.0EA/&-&4(Z/)[$$HJ%Q9[:S(C.*$["S;6.7.(GQ!]J6T:M86'-
M?<*/^'&OV^5WMTR?HS[D+;OA^D+53)._1F_.X.T@&B5Q/UT"JHN5.ATN;2\I
M-B]#<Z]40E7@#,ZI:)V/%;\C"SAKI#I(&G>9*9M1&>V451V4FOU)E(M$>_P<
MP\<DN4:S=9TI(0AP1O)/Y7Q6F[.RCI*B CST<$E6J ="4H&*JN?]*B,($ Z9
MR)]_FQ3]9!+;C[TTOLPU5Y-;R>&!G;!<RN B5U('QWODHJ/DU7A'G(@Q2%SL
MJ;CP]S^4&[D9B)E=/1=E=C*AIM:&Z+"C]Z6'_>62 -%+V?Q[XVXH9,/*.Z)/
M4"FX=-7M*[+:9H508#@PIL(<9@FEKX-<._?0VS+RJV(RGTJ!2B)W<6O(O:]9
M,;SC3&Z= ;T=>.E?X9:[1?CJ%YW!: E:=\)>=<K-;BLE@!L=%0G!I1]0*W%;
MND,'E%$$W3;T@@".+)0108&4@O&E"F;MI R+;:^_/OIQ>Z\;=[OT?]&L,'MB
MUI)HS6LB&*$;/I(CDE7$QG,;V^6/O:/M^&![-S[8ZW(5O9BJK/_,Y33C&!=Q
M>'W@0#%?M_G*C[V=@\[.$>X*UX]XVTVD2+X-*L-FB*0%9Y0N@<FO9TU/X\A.
ME[PR9X31),A2H/W73UE*#GI:4KLQ$-B:^WQ/%E Z5(0G_(NF)YER!5"R'R6
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M\G#;)\L?T "D]*H<N,\%'7YB;)#9;$+1B[UN=ZJM/A0_G,Y=[K?Q<3Q14CL
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M5QGO.2^8+%'5,ORL]A>]:BQZI9;%RLD1RT#KQ'(0&2*AN- 5T-'[2RK<(SI
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MF;+?ZK>C/RLM!QG0C&DK !.]/-&[&S9,Q$'EE?/JUH4=H;#D4M]G3/+Y5 J
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M)[5M)G4)@-+>$$U*^>=<$U <S%J^!^(R;"[ Y@)\FPM 28]T>.,%6&V=T-5
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M^_'1SMZJG698V<(7*!S(Z'E&@8H!?X2NG@7GJ1<?[._&AP?[-U0UR8 .;PP
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M%)J:VMNX\IZ2*@2+A8IQ]WB/ -'QV=O=WMYT\#8[46?6Q-+,'$H8D3I+PQ6
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MEF9CU@F76Y)P^:X,"WMH^NQ%?>_#_P%02P,$%     @ =9.!6XU?O)P #0
MR@T   \   !U<'AI7W,Q:6UG,2YJ<&>=EGDTVUN[QW^AAHZFT*(H10VEKS'H
MH,,Q5Y4V42%RS)44I:88FG/:0VL(1Q5%VYR:)0U%(C7FG)8ZE:JB,47D1:FJ
MI!HEB"1O>M[WOG?=M>Y=Z][[W>O9?^QGK[V?SWJ>/8C'Q7\'%-V=W9P!$ @$
M_"AI@)@)G -D=D@D_;V7E9&1E=\K+R\G)Z^X>\_.O2J*8!5E165E\'XM=;#:
M035E98W#&@>U=71U=<'J^D?T#QEJ'=(]]'T1D(RLK+R<O(*\O,(A56750_]G
MB7\'E.0!*+ E#=(#I)1 TDH@<0^@ P @&=!? OXED)3T#AE9.?F=NW9+)E 4
M 2F0M+24)'X)@,2;+O$#.Y1DE'4MSLBJ> ?)Z<6"+7\N>")_^&S3'ZH^0ROZ
M5L%QMW;N4MM_0%W#P/"(D;&)M8TMQ,[>X=P/3LXNKF[NERY#8;Y7_. AH6'A
M$5<C43?B$Q*3DC$IMW_)R+QS-RO[7N']HN*2!Z5E%955U36U=?6$YA8RI97Z
MO*W]Q<N>WE=]?[[N'QYYSQ@=&Y^8G)F=^S"_\''QT])7WNJWM77^QN;6=RX0
M( WZ#_VW7$H2+BE)6G;(?><"225]GZ"T0T;70E;YC+=<4*R*GN7/\N"S!4^:
M_MAYV,IG134X;FB7FK[UC,'7[VA_D?WOP&[]O\C^#?:?7)/ 'FF0)'G22H C
M(##/O72BMWJ/9G7$@)IT747V.ZELH]_^:>Z0BU)#O59OD/#KU]X;._U$QGEX
M!I5=DW]4=#-\$U8W0!Q_R:]AB;X,P&+,;HZAWK6$)-Q CD.FT>8?F,+EL<+L
M1U?%P%XM<.7.M/,T<YH<*P\2LYU(<)M5X#+% -O3*_]EE!@P,Y?;ED&=/'>>
MVD2.A%CGL4VXC=K447M,57S?./M^Q/K:V,I+C1$L]9CC.')CKT>%G\OU50^]
M+' :L9TZ]XSJU;$#+09 U>?VP@D+;5;W=<W]#[+7&7R^-^WO-B;H,:"Q5$KC
MT\V!_=NK7H*% E)(S&8XGC^0HO0[(^\-??)EDQ9N*JGXL_6/ L8?WGV*N5%.
M4"2JD#M&]2JSX.<E!8W7G-0.'O$C1!CQ[H4O4=DAE"G:9TWNZ,T,LQ[28=<!
M/3% $2X-CIIKS%T,$X$W8=1O])B6"<GP_FF;U?<?'<8SMPZW>N<:8\KJO>J*
MGJ$\&=_((I6[<&-C]&F[MK4<FD41$L4E<30BRKWRW#1OI(P9.-*ML%T(V!TQ
MH*TD-)V)RT6X,[H^:3<8/@SQ8ME&&F<0GK9G=%IBXLX3V*Q&<I&KR^R)GG+S
MH8M.-\"?VR%[*#!/GTEC#7M#:)A(X\[=6M6!Z_/A.%6X9M7S_#=9C.*LALJ,
M)#<]@B1TEU%CWFJ O5]PW9(EV=;2.HK2!!4#K4?YV,8 'Y1*GVVY=4%S,T>D
M,=,S9RPP3K5'H36BW&X<L*66^"!=%@*.I[&G&WHUJZ^/(K\*%02,]PB4TL2+
M_"/VT3F!,$0.%4(N&+E;3?"VN4JP0"7R7H7FG>ZGI0K+[@CB^D2I-XN^Z?A7
M;O?IM)2$P'*A&/,=L=:X(=\$* +5NSX;#<\*-CZ65=A/_Y!&H2??FBF;/9X@
M4FIO1UH9!X0),%OW<VF0+[9C1;DD[< KC\ AB?$I!P,#'^,Y:0S2-(%YK&A/
MY&('*OS7[&]_8^AJ>%O@N_10=G5J"(;AUN?U9U9J1*3[.S\W?72Q=^_YX2#4
M;]W4XAE26F_D_@U8<[W/B4ZJB:%S)K]PP'K8-:V8A'Z]G6.O+UIB9.!"$$T$
M4M#&K;33OT8+IB@8!MM QRI9L/J./O*C /9$^\L#TVC4<A'ZT<HW?Y@;K8M'
MBL\9K02Y#RWLXO';SN<PLX[&A#R/6;-,:W#L@.<8SL.0I9ZA&[=%)WZ.'KCP
MCJN!UL*)@:-O)T=M-M$.H<\%#U^]LZ:4M3@@R)9I]$,L'=$;RI'U#!H_(^7Q
MJ"S,K@._-BRIF$!)Q1Q:_%Q06LZQ% /=["W5!+@FMJ<+.]TX&(=-4DP]0)LY
M#+]0]"<:SU..X:,;6 %Y%#&@:R@&$KL++4NXPI'!)U\UX K;*30!HZ >^Z=[
M#)^(/"L&\FW%0$IS0OZ&&"@4+JTL,4J:LD:\-C(;\AUZJZUQ?&@I49G'0]-Q
MP]C??064!(AY-A-+N_Q4*5!T@,EM@268OD6!AYZ"@^<MB"')S%!_C#J61?J%
MBD[?YTE?=>"B6+B;R&(""O]U'B*@?$KWG1A9+[%_Y&M_\!'1A.7\AIU \*#7
M=!:^$>G,$"C!@_2\)<?C7&YC>:W/S9'"ML5^DZF%KDS\APFW6,A6G_,FMN.*
MOV^2P&;B35MK4;K/\WGDM,D8T9\?4'^0[(^WBD#$L;^:%@K[/\Q&497$0!?B
MO!C@[?L^4"F!O2L&I@GU,-Y/=7UN6D^'KY&/=A6W19URA%S&82>G&!2"Q_PG
MW-(X?/#=K!APO^?514'#*?9+/[S57O8CU:$<@W-V4VIBVBF#I/4GUMVA<<<A
M FN4BK#V8F),.XF"&N-^8X*H"X^A(HUY8@[>L<-,B5!]H#<IV(T48$,KH5YC
M)Y0U+/I"E#?IA]55;W)N=%!;%S9+B77#O_G[JX9O^M&2&=T**CY5;56]@0^#
MM"][U0>DE[W!SY[8]3'^P20"JIYJNU"S!!$#47@^=LFW8K3F9]GQ#\]%_'Y*
M2T][T7!>CU&J@^%J&K$CR7V.LAM/0;K25\TY1'^'UB?KR=L/F!\=,;2.*S +
M#'^H3[A :E(5/IV[H%>YSU7@IA6-CWX&=]+Y&D4<X#4LX9+=L]W4[#X4=$-W
M!W+LS^*.'_3A5X5L9")9?0K\LHIW^'XWOVYH.(+&@857)JS3:PHWL)ED:P]U
MK=&EL]-P(4.TEOPWDLE&B9$6[X[!L>3)JZ4-HX@I/0Z27U8JO(=GHX;/9-2&
MCC$N5;5Y.2RO"C*%V_C>51MX"Z.FY38]SP;587XG5C^7KK<]X"T&?D1@]^0@
M\2X[LRI/H2*HG*O])YJUM&GQPR:;ILX=NZ,SYS;<A\UO)SXE+1C$*T2W3 H?
MQY0F<E!KBT,]OK5&H^PGO?8OE'UJXFP=?BF.TN.P-"_OMZ3TX ZG+T0QR-,'
M-\5 4BQ/#) E17@N<]K+,O+$*YT$;&:;;DGP$0.YE4J,;T6)Y53>;K6HP\O+
M- L$8Y![;W<^EYPPS9DT=1"X4#M/1;"P7\R29IM?VSE?ICJ#T;T>T^.O/5-"
MO<H4!T1KJ( IS-8Y3^'\TX65Y7+:V%X*4;N<ZBDX5BH&I.HKO51,XG!G&$6F
M]:?GYO+CLVG3*$H=7%@\%[/"V43#3H(J"_PYFJU4/HI;7RMLGDCKQ-SFCH$M
M^\M:<8\-3[Q&GFW(QWQDIC_VZL1O[0T>E#Z#T<>R4.SFH=&!8N?">/S&TC#2
M!1WKP'1EAH5MNC/&7GJ-3Z96VD%OU6TF6B(OEGEX-3>+@7VC40R\LABH<I&$
MC(B,G?Q#?^ XI'5RL!5I.>NX7M:I,TUHRLU;M(N#J* #TEM7&OEE)4[Y?.77
MV^>9J.YF=G>F([=AZ?W0I:A;K:P.7.HW8X'?0^4T\MO@^31BO6HWC\HB%MNN
MHGSWC*0S&C(_NE,DQ[_ +U3$8^2DNG)">+,((AP;\GJP=%D!_/#$6TO7SO)7
MN-;&+Z;N2UL>+UH3:4G<EGUKE76+GQ..E&K*%&[0)NNM!RRN04N[(S4WZBI+
MWN=.V9[QZ310-:_9]Z36[&$L%G/G#7L:U1)3YQ(27%#O=T#R?XD)].M+D'8Y
MLBU#Z_!3$VDSCWWY ,N?;,"DNT-/OJW )5]0*[TP_=:C;KZS;8J^:MG(KY_4
M'NV.8F/4VH/DG7ACW#&KU*"$L+@1.-&2RRHBUM\N4G>N@@H*-0B1/9^T9^U"
M5O5_-9$\Q0'=M823(YNQVTVF6#84CJ0B=*:/-ML$4-Y%5T>-W)Q/_P3=ZL7&
M&;5?K/6:+C09GWP=&T]HXFY*]DKL< T9SR9T7+YLFWA]LF^^A[9R#-Y>J?HY
M;$/U+"3B9(IH*)M,]@X<ZG>9-SM63&/5#OGQ?I#?IJWC3/JH7:>R[8.E;;V;
M\4['#ZDW/VHMSGZFWB(DV%Y:K&L&E1N%U@Y#W.V#92*+<J/F6S5U4I[GU)F;
M<34YNYC4-!)BP>1(IKWLJ%.8Z+,9)GE*IS5KZ&QCR^)UG/YP^D*XY-V@6/NK
M:\R]O7>20$MLEQE9GHNBH[+97$8&@C([W-]F,&@;/Z@ZH'VELF0LD[DH!J9(
M+#/LK+_4%BDX^8[(47(C)U+)8F#CZQTAH^&IP2GX<G\5+3&GOR.2>14.W[J1
MZTEFX3F28.=/6X69#WV^4($WVC,A8F@:?[O?=@GT^$KUQ(5><)O>3ZJ)PT-.
M5T%.X(O_DTEY.X&!2WO!,.@I18NU'+N%5BMEF%/@ 5C& V:4HLY413;O$U:]
MS&/&B5)=D;U^_L6_?\O_U13$$_\ 4$L#!!0    ( '63@5LN[^ %[Q,  "(5
M   0    =7!X:5]S,6EM9S$P+FIP9ZU7"334W]O_3I:QQ-B%,D2(I&3(-D/]
MD-"D0K)ERS)V*31CR%:R9DO**&N)28R]&3NE0O8ENU^6,"/+8)9W^I]W^Y_S
MON>\[WO>YWON/>=[[SWWWL_SG.?SN0]SE#D#"%PV-C4&0" 0<)OU <P)X"+
MP<XRMC\])P<')Q<?%Q<8S"7 >YB;3UA 1%A(0$A(1/R8A(C843$A(4DYR:/2
M4%E961$)>45Y&85C,K(R?S8!<7!R<H&Y(%Q<$!E1(5&9_[4QFP%!+L 8!&<#
M'0<."8+8!$',=@ * " .T#\,^%<#'6)CY^ $<W'S\+(6$ 2 0R VMD.L^[,
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M6%WEV>YV_AV8;+J+KZI>@P^8?B_7:#P2HUF3=DJ@4T=9J1F:6C9X%>2DS1C
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M><OF92=JFEI:.MHZ>CHZ>IN-#(PV_Z\-?@WHZP 'U6PUU+8"ZOIJ&OIJ< N
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MMR($CI'=+2]JL'.YX.=_ E!+ P04    " !UDX%;^8]&=.$3   G%@  #P
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M'24FD$DNL='&#H3U;*5OJI[.Y=J[B#D>9^(H+H>M5E2_[5ZE!G(<0B>G/L%
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ME05=6A=88[RL!V2=;?Y?# CN_0M02P,$%     @ =9.!6R[OX 7O$P  (A4
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MO^5^HS_VD"0F\@*WWB@!KQ,>RR<;F/M4@%J4@Z,-A/HM]=*Z:K^$6'2Q*4K
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M O"'#D#GS)XKY;-IW&&QPE<)UN Y8\_7D8?[_W\'35G_$.;8OP!02P,$%
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M>;WB=T ]L]YB8:JV_&IRK2&)1Y]UY3=KV P.Z55U'4__.)XY=],F)='V2=_
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MEI"4.!P$Q'[D""<')YB3$RPAR"<H\7\V1CW RPGH@\Q906< %EX0*R^(T01
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MMAEU88"F[VV85F0';0&3BF#GZ5PO*.;!B1DMN476BX.>*4I/\N^>T:3=_RD
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MHSU!Y]XO"MD+]7HH*2)[59^<+8^9U&&=?]CD^'O^,YIH1P'37TWP,UG@S*&
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M5$R@-H2JUA5_S=X)WO?@ZZ8,7&\1UM:PP "J!P->MNW<QZW<R1T5;\KU=3C
MO72M6,A]<A?C!PV$APJV<[=NVG-)!53.IH$6C:,".G1(.:J]UU27ORNIUVNY
M=E)B7Z5D]Q=_[=6VMLQB&SFNE.EZ2GT,QL$1MVSX7AWD) 3,78\5C0U!=W19
MFOVC\?Z!INPHAA/&D]Y2C7G')"\M'U-]^4C>%.BM]@S4/T3(3?WXP "8'!KH
MKQK>)VN](KV"S_?0UQ?HD.2([/@*QW _VW1EZ%W^Z QX^/4P6BJUDG/M!](B
MNZ^4**1U!=R@E9T\MIUQO](K\HGA\&XZ'I7P^F&L06Z-VG9RF5!= UI-;+05
M:Z+Q7&,483L3\"+TX\N!XN:"@&O^Z5U_HT#.+K]_4$S!#EG3!DV).Q1]K_#R
MSK2Q&Q3?W,[TU#6IA3>AXD.H5OOKV3L;#UYRX-X[53&1_8+V?L=:SUA]*$<Z
M]UD1/!SY2XPW?7N7]LH_'T8P .A5!D"6HN,6\SK_F_%QV$-83C+L^9:3$/V&
M.FQ[#4*/4S!M<O=LV0!5,0!L. /8XK6/61IH9P!<D2)&DVXHDK/!9'F$ZK@@
MPK]%-I0?RAT;M#^W@76J].BT%QZNN*+W.(SU-FKE]!(=A?&?DC4LAH4%KR;+
M(>#VRU^U+M'$C&[';?"I=]=##TKJ#KF<.&&-SN9_[<4MM9/]O$+X:UF:/?M8
M3#_T16Y%B049#?*H8::]27MV^(^'7*[PX!GPF91^A\)B$?V%JA*"W_I@@9)N
M/[RT/N?&M@QZ-@0KXD7QOIV]H31$TK?2-(OIV[.Q*C,O.?L^J3\SKR+D[ >L
MZCIER;Z+J"9W/DTW.4?T#1.]FP&<'L\"]VSG'&4NVT@WY!<P %!ED.-Z?D&%
M^[WK_XAG $H\(;24[7Z0X4,R1A<,]5+(Z;+X1X-'IF,XOWW"<X+GK,F/:/X]
M4:N'OUMXM05OM:4BT_UA4.<:=$C$&DBHQG. TKWY]<K$JIC;8&5[) FB>6BZ
M9^/WT,//]4'VSL?GDR9H7"!ZL2@A02N[J5/^1?;R_2#:7$+MBNON"SDT:G\^
M'CL85IF2C?]S^!>U0*B<_NCE+\K:D,7O>*55R1RM,# LG0&<0<- 2TFMJNF2
MN](,H%UM/FRW[V%825O54Z'+PJ\*)LXBN@_+C;RPUQ95:8YD2H\H,N/W-8<K
M=MCW![?CTQ[=A4%<^AOUS<K <!;MG-WRAI0S>1H;G;:))I:15:,*J52A)^[#
M(1I8B0;;];=V+EJ-239W$82Q2JM"LF+6=WD3Y7FLER\>;^:@(&CK:OM)RX15
M?NZ![)*#5&%%(J=LX2O1G:J)O"OV%AND&5.*[1XL%1/PTAD8DG#=,7I>8EHY
ML"\.L]^B.6?-(C^UO:O/K5E-=K4P[Y][@6H[.WF^C6A8ONCFR#V,K^T#RK)>
M(^LVK^V;[]((^S1R[.6")M-?=I:M^H:K:X,E2&.'>YBF"O6/BH+4"O-S;65)
M('W'3O"XJ"I?5=;?3D&6,><I8_>?]?*95%WB)NJPK1Y0K2E^ A'N"S[>NE/^
M.,7.[JWQ =A3>11/2#]J64)H&]- ^3INING@\]!L&,KGN9,H<(-K<W0:^-%C
M5O0"'CD'#NPS:W:Z[=50H:*X)O)"[HZ,VZ,0X>MQEXTF7/:%R/3&KPR@R#[9
MD@YO8J./P;9 %O6U/L_2??S>^?%\*8EP_6(4\AH5:,2;VI^,I&X=B:_NJ)W^
M!N\%-XARODLFD"SE?N/SGT1-POLV2Z-O?XI6*IU[=.=N7PO8)M0;.<0]N,VA
MZ"WQ0@/ID#A]RU77O_C7("VD[+@G<JA]W/QB-YZ"8?:\Y[=WDD_G\,'*3')S
M44DQID<AKR()@TM_)I%)0W]^L]1@W#@:4R9F. R^(-F=[_C6P)'WT[E(M/W8
MLENS9-V!4E>Z_W=BL6]=,JM=8O(C)FJIN(N _-F"FI]@R)6?>BJ!6E>V^B;0
MQH;6=<3U0^JFZ,MK@P?"K]#S4699OP:O0J$'%IK$JS1<V9J+Q'MK/S..3X=P
M!?4!LR%<N75]S88W9B=US%@D".HZV]K=%I^>01;X>H&.F"$?!=4??PWR":K6
MUM]49ZR!DYY[D%6T6HS>O>39XO!=#^/^*;1#IMD 0CFZ[O%"FJ84S<K2\6&N
MH_OB"@:+27/7.>6NR1,&E8ICFS#]KEZ)K=23H3$ ',?IR$S91M1I+F]CJ0 =
MJ8R+O&79@9$ FZK42M33SFL8BV&RT9GLV]^OEB;!+[DI[=[8U2Q#-Y_/BSYN
MC%W?\I&LR>](->H&,!U;_.*WO:AVBQ$Y6XL%NYI#"<*RS*^LRMGG^%VVMXGO
M%RV<>M2*1R >3012CK FDJU(;I5[P>KNL)K14N,7+>TNZ:@(BGI=3FIVV55_
M325RB@H)8[?O1FUXM:]BQRLGQNH(9AN/\Z*+,8!7+4=/W.F93OBLUE)UP@<O
M2TQEJ7M-ST4&8!!U(T#!C>L)I"%"= Y\=Y9ZT_\UML;V(U, #GEO.I)MH: =
M?!X;7SFOR0 *$F%;ELC1,XWERZPN.YC2;RD?ZSV9SWN?KF-*WUZQ*F( 3PH]
M!1?<JY]_/(7_>E:4Z4=S)%T@7RQ%A"A]2H@3<RK_P26"[JDD%=V%AK$WC<%-
M".5S+HU^H3FM6Z<U#Q><YMM=W7L1L[4(9:6OQ(YHJB!7[9&!O7QS1JR:EJ8R
ML8A_)GU*1EK$A/VP$UP=R:=3(=D=O-*^.@9O%Z]3J]$':WV^%"QL,7[+UK7W
MN^JHB2EM^ ..V7)22=QR]V4OJ62D$%U0'5]J:5]KI_JIW$ US8GB4--%G:J;
MYM%ACD)JQRO2S]=NAGA1;DVV[\N>*$H?"&4U'= H1*<47W@RCRO7J*SM41;)
MU\1L4!%G?=PT5IR%WAT565+5,<6.SKWXXV\(>[>?8H(7:)&#I#<N7(C6_J:4
M&C)X-]E/];XUI6HD^J]@2..#7X7HNM5N30<-).S9KFS%CXVYZ?Q(G.^"9_D[
M.UE1=DO(;G<AVNBORV?M<98^RIA3J7X1/IEV4-+?+:-W=)B1,L_6+ERWJ%1S
MR+XH=4^/^88DK";@A=8Q? %%R3MT5SUT-]3'(T X7,JIXME;\-S5?%RY)[G@
MYS"A3^I& C+'>M2 +$K7+$27KB;P-PYXGZLB)!<J;XSP]'^!^H9IK#YH?H0^
M:]%Z0.ZOHE'UP87SRI.+MUI^T:ZY9N50&4!L+KXO4K9XQ"D%=7L XTM4Q%N6
MAB/\=:X?;01M?PVL7J(T-1.#U9K=$]TW;O:6W2==GQ/N:Y8MK(F2)%L2JFJ?
M?FX;&^8)Y2I1#$3(2&4LY<H6$E(Z((R?_P102P,$%     @ =9.!6_F/1G3A
M$P  )Q8   \   !U<'AI7W,Q:6UG.2YJ<&?55WLX5&^[?H><DL8Q9Z.<*J'D
ME!\F%9(D]5-4FJ(2DH0HS%)"#B4IBC(I.>0P)4,)D^-028[C$,,,.6?&<9C#
M^E;?]^WO<%U[7]?>^[KV'_N9ZUU_K/6N]3[W_=S/_;X#]\!#0/* K;TM0*%0
MX SR W _V N$UB A^/LJ+"0D+"HA*BHB(BHIODY,0D925D9:4EI:5EY547:#
MR@9I:24-)14US,:-&V45-74TU;55U3>J__X(2DA86%1$%"TJBE:7DY93_Q\'
M_ E(B8)+J!V"J$U 0 HE*(6"ZP$& )00ZJ\!_AXH <$U0L(BHF)KQ9$))$D@
M@!(4%$#R1P @3R.0YV"-E)#TQAW6PC+.9T4V!<@:WDS.$M78\[9&[D@;4W.G
MQ]5;8FLWR"LH*FEIZVS>LM7(V,34;)?YWGTVMG;[[0\<_=/EV'%7MQ.>Y\Y?
M\+KH[1,8%'PM)/3ZC:C;T3&Q=^+B'Z0\?)2:]OA)^HN7V:]R<O/R7Y>\*R65
ME;__4%%;5]_02&EJ_MS>T=G53>WI[1NF,T9&?XZ-3TRRYN87%I>6V2NKOW&A
M@"#J/^(_Q26%X!) RK)&Y#<NE$#([PE2:X0V[A"6MG86.1L@L\GPIJCLGN2L
MMS5B&CN/,.4\KK:MW:!I-*S%^@WMK\C^>\!N_:^0_0/8/W'U@76"**1X@E(
M"SCZ\9N?"_R?CJ^=B\\,;-[YMG@>+NN828O2^UJ@--:AV2W/U4/':K(8=V5@
M(.@) R4PO;E0F;@A%'>HO6C185;*N[M;'CMY6?.#C3TTL*N&JVN.C2.O'TWV
M3&I<U?A#!1AXCO"#4-0V%T;JKA=N'LFG394?/1R1FI0(#"%(68CD#C1[13 D
MU ;I.V/O.335;5G0,$)U.Y\*96<Q1Q]O9C7>L8=!;@\,&BM.AF6$?7']Y:>O
M\3[&^H-67)0N^K"=<*1>VRD2#)*X4MF#EO=>T5NTVT?-0E]]M#EOQ;#X$\,L
MQ:MX\>W^-?W7)GW1T3\SR[O3WIPZ89@JTZ!^3H-ZA?ZFT$H]%'.T<U/' FW#
MA&E(BDG/4/R,XH]5@-:.-*_053[!4HL:[M%X3R4E6!IN.>EAV?E%(7!\9_>+
MMG"78;+T=4;=ZFAJWAE*QI);M^.3;SNC&J]<%+P1S^BGX^JZWF\WO6MT=K-?
MM 3]G$E HE>QKY,KRR[6 JMBZ-LWFOHXQ>NS;W[J#FUSADXZ&'CQIA0G$PK5
M.[=H1Q6Y3<:AQ#5.?"U9H_/<;,*-BI.J%/0,,7XVEFB4$';'-3O9_EI\4UV>
MAH42F,HKU'-H4,.T!8T;J^).EKQY]X&28EG_.4[;UK;=R2+0-H%.E&#?_VJ!
M+7:=C%EW_59W<,J%&UXB\<B2\2-$JTVA,D[5Z93#+'RR7["@[(,ME]O<%*ZI
M9TJ X-)C>DL?7TZD[^XV5CW2W>&X\>3,T0,;+$P'_DA2&?%X[6UEPDRZ8W W
M)I;N^(=SQ5I<<]E[-^6+DU?0!\#$Q>*CA]E10WX&AS.<.BO=LWL'/O6?B_'-
M/KYWW-KB3QRSM%H%^C[_ AJZ!#%VJT;+);UDIUBSUAF81!7V^ER,7>?GY6;"
MNQ):% \VO_CGT!TE)I!)+K'1Q@Z$]6RE;ZJ>SN7:NX@Y'F?B*"Z'K594O^U>
MI09R'$(GIS[!0(BHV7%ANX]YX:U:1=GA^]NU>L)F1.:)+<<\OMJ/I(-E,:P/
M,;']E*+=';W[,L\2O-3:5H\7<W?PB#D5G5GM>$W7FG6&DE%_OCN2A2Z,:U5C
MS!$3MU@W 'S#B8&3@R=L@KT-G=9\UKRW[U)!ON(:-7HQ]0OF+2U)?[%5:#)3
MO%/;^UR;VWG2MJO[T(2T<04,9[(Z]SDZ!NMG>62Q,F"X2N6'6<F]FEPIP;E9
M;]%M=L6RQV,N8L7"K],A(7=VG6U;0V."U\\5JO Y]^H3O_!BK0)5A*5N&#QX
M-0P#CA T<[R8,V3 ?6*7 (-?6C!XL2'2:G>[7K@-0\)I/S.3L*V\I#)&6?EX
MFFCBF*;^(7GMHM!^Y,WX:K7)[E5<@A$,WKBWRA.4Q.3FGFCL.A(6=9(@ (T,
MA2-=<]9LJ@L&?DXKNDHZO%NQ_,0;8(%XNWIS%X,7;V&-+W^@7+15N<=OU$OK
MT>[/0TN-OW09$H+6W1;N=%]'M/WM@<F0.;DXQ4^&)F(6A"QB8;44#)KC0FE\
M&K0@1!3B94(C= ME&.!B8;#;!]2P*'4X^?!=%27EK&OIV[2J;!_(21?\<E''
M5!PRIW832GX5Y4-UYJ%%U=UC'*N3A)*1D0;._1]X"ZHRQQ\&3;U#,%B=(\!@
M[XEQ&)PGKIC0U""J X&G+8MB_4K+F:S>S-(J2_,H"LF?W'F'L9[;K*$VLDHX
M,1X>R"QOI*T_ULQU?Q41>3I5TL,EHC^ @*P:'U+3NJ+'7X]PE(U952!F(VS
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M4$L! A0#%     @ =9.!6_&*R?BI> $ [P8)  L              ( !^RD
M '5P>&E?<S$N:'1M4$L! A0#%     @ =9.!6XU?O)P #0  R@T   \
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M   /              "  6(- @!U<'AI7W,Q:6UG-BYJ<&=02P$"% ,4
M" !UDX%;$ROG9G86  "/%P  #P              @ 'H'P( =7!X:5]S,6EM
M9S<N:G!G4$L! A0#%     @ =9.!6VZJ:414$0  ^A$   \
M ( !BS8" '5P>&E?<S%I;6<X+FIP9U!+ 0(4 Q0    ( '63@5OYCT9TX1,
M "<6   /              "  0Q( @!U<'AI7W,Q:6UG.2YJ<&=02P4&
/ !, $P":!   &EP"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>upxi_s1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="upxi-20251201.xsd" xlink:type="simple"/>
    <context id="From2025-12-01to2025-12-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001775194</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2025-12-01to2025-12-01" id="ixv-5132">0001775194</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2025-12-01to2025-12-01" id="ixv-5133">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2025-12-01to2025-12-01" id="ixv-5153">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2025-12-01to2025-12-01" id="ixv-5154">UPEXI, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-12-01to2025-12-01" id="ixv-5155">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-12-01to2025-12-01" id="ixv-5156">83-3378978</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-12-01to2025-12-01" id="ixv-5157">3030 North Rocky Point Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-12-01to2025-12-01" id="ixv-5158">Suite 420</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-12-01to2025-12-01" id="ixv-5159">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-12-01to2025-12-01" id="ixv-5160">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-12-01to2025-12-01" id="ixv-5161">33607</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-12-01to2025-12-01" id="ixv-5162">727</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-12-01to2025-12-01" id="ixv-5163">287-2800</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2025-12-01to2025-12-01" id="ixv-5164">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-12-01to2025-12-01" id="ixv-5165">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-12-01to2025-12-01" id="ixv-5166">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2025-12-01to2025-12-01" id="ixv-5167">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>upxi_ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="From2025-12-01to2025-12-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001775194</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <context id="Scties424iAxis_From2025-12-01to2025-12-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001775194</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:Scties424iAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <context id="OfferingAxis_From2025-12-01to2025-12-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001775194</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FeeExhibitTp contextRef="From2025-12-01to2025-12-01" id="ixv-369">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:SubmissnTp contextRef="From2025-12-01to2025-12-01" id="ixv-370">S-1</ffd:SubmissnTp>
    <dei:EntityCentralIndexKey contextRef="From2025-12-01to2025-12-01" id="ixv-371">0001775194</dei:EntityCentralIndexKey>
    <ffd:FormTp contextRef="From2025-12-01to2025-12-01" id="fid_b87899e1">S-1</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="From2025-12-01to2025-12-01" id="ixv-406">Upexi, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg
      contextRef="Scties424iAxis_From2025-12-01to2025-12-01"
      id="fid_819a96cd">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="OfferingAxis_From2025-12-01to2025-12-01"
      id="fid_71f4cc4a">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="Scties424iAxis_From2025-12-01to2025-12-01"
      id="fid_e5a841a9">Common Stock, par value $0.00001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg
      contextRef="OfferingAxis_From2025-12-01to2025-12-01"
      id="fid_70cbf21d">false</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="OfferingAxis_From2025-12-01to2025-12-01"
      decimals="0"
      id="fid_53eaf3f8"
      unitRef="USD">6578948</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="OfferingAxis_From2025-12-01to2025-12-01"
      decimals="INF"
      id="fid_d9a5ac74"
      unitRef="USD">2.8</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="OfferingAxis_From2025-12-01to2025-12-01"
      decimals="INF"
      id="fid_9eb473f0"
      unitRef="USD">18421055</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="Scties424iAxis_From2025-12-01to2025-12-01"
      decimals="INF"
      id="fid_bf1e0cd6"
      unitRef="Pure">0.0000013810</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="Scties424iAxis_From2025-12-01to2025-12-01"
      decimals="INF"
      id="fid_5692a200"
      unitRef="USD">2544</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="From2025-12-01to2025-12-01"
      decimals="INF"
      id="fid_bce6ae62"
      unitRef="USD">18421055</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="From2025-12-01to2025-12-01"
      decimals="INF"
      id="fid_97e183de"
      unitRef="USD">2544</ffd:TtlFeeAmt>
    <ffd:NetFeeAmt
      contextRef="From2025-12-01to2025-12-01"
      decimals="0"
      id="fid_7ba93d01"
      unitRef="USD">2544</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="OfferingAxis_From2025-12-01to2025-12-01"
      id="fid_d8436ac9">&lt;table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:4%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;(1)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), the securities being registered hereunder include such indeterminate number of additional shares of Common Stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or other similar transactions.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;(2)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;Consists of 3,289,474 shares of Common Stock registered for sale by the selling stockholder named in this registration statement and 3,289,474 shares of Common Stock issuable upon the exercise of Warrants for $4.00 per share registered for sale by the selling stockholder named in this registration statement.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;(3)&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Pursuant to Rule 457(c) under the Securities Act of 1933, and estimated solely for the purpose of calculating the registration fee, the proposed maximum offering price per share of the Common Stock covered by this Registration Statement is estimated to be $2.80, which is the closing price per share of Common Stock as reported on Nasdaq as of November 26, 2025.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
